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ABSTRACT 
 Over billions of years, organisms have organized chemical reactions into metabolic 
pathways to sustain life. However, metabolic substrates can undergo many uncatalyzed, extra-
metabolic reactions. Acetyl phosphate (AcP), an intermediate of the acetate fermentation 
pathway in E. coli, is one such metabolite that has been shown to non-enzymatically acetylate 
hundreds of proteins. This diverse set of targets suggests that acetylation could be a way for the 
cell to sense its nutritional status and regulate protein activity accordingly. However, how E. coli 
regulates acetylation, if at all, is unknown. 
 Previous work showed that acetylation becomes pronounced in stationary phase cells. I 
determined that acetylation only increases once the culture enters stationary phase and continues 
to accumulate until carbon source depletion. Mass spectrometry indicated that the accumulation 
results from both additional lysine residues becoming acetylated and an increased ratio of 
acetylated to unacetylated isoforms. I performed anti-acetyllysine western blot analysis and 
metabolite measurements that suggested acetylation does not accumulate during exponential 
phase because 1) acetylated isoforms are diluted into nascent proteins and 2) glucose is not 
consumed until stationary phase. Additionally, I found that acetylation required rapid flux of 
carbon into the cell and through glycolysis. These data suggest that AcP-dependent acetylation is 
an unavoidable consequence of fermentation. I hypothesized that there is a physiological 
relevance to AcP-dependent acetylation such as utilization of acetylation as a carbon source or as 
protection against non-enzymatic protein damage, but I was unsuccessful in showing any effect.
 xvi 
In addition to non-enzymatic acetylation, one lysine acetyltransferase (KAT), YfiQ, had 
been described in E. coli. I recognized that acetylation could occur without AcP or YfiQ. Indeed, 
I identified four proteins that produced acetylated bands in a strain lacking both mechanisms of 
acetylation. Variants of these proteins with conserved catalytic residues changed to alanine did 
not produce these acetylated bands, consistent with these proteins having KAT activity. One of 
these KATs, YiaC, inhibited migration in soft agar dependent on its KAT activity. To determine 
targets of these KATs, we determined proteins whose acetylation increased upon overexpresson 
of each of these proteins. Thus, this work opens new avenues of study to determine the 
regulatory potential of acetylation by these KATs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1 
CHAPTER ONE  
LITERATURE REVIEW 
Introduction 
The two competing theories for the origin of life (metabolism-first and gene-first) assert 
that abiotic chemical reactions were the progenitors of biotic life. These chemical reactions 
formed the basis for metabolism and provided building blocks for both RNA and protein 
synthesis. Over millions of years, cells formed and then evolved and, in doing so, generated the 
diversity of life we observe today. Across phylogeny, the core metabolic pathways necessary for 
life have been well conserved (1). In these pathways, anabolism and catabolism generate a 
multitude of different metabolites. The potential chemical reactions in which these metabolites 
can participate greatly exceed the metabolic requirements. Indeed, these “extra-metabolic” non-
enzymatic reactions can and do occur, which results in the production of toxic compounds and 
causes damage to macromolecular structures within cells (2).  While cells have evolved means of 
controlling the damage incurred by these deleterious chemistries, it is thought that accumulation 
of this damage may be a prototypic driver of aging (3). 
Despite the constant possibility for damage to occur because of their own metabolism, 
bacteria have survived and evolved to adapt to various niches. However, these environments are 
rarely constant outside of a laboratory setting, and bacteria will often face adverse conditions. In 
these niches, one of the major challenges is acquisition of nutrients necessary to grow and divide. 
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While some nutrients like carbon may be readily abundant, other nutrients can be scarce, 
like iron sequestered by a host (4). These conditions may come on suddenly, so the bacteria must 
respond accordingly or perish. While transcription and translation are time- and energy-intensive 
processes, post-translational control of protein function can rapidly alter cellular physiology and 
permit fitness or survival in otherwise suboptimal or lethal conditions. While small ligands may 
allosterically regulate proteins in a reversible manner, covalent chemical modification of the 
existing proteome also occurs, a process that may or may not be reversible. These chemical 
modifications of the proteome are called post-translational modifications (PTMs). With hundreds 
of PTMs known and more being discovered, understanding how these modifications interact 
with one another and affect protein function are critical to generating a complete picture of the 
cell. 
 Of these hundreds of PTMs, many occur on lysines, including propionylation (5), 
butyrylation (5), crotonylation (6, 7), succinylation (8), malonylation (9, 10), glutarylation (11), 
2-hydroxyisobutyrylation (12), β-hydroxybutyrylation (13) and Nε-lysine acetylation, which is 
becoming recognized as a prominent modification that is conserved across phylogeny (14, 15). 
While lysine acetylation is best understood as an activating modification of eukaryotic histones 
(16), extensive study into the role of lysine acetylation in bacteria only began about a decade 
ago. While acetylation of certain lysines may have a clear consequence, such as inhibition of 
enzyme activity due to modification of an active site, the functional importance of many 
acetyllysine modifications are more difficult to discern. To uncover the role of lysine acetylation 
in these unclear cases, it is helpful to use a model bacterium (e.g., Escherichia coli) with a vast 
knowledgebase of pathways, protein structure-function relationships, and physiology. 
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 This first chapter will detail what is known about lysine acetylation in bacteria with some 
attention paid to eukaryotic acetylation for context. I will begin by describing the different types 
of acetylation, the mechanisms of lysine acetylation, and some of the known effects of 
acetylation on protein function. Then, I will describe metabolism in E. coli, as it is required to 
generate both acetyl coenzyme A and the predominant acetyl donor, acetyl phosphate. Finally, I 
will describe the behavior of E. coli in stationary phase, as this is the phase of growth when we 
observe the most elevated levels of acetylation. 
Acetylation 
Acetylation – From Small Molecules to Proteins 
Acetylation is simply the transfer of an acetyl group (CH3CO) onto a molecule. These 
acetylation reactions can occur on small molecules and metabolites, or they can occur on 
proteins. The acetyl group can be added to a variety of atoms on the target molecule. The atom to 
which the acetyl group is attached is usually denoted in the name of either the final molecule or 
the enzyme that performs the acetylation. These atoms can be sulfur, oxygen, carbon, and often 
nitrogen.  
Multiple metabolic pathways require the transfer of acetyl groups from one metabolite to 
the next. For example, N-acetylglutamate synthase catalyzes acetylation of L-glutamate, the first 
step in arginine biosynthesis (17). Acetylation of multiple aminoglycoside antibiotics has been 
reported to inactivate their bactericidal or bacteriostatic activity (18-20). For example, the gene 
commonly used to confer resistance to chloramphenicol encodes a protein called 
chloramphenicol acetyltransferase (19). This protein adds two acetyl groups onto 
chloramphenicol to generate 1,3-diacetyl chloramphenicol. The acetylated antibiotic is unable to 
inhibit translation because it no longer can bind to the 23S ribosomal RNA of the 50S ribosomal 
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subunit (21). The chitin of insects, plants, and fungi and the peptidoglycan of the bacterial cell 
wall are composed of complex polysaccharides (22). These polysaccharides often contain 
monomers such as N-acetylglucosamine (GlcNAc) and N-acetylmuramic acid (MurNAc), which 
are monosaccharide derivatives acetylated on the primary amine (N) group, as their names 
suggest. However, these can be further acetylated on hydroxyl groups to increase resistance to 
degradative enzymes, such as lysozyme and autolysins (22). 
 The most widely studied protein acetylations occur on amino groups, although 
acetylations on serine, threonine, and histidine residues of proteins have recently been detected 
(23-26). The two varieties of amino group acetylations that occur on proteins are lysine 
acetylation (Nε-acetylation) and N-terminal acetylation (Nα-acetylation). Lysine acetylation will 
be discussed in more detail below. Nα-acetylation is very common in eukaryotes, but rare in 
bacteria with only 47 proteins N-terminally acetylated in E. coli and 117 in Pseudomonas 
aeruginosa (27, 28). It occurs either on the free amino group of methionine or on the exposed 
amino acid after cleavage of the N-terminal methionine. The modification is usually co-
translational in eukaryotes but post-translational in bacteria, mitochondria, and chloroplasts, as 
the methionine first must be deformylated (29). Nα-acetylation has been shown to alter protein 
stability in eukaryotes and is typically irreversible (30, 31). E. coli encodes three proteins that 
have demonstrated Nα-acetyltransferase activity: RimI, RimJ, and RimL. The only known 
targets of RimI, RimJ, and RimL are the ribosomal proteins S5, L12, and S18, respectively (32, 
33). The exact physiological effects of Nα-acetylation in E. coli are not known. There is 
evidence that RimJ plays a role in ribosome assembly, but it is not known whether this 
phenotype requires the Nα-acetyltransferase activity of RimJ (32, 34). RimJ also plays a role in 
transcriptional regulation of the P pilus of uropathogenic E. coli, but the specific target and 
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whether Nα-acetyltransferase activity is required remain unknown (35, 36). One defined role for 
Nα-acetylation comes from the ESAT-6 virulence factor of Mycobacterium tuberculosis. 
Cleavage of the N-terminal methionine of ESAT-6 reveals a threonine, which is then acetylated 
on the amino terminus. This acetylation alters protein-protein interactions with the binding 
partner CFP-10, which attenuates virulence (37-39). 
 Until recently, the only known internal residue that could be acetylated was lysine. 
However, recent work of a few groups found that a family of bacterial effector molecules from 
certain pathogenic species can acetylate serine, threonine, and histidine in addition to lysine 
residues. In some Yersinia species, YopJ can act as an acetyltransferase to modify serine and 
threonine residues of kinases in mammalian host cells to subvert host immunity (24-26, 40). 
Similarly, HopZ3, a YopJ family member from the plant pathogen Pseudomonas syringae, can 
acetylate plant proteins on lysine, serine, threonine, and histidine residues, as well as bacterial 
effector proteins AvrB and AvrB3 (23). In both cases, the acetylation by YopJ or HopZ3 
prevents effective immune signaling, which results in successful bacterial infection.  This does 
not appear to be an exclusively inter-kingdom modification, because O-acetylation of serine and 
threonine was found to occur on a proteome-wide scale in M. tuberculosis (41). Finally, O-
acetylation of a single serine (S608) in acetyl-CoA synthetase (Acs) regulates the ability of a 
neighboring lysine (K610) to be acetylated in Streptomyces lividans (42). The discovery of these 
unusual acetylated residues opens new questions concerning the prevalence of these 
modifications and their potential interaction with other PTMs. 
Nε-Lysine Acetylation 
Nε-lysine acetylation (hereafter acetylation) is the donation of an acetyl group onto the 
epsilon amino group of the lysine sidechain (Fig. 1). Acetylation increases the size of the side 
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chain and neutralizes the positive charge (+1 to 0). Losing the positive charge and increasing the 
size of lysine disrupts salt bridges and introduces steric bulk that can alter protein-protein 
interactions, protein-DNA interactions, stability, and enzymatic activity (43-45). This was first 
and extensively studied in the context of the histone code (46), where acetylation of the lysine 
rich C-terminal tail reduces protein-DNA binding. This remodels chromatin to activate gene 
transcription (16, 47-49). However, recent mass spectrometric studies of acetylation have 
detected acetylation in all three domains of life (50-53). The first acetylome in a bacterium was 
reported in 2008 (54); since then >50 bacterial acetylomes have been reported (Table 1). As 
mass spectrometric techniques and software have improved, the breadth of targets modified by 
acetylation has expanded. It is now clear that the extent of acetylation, the mechanisms by which 
acetylation occurs, the identities of acetylated proteins, and the locations of acetylation on those 
proteins can vary between organisms; yet, in most cases, there is great conservation among the 
identities of the lysines being acetylated (55). 
It is well known that acetylation can be catalyzed by a lysine acetyltransferase (KAT) 
that transfers the acetyl group from acetyl-CoA (AcCoA) onto the target lysine residue. 
However, evidence has accumulated showing that non-enzymatic acetylation is also possible. In 
vitro, AcCoA and the bacterial metabolite acetyl phosphate (AcP) can non-enzymatically 
acetylate lysine residues. In vivo, the impact that AcP has on the consortium of acetylated 
proteins, the acetylome, has been assessed in multiple bacteria. In the cases of E. coli (56, 57), 
Bacillus subtilis (58), and Neisseria gonorrhoeae (59), it is the predominant acetyl donor.  
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Figure 1. Two Mechanisms of Lysine Acetylation in E. coli. Acetyl phosphate can non-
enzymatically acetylate lysine, while Acetyl-CoA can acetylate a lysine with or without a lysine 
acetyltransferase (KAT). Some acetylations are reversed by a lysine deacetylase (KDAC). 
  
 While multiple families of acetyltransferases have been described, all bacterial 
acetyltransferases discovered thus far are part of the Gcn5-related N-acetyltransferase (GNAT) 
family (60-62). Thus, the subset of acetyltransferases that have KAT activity are also GNAT 
family members. In E. coli, there is only one known KAT, YfiQ (also called Pat, PatZ or Pka) 
(63). Homologs of YfiQ exist in many bacterial species, but as described below, additional 
KATs with distinctly different structures have been identified.
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Table 1. List of archaeal, bacterial, and some simple eukaryotic acetylomes 
   
Conditions assessed 
  
Ref. Organism(s)a Mutants assessed 
Time/Growth 
phaseb 
Media 
# of 
lysines 
# of 
proteins 
(55) 
48 bacteria from Proteobacteria, 
Firmicutes, Bacteroidetes, 
Actinobacteria, Cyanobacteria, 
and Fibrobacteres 
None See (55) Table S1 24397 9107 
(64) 
Acinetobacter baumannii ATCC 
17978 
None SP MHB 551 411 
(65) Aspergillus flavus CA43 None 48 hours PDA-cellophane 1383 652 
(66) Bacillus amyloliquefaciens DSM7 None EP LB 3268 1254 
(67) Bacillus nematocida B16 None 12 hours 
Solid LB with or 
without nematode 
incubation 
529 349 
(68) Bacillus subtilis 168 None SP LB 332 185 
(58) Bacillus subtilis 168 None 0.5 OD (EP) 
Minimal medium with 
glucose 
1355 629 
(69) Bacillus subtilis 168 None 
Multiple conditions from previous mass 
spectrometry runs 
4893 1277 
(70) Bacillus subtilis 3610 pta, acuA SP 
LB with 1% glycerol 
and 100 μM manganese 
1172 826 
(71) Bacillus subtilis BD630 None EP and SP 
Minimal glucose 
medium 
2372 841 
(72) Borrelia burgdorferi B31-A3 pta, ackA EP and SP BSK-II medium 199 68 
(73) Clostridium acetobutylicum None 
EP, transition, 
and SP 
Defined medium 458 254 
(74) 
Corynebacterium glutamicum 
ATCC13869 
None 9 hours 
Glutamate-producing 
medium +/- Tween 40 
1328 288 
(75) 
Cyanobacterium Synechococcus 
sp. PCC 7002 
None 
EP (under 
various stresses) 
A+ medium 1653 802 
(76) Erwinia amylovora  None SP MBMA minimal 141 96 
  
  
 
9
 
Ea1189, Ea273 medium 
(77) Escherichia coli BL21 cobB SP 2XYT 2206 899 
(78) Escherichia coli BW25113 None 
EP and SP 
SP 
TB7/glucose 
TB7 
2813 780 
(56) 
Escherichia coli  
BW25113, BL21, MG1655 
yfiQ, cobB, ackA, 
pta 
EP and SP 
Growth arrested 
M9/glucose 
Nitrogen limited 
M9/glucose 
8284 1000 
(79) Escherichia coli DH10 None EP LB 1070 349 
(80) Escherichia coli DH10B None EP 
M9/glucose/lysine/ 
arginine 
2803 782 
(50) Escherichia coli DH5α None EP LB 138 91 
(57) Escherichia coli MG1655 
ackA, pta ackA, 
cobB, yfiQ 
1 OD (EP-SP 
transition) 
TB7 and TB7/glucose 2730 806 
(81) 
Escherichia coli MG1655  
and BW25113 
MG1655: cobB  
BW25113: ackA, 
pta 
EP and SP 
EP 
M9/glucose/lysine/ 
arginine 
3669 
Not 
stated 
(54) Escherichia coli W3110 None EP and SP LB 125 85 
(82) Escherichia coli BW25113 yfiQ, cobB 
EP and SP 
EP 
Steady state 
Minimal glucose batch 
Minimal acetate batch 
Glucose chemostat 
2502 809 
(83) Geobacillus kaustophilus 7263 None SP Difco nutrient broth 253 114 
(84) Haloferax mediterranei None EP MG medium 1017 643 
(85) Mycobacterium abscessus GZ002 None EP 
Middlebrook 7H9 
medium 
459 289 
(86) 
Mycobacterium smegmatis MC2 
155 
None 
EP, early SP, 
and middle SP 
Middlebrook H79 
liquid with 10 mM 
glucose 
146 121 
(87) 
Mycobacterium tuberculosis 
H37Ra 
None EP and SP 
Middlebrook 7H9 
liquid culture medium 
226 137 
(88) 
Mycobacterium tuberculosis 
H37Ra 
None 
EP 
 
3 weeks 
Middlebrook 7H9 
aerobically 
Middlebrook 7H9 
441 
111 
286 
83 
  
  
 
1
0
 
 anaerobically 
(89) 
Mycobacterium tuberculosis 
H37Rv 
None EP 
Middlebrook 7H9 
medium 
1128 658 
(90) 
Mycobacterium tuberculosis 
H37Rv 
None 12 days (EP) 
7H9 broth aerobically 
and anaerobically 
1215 679 
(41) 
Mycobacterium tuberculosis  
L7-35, L7-28, and H37Rv 
None 32 days 
Middlebrook 7H10 
plates 
141 109 
(91) Mycoplasma pneumoniae M129 
pnkB, hprK, prpC 
Mpn027, Mpn114 
EP Hayflick medium 719 221 
(59) Neisseria gonorrhoeae 1291 ackA Overnight 
IsoVitaleX-
supplemented GC broth 
2686 656 
(92) Porphyromonas gingivalis W50 None SP BHI 130 92 
(27) Pseudomonas aeruginosa PA14 None 24 hours 
Minimal glucose 
medium 
430 320 
(93) Pseudomonas aeruginosa PA14 None SP (24 hours) 
Minimal medium with 
citrate, glucose, 
glutamate, or succinate 
1102 522 
(94) 
Rhodopseudomonas palustris 
CGA009 
ldaA srtN, ldaA 
srtN pat, ldaA srtN 
pat katA 
0.5 OD 
Photosynthetic medium 
with benzoate 
32 24 
(95) 
Saccharomyces cerevisiae 
BY4742 
rpd3 EP 
Synthetic complete 
medium 
2878 1059 
(96) 
Saccharopolyspora erythraea 
NRRL233338 
None EP TSBY 664 363 
(97) 
Salmonella enterica 
Typhimurium ATCC 13311 
Ciprofloxacin 
resistant vs WT 
EP LB 1259 631 
(63) 
Salmonella enterica serovar 
typhimurium LT2 (G2466) 
pat, cobB EP 
M9/glucose and 
M9/citrate 
235 191 
(98) 
Spiroplasma eriocheiris  
TDA-040725-5T 
None EP R2 medium 2567 555 
(99) Staphylococcus aureus 209P None 24 hours Cell medium 1361 412 
(100) Streptococcus pneumoniae D39 None EP THY medium 653 392 
  
  
 
1
1
 
(101) Streptomyces griseus IFO13350 None 
SP 
Sporulation 
Liquid TMPD medium 
Solid YMPD medium 
162 134 
(102) 
Streptomyces roseosporus 
NRRL15998 
None EP (3 days) F10A medium 1143 667 
(103) 
Sulfurospirillum halorespirans 
DSM 13726 
None 
Early and late 
EP 
Defined mineral 
medium 
Not 
stated 
640 
(104) Synechocystis sp PCC 6803 None EP BG11 medium 776 513 
(105) Thermus thermophilus HB8 None SP TT broth 197 128 
(106) Toxoplasma gondii RH strain None 
64-128 
parasites/vacuol
e 
Infected hTERT+HFF 
cells in DMEM 
411 274 
(107) Toxoplasma gondii RH strain None 95% host lysis 
Infected hTERT+HFF 
cells in DMEM 
571 386 
(108) Trichophyton rubrum None 
Conidia 
Mycelia 
PDA 
Sabouraud liquid 
medium 
386 
5414 
285 
2335 
(109) Vibrio cholerae V52 None EP and SP LB 3402 1240 
(110) Vibrio parahemolyticus O3:K6 None 8 hours High salt LB 1413 656 
 
aOrganism species and strains bExponential phase (EP) and Stationary phase (SP) 
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Acetyltransferases in Bacteria 
 Multiple families of acetyltransferases have been discovered since the initial finding that 
an acetyltransferase can inactivate aminoglycoside antibiotics (111). Most of these families have 
been discovered in relation to histone acetylation in eukaryotes. The two major families of 
acetyltransferases are the GNAT and MYST families (112, 113). Two smaller groups of 
acetyltransferases known as p300/CBP family and SRC family also exist, as well as the unique 
acetyltransferases TAFII250, TFIIIC, Rtt109, and CLOCK (114-117). The mechanisms of these 
acetyltransferases vary. While GNATs form a ternary complex allowing a direct transfer of the 
acetyl group, the MYST family can either use this ternary complex mechanism or utilize a ping-
pong mechanism that generates an acetylated KAT intermediate (118). In contrast to these larger 
families, the p300/CBP family has been shown to use a sequential mechanism called a Theorell-
Chance mechanism (119). Since only GNATs are present in bacteria, we will focus on them. 
In bacteria, GNATs were first characterized as aminoglycoside N-acetyltransferases (120, 
121) and, to date, every acetyltransferase discovered in bacteria belongs to the GNAT family. 
These GNATs are present across bacterial phylogeny (122) and modify a wide range of 
substrates, including proteins and small molecules/metabolites (113, 123, 124). They are 
generally small, AcCoA-binding proteins that share low sequence identity, but share a 
characteristic fold by which they are identified (125). The number of GNATs contained in a 
given genome can vary wildly with Listeria monocytogenes containing ~14 GNATs and 
Streptomyces lividans containing ~72 GNATs (126). 
The lysine acetylation reaction commonly occurs in a ternary complex between the 
substrate, AcCoA, and the GNAT, or more specifically KAT. There are three key steps to this 
acetylation reaction: 1) deprotonation of the target lysine, 2) nucleophilic attack of the lysine on 
13 
 
the carbonyl carbon of the acetyl group of AcCoA, and 3) protonation and dissociation of CoA 
(113). Within the catalytic pocket of the KAT, there is often a catalytic glutamate that acts as a 
general base to deprotonate the target lysine. In the namesake Gcn5 enzyme of yeast, this 
glutamate is E173, which can be found conserved in many of the bacterial GNATs (127-129) and 
some MYST family members in eukaryotes (118, 130). However, in the absence of this 
conserved glutamate, it is hypothesized that a series of residues form a water channel instead to 
create a “proton wire” whereby protons are carried away from active site to other residues or to 
the solvent (131). Once the lysine is deprotonated, it can perform a nucleophilic attack on the 
carbonyl carbon of AcCoA, which is bound to the KAT via a positively charged patch that 
coordinates the CoA moiety via pyrophosphate and pantothenate moieties (116, 119, 128, 132, 
133). The newly acetylated substrate dissociates from the KAT, but for the CoA to dissociate, it 
must first be protonated. Often, a tyrosine in the active site donates a proton to the thiolate of 
CoA. 
The GNATs can be categorized into three main classes based on sequence length and 
number of GNAT domains present that are subdivided into five types based on domain identities 
and arrangements. Class I GNATs (Types I-III) are large, multi-domain enzymes with a single 
GNAT domain. Class II GNATs (Type IV) are smaller enzymes composed of a single GNAT 
domain. Class III GNATs (Type IV) have multiple GNAT domains (Christensen et al 2019, 
accepted).  
Within Class I, there are two families: Class Iα (NDP-forming acyl-CoA synthetase 
domain and a GNAT catalytic domain) and Class Iβ (effector/regulatory domain and a GNAT 
catalytic domain). If a Class Iα GNAT encodes the GNAT domain at the C-terminus, this 
enzyme is considered Type I, but if it the GNAT domain is at the N-terminus, it is considered 
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Type II (134). YfiQ of E. coli and its homologs are members of Type I (135), while PatA of 
Streptomyces lividans and its homologs in other actinomycetes are members of Type II (136). 
The NDP-forming acyl-CoA synthetase domain of both Type I and Type II is a major target of 
regulation via acetylation, as will be discussed below. These large NDP-forming acyl-CoA 
synthetase domains lack catalytic activity because a catalytic histidine is mutated (137, 138), but 
they can still bind AcCoA, which may have regulatory implications.  
In Class Iβ (Type III), three different types of regulatory domains have been found fused 
to the classical GNAT catalytic domain: an amino acid binding domain (ACT), a cAMP binding 
domain, and an NADP+ binding domain (139-142). In mycobacterial species, Type III GNATs 
have an N-terminal cyclic AMP (cAMP) binding domain fused to the small C-terminal GNAT 
domain. Binding of cAMP to the N-terminal domain has been shown to enhance KAT activity of 
these Type III GNATs (140, 141, 143, 144). In the case of Pat from Mycobacterium tuberculosis, 
the active site is blocked via auto-inhibition until cAMP is bound (145). Type III GNATs found 
in Actinobacteria have been shown to be regulated by amino acid binding. First described in 
Micromonospora aurantiaca, these GNATs have an N-terminal ACT domain attached to the C-
terminal GNAT domain (146). ACT domains are regulatory domains that respond to amino acids 
and are often found attached to metabolic enzymes. There appear to be two main subclasses of 
these ACT-GNAT enzymes: those that have enhanced activity in the presence of cysteine or 
those that have enhanced activity in the presence of asparagine (139). Addition of cysteine to 
PatA was shown to cause a conformational change with a subsequent decrease in the Km for a 
substrate protein, Acs. Another Type III GNAT that appears unique is the Pat enzyme of 
Myxococcus xanthus which contains a Rossmann fold that binds and responds to NADP+ (142). 
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Whether this domain structure exists outside of M. xanthus or is truly unique remains to be 
determined. 
Class II GNATs (Type IV) are minimal enzymes that consist solely of the GNAT 
domain. While these enzymes are smaller than members of the other types (150-200 amino acids 
long), they appear able to perform the same functions. Bacillus subtilus AcuA (147), 
Saccharopolyspora erythraea SacAcuA (148), Rhodopseudomonas palustris RpKatA (94), 
Sulfolobus solfataricus Pat (51, 149), S. enterica TacT (150), and M. tuberculosis Rv2170 (151) 
are each members of this class. The M. tuberculosis Rv2170 KAT protein was found to acetylate 
key lysine residues on isocitrate dehydrogenase (ICDH), which results in a reduction of ICDH 
activity (151). TacT (STM3651) from S. enterica is the toxin protein of the TacAT 
toxin/antitoxin system, which acetylates amino acyl tRNAs (152) and Lys44 of its own TacA 
antitoxin pair (150). Recently, four new Class II GNATs from E. coli have been identified 
(YiaC, YjaB, RimI, and PhnO), and they appear to acetylate a wide range of protein substrates 
(153). 
Finally, the only Class III (Type V) GNAT is the enhanced intracellular survival (Eis) 
from M. tuberculosis (154-156). This Class III KAT was initially discovered as an 
aminoglycoside acetyltransferase (157, 158), but it also has protein acetylation activity, 
acetylating over thirty lysine residues on an M. tuberculosis nucleoid-associated protein (MtHU 
or HupB) (154) and acetylating Lys55 of host macrophage dual-specificity protein phosphatase 
16/mitogen-activated protein kinase phosphatase-7 (DUSP16/MKP-7) (156). 
While KATs and GNATs are typically associated with and studied in the context of 
acetyl groups, the capabilities of these proteins may extend beyond acetylation. Pat from 
Salmonella enterica could catalyze the propionylation of propionyl-CoA synthetase (PrpE) using 
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propionyl-CoA instead of AcCoA (159). In E. coli, overexpression of YfiQ results in increased 
propionylation (160). Though these results are not direct evidence for YfiQ-dependent 
propionylation in E. coli, based on the S. enterica data, it follows that E. coli YfiQ could catalyze 
some of these propionylations. Utilization of an additional acyl-CoA substrate may not be 
entirely surprising because binding of AcCoA occurs via interactions with the pyrophosphate and 
pantothenate moieties of CoA with no discernable contribution of the acetyl group. It is due to 
this binding that these acyl-CoA thioesters are bound with high affinity but low specificity (131, 
161). Thus, it is worth considering the possibility that these acetyltransferases are 
acyltransferases. This makes even more sense in the context of sirtuins (NAD+-dependent 
deacylases) that appear to have broader specificity than originally determined, as discussed 
below. 
YfiQ, the Only Known Acetyltransferase in E. coli and S. enterica 
There are 26 genes encoding GNATs or putative GNATs in E. coli and S. enterica, and 
of these, only half have known functions (113, 126, 162). Three of these, RimI, RimJ, and RimL, 
acetylate the α-amine group at the N-terminus of the ribosomal proteins S18, S5, and L12, 
respectively (32, 33). However, the only Nε-lysine acetyltransferase in E. coli prior to this work 
was YfiQ (also known as PatZ or Pka) (63). This protein was first characterized via its homolog, 
Pat, in S. enterica, which is 96% similar and 92% identical (163), and homologs exist in 
Rhodopseudomonas palustris, Vibrio species, cyanobacteria, and more (126, 164). YfiQ is a 
Type I GNAT and, as such, contains a large (~700 amino acid) N-terminal domain attached to a 
smaller (~200 amino acid) GNAT domain at the C-terminus. While the exact role of the large N-
terminal domain is not clear, there is evidence it plays a regulatory role. Indeed, YfiQ can be 
regulated both post-translationally and transcriptionally. 
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Mutations within the N-terminal domain of the YfiQ homolog of S. enterica reduce 
activity (165), while deletion of the N-terminal domain completely inactivates the enzyme (166, 
167). As mentioned above, this large domain looks like an NDP-forming acyl-CoA synthetase 
(Pfam 13380), but is unable to catalyze the synthetase reaction due to the lack of a catalytic 
histidine (166). As the normal enzymatic activity of an acyl-CoA synthetase is reversible 
interconversion of acyl-CoA and free acid, YfiQ/Pat is still capable of binding AcCoA. Thus, 
there are two sites of AcCoA binding per YfiQ enzyme, one in the N-terminal domain and one in 
the GNAT domain (166-168). Pat was found to oligomerize and form tetramers in response to 
AcCoA (166). YfiQ can also form tetramers in vitro; however, it favors formation of octamers in 
the presence of high concentrations of AcCoA (167). It is at these high AcCoA concentrations 
that YfiQ can undergo autoacetylation on six lysines that, via structural modeling, is suggested to 
alter shape and charge of a surface patch that allows multimerization (167). 
YfiQ expression is transcriptionally regulated. One known mechanism of transcriptional 
activation is through the cyclic AMP – catabolite activator protein (cAMP-CRP) complex. CRP 
is a transcription factor that binds cAMP and activates or represses transcription via interaction 
with RNA polymerase (169). The yfiQ promoter contains a CRP binding site -41.5 bp upstream 
of the +1, which designates this as a Class II site (170). However, yfiQ is also in an operon with 
the upstream gene, yfiP. The yfiP promoter has a CRP binding site -61.5 bp upstream of the +1, 
which designates this as a Class I site (170). Thus, yfiQ has the potential to be regulated via two 
different promoters, but both in a CRP-dependent manner. In the presence of glucose, cAMP 
levels are low; thus, YfiQ expression is minimal due to weakly active CRP. Indeed, exponential 
growth of E. coli in minimal glucose medium results in low yfiQ expression, but once the cells 
deplete the glucose and enter stationary phase, yfiQ expression greatly increases. Conversely, 
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expression of yfiQ is high regardless of growth phase when E. coli is grown in the presence of a 
non-catabolite repressing carbon source (e.g., acetate) instead of glucose (135). This regulation 
may be conserved in the human pathogen, Yersinia pestis (171). 
Comparisons are often made between YfiQ of E. coli and Pat of S. enterica because of 
the evolutionary relatedness of both the organisms and the genes themselves; however, one 
major difference comes in the regulation of these genes. In S. enterica, expression of pat depends 
on IolR, a repressor of myo-inositol catabolism, in addition to CRP (168). The reason for this 
additional layer of regulation, however, is not clear. The regulation of yfiQ/pat expression 
appears to be linked to at least one target, Acs. Acs is required for assimilation of and growth on 
low concentrations of acetate (<10 mM) when cells have exhausted a preferred catabolite-
repressing carbon source, such as glucose. Acetylation of a conserved lysine by YfiQ/Pat 
inactivates Acs (172). In E. coli and S. enterica, the transcription of yfiQ/pat and acs are linked, 
as they are both activated by CRP. In S. enterica, IolR can activate acs expression as it does pat. 
 Mass spectrometry of the proteome and in vitro acetylation with YfiQ have revealed 
dozens of YfiQ-dependent acetylated lysines (56, 57, 173). However, when inspecting a yfiQ 
mutant via anti-acetyllysine western blot, the deletion casuses little effect on the acetylome 
compared to WT cells. Indeed, in E. coli, our group and others have shown that most of the 
observed acetylation is YfiQ-independent and instead depends on AcP, which will be discussed 
below (56, 57). The determinants that direct YfiQ to a given protein substrate are not fully 
defined and a linear motif is generally insufficient to predict whether a protein will be a target of 
YfiQ or not (57). However, specificity clearly exists, as certain lysines on the same protein can 
be acetylated by YfiQ, while others cannot. Specificity of YfiQ therefore is predicted to be based 
on a 3D interface formed between the KAT and the substrate protein. One example of this was 
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shown for RpPat, the YfiQ homolog in R. palustris. RpPat was found to be unable to acetylate 
MatB, but chimeric proteins that fused parts of the RpPat substrate PimA with the unacetylatable 
MatB yielded certain MatB variants that could then be acetylated. This “chimeric loop” was 
around 20 Å away from the acetylated lysine, suggesting RpPat recognizes additional structural 
components beyond those adjacent to the lysine (94, 174). Furthermore, slight differences in 
KAT sequence from nearly identical homologs yield very different substrate specificity (42). 
Deacetylases in Bacteria 
 To make a PTM versatile and energetically efficient, the ability to add and remove the 
PTM is essential. Lysine acetylation can be reversed via the action of a lysine deacetylase 
(KDAC). Two types of deacetylases are known: NAD+-dependent sirtuins (175) and Zn2+-
dependent deacetylases, which can be broken further into three other classes (I, II, and IV with 
sirtuins being III) (176-179). Putative homologs of both families are encoded by bacteria, but 
only a few have been shown to function as true deacetylases (126, 180). 
 The Zn2+-dependent deacetylases are simple hydrolases that cleave the acetyl group from 
the lysine to release acetate. To do this, a conserved histidine residue acts as a general base to 
activate a metal-bound water to attack the carbonyl of the acetyl group. This class of deacetylase 
has yet to be found in E. coli, but AcuC of B. subtilis (147) and LdaA of R. palustris (164) are  
family members. Enzymes of the hydrolase family can be inhibited by the addition of butyrate 
(181). 
 Sirtuins bind NAD+ through a Rossmann fold domain (182) and use the NAD+ as a co-
substrate to remove acetyl groups from proteins and produce nicotinamide (NAM) and 2'-O-
acetyl-ADP-ribose as a result. Since NAD+ levels are linked to nutritional status of the cell, it is 
thought that sirtuins allow the cell to recognize these changes and adjust acetylation accordingly 
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(183). Furthermore, sirtuins may regulate their own activity by producing NAM. NAM inhibits 
noncompetitively by condensing with an ADP-ribose-like intermediate formed during the 
deacetylation reaction; this condensation blocks the progression of the reaction (184) at 
physiological levels (185-190). NADH also competitively inhibits the reaction at physiological 
levels (191-193). 
 While sirtuins are classically thought of as deacetylases, it appears that they may have a 
broader specificity than originally thought. Sirtuins in the mitochondria have been reported to 
desuccinylate (10, 80), demalonylate (9, 10, 194), depropionylate (195), deglutarylate (11), 
decrotonylate (196), and debutyrylate (195) lysines in addition to their role as deacetylases. 
Bacterial sirtuins have similar abilities to desuccinylate (80), depropionylate (159, 160), and 
possibly debutyrylate (197) lysines. Many of these PTMs occur on the same lysine, possibly 
implicating sirtuins with a role as a general cleanup enzyme for certain lysines. Further 
complicating the possible role of sirtuins, there is evidence that a sirtuins can ADP ribosylate 
proteins using the NAD+ substrate (198). 
CobB, the Only Known Deacetylase in E. coli 
 CobB is a member of the sirtuin family. Like YfiQ, its activity was first described in S. 
enterica (199, 200), and later in E. coli (63, 201). As described above, CobB is a deacetylase, but 
it can also desuccinylate, depropionylate, and debutyrylate lysines in E. coli (80, 159, 160, 197), 
M. tuberculosis (202), and Lactobacillus acidophilus (203). It also has been implicated as a 
lipoamidase (204). CobB is the only gene product annotated as a deacetylase in the E. coli 
genome and, under at least one condition, it was determined to be the sole deacetylase of E. coli, 
as all deacetylase activity was absent from a ΔcobB mutant (205). While YcgC was suggested to 
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be a novel class of deacetylase (206), this was found to be an erroneous result due to preparations 
of the YcgC protein contaminated with proteases (207). 
 Depending on the study, the number of acetylated proteins that are deacetylated by CobB 
fall between 3% and 17% (56, 57, 82, 205). However, the effect of CobB is small when assessed 
via anti-acetyllysine western blot (50, 57, 201). Like lysines acetylated by YfiQ, there is no 
obvious linear motif that defines a CobB-sensitive lysine. However, CobB shows a preference 
for deacetylating lysines contained in disordered regions, loops, α-helices and termini (82, 205). 
The propensity for CobB to recognize disordered regions appears to be a shared trait among 
sirtuins (208). To determine whether there was a motif that CobB recognized in linear space, 
self-assembled monolayers and matrix assisted laser desorption-ionization (SAMDI) mass 
spectrometry was used to monitor peptide modification of a peptide library immobilized onto a 
gold surface (209-211). Analysis of acetylated linear peptide motifs did show that CobB prefers 
lysines with adjacent hydrophobic/non-polar amino acids, while CobB was not able to 
deacetylate lysine with a proline in the +1 position. In vivo, negatively charged amino acids can 
more commonly be found in the +1 and -1 positions, while CobB-insensitive acetyllysines tend 
to not have negatively charged amino acids in an adjacent position (205). 
 The counteracting activities of YfiQ and CobB have been referred to as the “reversible 
lysine acetylation” or RLA system of E. coli. Specific lysines susceptible to these enzymes 
permit the bacterium to rapidly add or remove acetyl groups from proteins. This process was first 
established in S. enterica on Acs, where initially CobB was found to deacetylate Acs (199) and 
later it was found that K609 could be acetylated by YfiQ (163). Acetylation and deacetylation of 
Acs was then confirmed to behave in the exact same manner in E. coli (63, 135). The number of 
lysines and proteins known to be regulated by RLA has been greatly expanded through mass 
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spectrometric studies, as well as more directed biochemical studies (Table 2). However, not all 
lysines that are acetylated by YfiQ are deacetylated by CobB and vice versa (153, 205). Thus, 
these enzymes do not act together on each lysine, and therefore the designation of these enzymes 
as a system should be tempered.
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Table 2. Acetylated Proteins in Bacteria 
Organism 
Acetylated 
protein 
Acetylated 
lysine(s) 
Acetylation 
mechanism 
KDAC(s) Effect Refs 
Actinosynnema 
mirium 
Acs 620 
AmiPatA and 23 
homologs 
Not determined Inhibits activity (139) 
Bacillus subtilis 
Acs 549 AcuA AcuC, SrtN Abolishes activity 
(147, 
212, 
213) 
Eno 339, 390 in vitro AcP Not determined Abolishes activity (55) 
TufA 42 Unknown AcuC, SrtN No effect (214) 
MreB 240 Not determined Not determined 
Reduces cell length, 
width, and peptidoglycan 
thickness 
(71) 
CshA 244, 296 Unknown Not determined 
Enhances induction of 
SigX and SigM-
dependent genes 
(215, 
216) 
Borrelia 
burgdorferi 
GapA Not determined AcP Not determined Inhibits activity 
(72) 
LDH Not determined AcP Not determined Mixed results 
Escherichia coli 
ArgRS 126, 408 AcP CobB Impairs tRNA charging (217) 
CRP 100 AcP Not determined 
Reduces interaction with 
RNAP, enhances protein 
stability 
(218) 
LeuRS 619, 624, 809 AcP CobB Impairs tRNA charging (217) 
Mdh 
99 
140 
AcP 
None 
CobB 
Cooperatively increases 
activity 
(219, 
220) 
RpoA 291 AcP Not determined 
Reduces cpxP 
transcription 
(221) 
TyrRS 85, 235, 238 AcP CobB Impairs tRNA charging (222) 
RcsB 154 AcP CobB 
Enhances migration, 
impairs acid survival 
(82, 
223) 
TopA 13, 45, 346, 488 AcP CobB 
Reduces relaxation 
activity by inhibiting 
(224, 
225) 
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DNA binding and 
cleavage activity 
DnaA 178 AcP, YfiQ CobB Inhibits ATP binding (226) 
DnaA 243 AcP, YfiQ CobB 
Inhibits oriC binding at 
low affinity sites 
(227) 
CheY 92, 109 Acs, AcCoA Acs, Pta, CobB 
Inhibits interaction with 
CheA, FliM, and CheZ 
Activates CheY, promotes 
clockwise rotation 
(228-
230) 
YfiQ 
146, 149, 391, 
446, 635, 819 
AcCoA CobB 
Favors formation of 
octamers 
(167) 
Eno 342, 393 in vitro AcP Not determined Abolishes activity (55) 
AceA 308 Not determined CobB Inhibits activity (82) 
AlaRS 73 Not determined CobB Inhibits activity (231) 
Mat 12 lysines Not determined 
CobB (9 lysines 
susceptible) 
Inhibits activity, may 
affect dimerization 
(232) 
NhoA 214, 281 Not determined CobB Inhibits activity (233) 
RcsB 180 SePat, YfiQ 
SeCobB, 
EcCobB 
Inhibits DNA binding (173) 
Acs 609 YfiQ CobB 
Inhibits activity by 
preventing first half 
reaction 
(82, 135, 
185) 
RNase II 501 YfiQ CobB 
Inhibits RNase II activity 
due to reduced substrate 
binding 
(234) 
RNase R 544 YfiQ None Destabilizes protein 
(235, 
236) 
RpoA 298 YfiQ Not determined 
Enhances cpxP 
transcription 
(201) 
Micromonospora 
aurantiaca 
Acs 619 MaKat Not determined Inhibits activity (146) 
Mycobacterium Acs 616 KATbcg Not determined Abolishes activity (144) 
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bovis BCG FadD13 487 KATbcg Not determined Inhibits activity (144) 
Mycobacterium 
smegmatis 
FadD33 511 MsPat MSMEG_5175 Abolishes activity (237) 
MbtA 546 MsPat Rv1151c Inhibits activity (238) 
PrpE 586 MsPat Not determined Abolishes activity (86) 
USP 104 
MtPatA, 
MsPatA 
Not determined Unknown (141) 
Ku 29, 40 Not determined Not determined 
Correlates with impaired 
NHEJ activity 
(239) 
HupB 86 Not determined Not determined 
Prevents small colony 
variant formation 
(240) 
Acs 589 PatA SrtN Impairs growth on acetate (241) 
Mycobacterium 
tuberculosis 
DUSP16 
(eukaryotic) 
55 Eis Not determined 
Inhibits activation of JNK 
pathway 
(156) 
Histone H3 
(eukaryotic) 
Not determined Eis Not determined 
Enhances binding to the 
IL-10 promoter 
(242) 
HupB 32 lysines Eis Rv1151c Inhibits DNA binding 
(154, 
155) 
Acs 617 MsPat 
Rv1151c, 
MSMEG_5175 
Abolishes activity 
(140, 
144, 
243) 
MbtA 542 MsPat Rv1151c Inhibits activity (238) 
DosR 182 MtPat Rv1151c Inhibits DNA binding 
(90, 
244) 
FadD2 
FadD4 
FadD5 
FadD10 
FadD12 
FadD13 
FadD22 
FadD35 
551  
525  
519  
519  
523  
487  
480  
529 
MtPat MSMEG_5175 
Impairs palmitoyl-AMP 
synthesis activity for 
FadD2, FadD5, and 
FadD15 
(144) 
PtpB 224 MtPat Rv1151c 
Decreases reaction rate 
due to reduced Vmax 
(245) 
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HspX 64, 78, 85 Not determined Not determined Reduced immunogenicity (87) 
ICL1 
(Rv0467) 
322 
331 
392 
Not determined Not determined 
Inhibits activity (K322) 
Enhances activity (K331) 
Enhances activity (K392) 
(88, 89) 
Histone H3 
(eukaryotic) 
9, 14 Rv3423.1 Not determined 
Inhibits DNA binding by 
histone H3 
(246) 
Myxococcus 
xanthus 
Acs 622 MxKat Not determined Inhibits activity (142) 
Neisseria 
gonorrhoeae 
PilT 117 AcP Not determined 
May contribute to 
membrane association, 
alters microcolony 
formation 
(247) 
Porphyromonas 
gingivalis 
RprY Not determined PgPat CobB Inhibits DNA binding (248) 
pro-RgpB 247, 248 VimA, PG1842 Not determined 
Permits proper processing 
of pro-RgpB 
(249) 
Rhodobacter 
sphaeroides 
FnrL 175, 213, 223 AcP RsCobB 
Impairs transcriptional 
activation 
(250) 
Rhodopseudomonas 
palustris 
FadD 546 RpPat Not determined Inhibits activity (94) 
HcsA 524 RpPat LdaA Inhibits activity (94) 
LcsA 499 RpPat LdaA Inhibits activity (94) 
PimA 534 RpPat Not determined Inhibits activity (251) 
Acs 606 RpPat, KatA SrtN and LdaA Inhibits activity 
(94, 
164) 
AliA 532 RpPat, KatA SrtN and LdaA Inhibits activity 
(94, 
164) 
BadA 512 RpPat, KatA SrtN and LdaA Inhibits activity 
(94, 
164) 
FcsA 496 RpPat, KatA LdaA Inhibits activity (94) 
HbaA 503 RpPat, KatA SrtN and LdaA Inhibits activity 
(94, 
164) 
IbuA 539 RpPat, KatA LdaA Inhibits activity (94) 
PrpE 598 RpPat, KatA LdaA Inhibits activity (94) 
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Saccharopolyspora 
erythraea 
AcsA2 611 AcP Not determined 
Inhibits activity by 
reducing affinity for 
acetate 
(148) 
AcsA1 
AcsA2 
AcsA3 
620 
628 
615 
AcuA SrtN Inhibits activity 
(148, 
252) 
GlnA1 179, 357 AcuA SrtN 
Enhances GlnA1 
interaction with GlnR, 
which enhances DNA 
binding affinity 
(253) 
GlnA4 319 AcuA SrtN Inhibits activity (253) 
AceA 308 Pat CobB Inhibits activity (63, 94) 
Salmonella enterica 
AceK 72, 83, 553 Pat CobB 
Enhances activation of 
ICDH 
(63, 94) 
GapA 331 Pat CobB 
Enhances glycolytic 
activity, decreases 
gluconeogenesis activity 
(63, 94) 
HilD 297 Pat None 
Enhances stability, 
inhibits DNA binding 
(254, 
255) 
PhoP 201 Pat CobB Inhibits DNA binding (256) 
PrpE 592 Pat CobB Abolishes activity (159) 
Lrp 36 Pat CobB Inhibits DNA binding (257) 
Acs 609 Pat CobB 
Inhibits activity by 
preventing first half 
reaction 
(163, 
199, 
258) 
charged 
aminoacyl 
tRNAs 
N-terminus TacT N/A Inhibits translation 
(152, 
259) 
TacA 44 TacT CobB Enhances TacT activity (259) 
Streptomyces 
coelicolor 
Acs 610 Not determined CobB1 Inhibits activity (260) 
GlnR 
142, 153, 159, 
200 
Not determined CobB2 Alters DNA binding (261) 
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Streptomyces 
griseus 
StrM 70 
SGR1683, 
EcYfiQ 
Not determined Inhibits activity (101) 
Streptomyces 
lividans 
Aacs 617 SlPat SeCobB Inhibits activity (134) 
Acs 610 SlPatA, SlPatB SlSrtA Inhibits activity 
(42, 
134) 
Streptomyces 
venezuelae 
Acs 665 SvePatA Not determined Inhibits activity (139) 
Sulfolobus 
solfataricus 
Alba 16 Pat Sir2 Inhibits DNA binding (51) 
Vibrio cholerae Acs 609 YfiQ CobB Inhibits activity (262) 
Yersinia pestis PhoP Not determined YfiQ CobB Not determined (171) 
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 In S. enterica, the regulation of cobB follows yfiQ in that it can be activated by IolR 
(168). In E. coli, cobB is constitutively transcribed (135), but protein levels have been observed 
to be higher in glucose-containing medium when compared to acetate-containing medium (204). 
Whether this discrepancy results from post-transcriptional regulation of CobB or from 
differences in media or strains used remains an open question. Both E. coli and S. enterica 
produce two forms of CobB, a long form (CobBL) and a short form (CobBS) that lacks the 37 N-
terminal amino acid extension found in the long form (263, 264). These two isoforms are 
generated from two monocistronic cobB mRNAs from two transcriptional start sites. cobBL is 
expressed from a promoter within the upstream gene, nagK, while cobBS is expressed from a 
promoter within cobBL itself. The CobBS isoform is made at 10-fold higher levels than CobBL. 
Current data suggests they are functionally equivalent at deacetylating two targets, Acs (263) and 
AlaRS (264). Thus, the reason that two isoforms exist is currently unknown, but one could 
hypothesize that the existence of the additional 37 amino acids may be a signal sequence to 
localize CobBL or to achieve specificity (263, 264). 
Effects of Enzymatic Acetylation and Deacetylation on Physiology and Pathogenesis 
 Many studies have explored the role of enzymatic acetylation on bacterial physiology, 
often through reverse genetics approaches where the deacetylase, acetyltransferase, or both are 
deleted or overexpressed. In this section, I will focus on CobB and YfiQ and their homologs in S. 
enterica, as they have been studied the most extensively. 
 As stated in the above sections, YfiQ and CobB perform opposing roles on the 
acetylation status of Acs, an enzyme that can irreversibly convert acetate into Acs via two half 
reactions. Acs requires lysine 609 (K609) for the first half-reaction that forms an acetyl-AMP 
intermediate (199). Thus, mutation or modification of this residue leads to a catalytically inactive 
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enzyme (160, 163, 199, 265). Indeed, an epistasis analysis of Δacs, ΔcobB, and ΔyfiQ mutants 
showed that regulation of Acs is essential for growth on acetate. E. coli Δacs mutants are unable 
to grow in the presence of <10 mM acetate as the sole carbon source since the alternative 
pathway, the Pta-AckA pathway, is insufficient due to its low affinity for acetate. A ΔcobB 
mutant phenocopies a Δacs mutant, while a double ΔyfiQ cobB mutant can grow on <10 mM 
acetate (135). This result confirmed that YfiQ-dependent acetylation of Acs shuts down acetate 
utilization through Acs; but, by deacetylating Acs with CobB, Acs activity is restored (135). Acs 
was found to be regulated in the exact same fashion in >15 organisms tested, ranging from 
bacteria to humans (Table 2) (266). Beyond Acs, RLA was found to extend to other AMP-
forming acyl-CoA synthetases, which are proteins that share a similar structure and the same 
conserved acetylated lysine found in Acs. Rhodopseudomonas palustris possesses 40 of these 
Acs-like proteins; 10 of them are reversibly acetylated on this conserved lysine (94, 164). As in 
Acs, acetylation inactivates these enzymes. 
 In addition to Acs, the Regulator of Capsule Synthesis B (RcsB) protein can be reversibly 
acetylated through YfiQ and CobB in vitro. RcsB is a major transcriptional regulator of E. coli 
and S. enterica that regulates approximately 5% and 20% of their respective genomes (267, 268). 
RcsB promotes capsule biosynthesis and biofilm formation, while impairing transcription of 
genes required for motility. In E. coli and S. enterica, RcsB is acetylated on multiple residues. 
K180 is acetylated in a YfiQ- or Pat-dependent manner and deacetylated by CobB from either 
bacterium (173). K180 is found in the RcsB DNA binding motif, and acetylation of this residue 
reduces DNA binding, which can then be reversed by CobB. In two independent studies, CobB 
was found to be an inhibitor of migration in E. coli (82, 269). A ΔcobB mutant has more 
numerous and longer flagella than the parent strain, which could partially be explained by the 
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ability of CobB to deacetylate RcsB (269). RNase II of E. coli was also shown to be a target of 
these enzymes (234). Acetylation of K501 by YfiQ inhibits substrate binding, which results in 
reduced exoribonuclease activity. Treatment of RNase II with CobB restores this activity. In S. 
enterica, there have been many more enzymes shown to be regulated by reversible lysine 
acetylation. PhoP is a member of a two-component regulatory system that responds to low Mg2+ 
and acid stress. It is acetylated by Pat on K201; a modification that decreases DNA binding and 
thus reduces expression of PhoP-regulated genes (256, 270). CobB could restore DNA binding to 
acetylated PhoP. Expression of a K201Q variant of PhoP that mimics a constitutively acetylated 
isoform impaired S. enterica virulence in mice. Lrp, an important global transcriptional regulator 
across bacteria and archaea (271, 272), was shown to be acetylated on K36 in S. enterica, which 
prevented DNA binding (257). CobB treatment permitted DNA binding of Lrp. 
 While the mechanistic role of RLA on Acs and other enzymes described above has been 
well established, multiple phenotypes have been found for Δpat and ΔcobB mutants in S. 
enterica that are not directly attributed to acetylation of a specific enzyme but are consistent with 
the opposing effects of these enzymes. Compared to wild-type cells, a Δpat mutant grows slower 
on minimal glucose but faster on minimal citrate, suggesting Pat plays a role in regulating 
glycolysis (63). CobB had the exact opposite effect on growth. Furthermore, a Δpat mutant had 
reduced flux through glycolysis and the TCA cycle, while a ΔcobB mutant again had the 
opposite phenotype and promoted gluconeogenesis (63). For this phenotype, a ΔcobB Δpat 
double mutant behaved like a Δpat mutant, which suggests that CobB is dispensable in the 
absence of acetylation via Pat. Acetylation by Pat was reported on isocitrate lyase (AceA), 
isocitrate dehydrogenase (Icd), and Isocitrate dehydrogenase kinase/phosphatase (AceK), and 
this acetylation was shown to reduce activity for each protein, which could partially explain this 
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phenotype (63). However, these results were called into question when another group could not 
confirm these findings (94). Thus, the exact role of Pat- or YfiQ-dependent acetylation in central 
metabolism is still unclear, but these data suggest they may play a role. 
A conserved role for YfiQ and CobB, as well as their homologs, could be as responders 
to stress, though the acetylated targets that exert these effects are still uncertain. Contrary to the 
above examples, the effects of YfiQ and CobB or their homologs in certain instances described 
below may be through independent pathways because deletion of either enzyme results in the 
same phenotype. For example, E. coli and Y. pestis both have reduced survival in acid stress 
when yfiQ or cobB are deleted, while S. enterica survives better when pat is deleted and more 
poorly when cobB is deleted (82, 171, 270). When exposed to heat stress, survival of E. coli is 
diminished in ΔyfiQ mutants but is increased in ΔcobB mutants (273).  In contrast, Y. pestis 
survival is diminished in both ΔcobB and ΔyfiQ mutants when exposed to heat, cold, or high salt 
stress (171). Additionally, E. coli ΔcobB mutants have enhanced survival against reactive oxygen 
species, while YfiQ has no effect. In a more distantly related organism, Mycobacterium 
tuberculosis, loss of its sirtuin (Rv1151c) instead promotes growth in acidic pH (88). 
Furthermore in Mycobacterium smegmatis, the acetyltransferase PatA acetylates Universal Stress 
Protein (MSMEG_4207) (141). While the effect of this acetylation is untested, it may suggest a 
common role for acetylation in stress response. The stresses that pat/yfiQ mutants become 
sensitized to indicates that acetylation is a general regulator of stress pathways that result in these 
sensitivities. 
Pat has been strongly implicated in S. enterica survival and infection. Pat enhances 
invasion of the bacteria into HeLa cells and enhances survival of the bacteria within 
macrophages (254). Pat also helps promote survival under acid stress, which may be partially 
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responsible for the macrophage survival phenotype (270). Importantly, expression of the 
Salmonella pathogenicity island (SPI-1) that is required for virulence is enhanced by Pat (254). 
SPI-1 is controlled by transcription factor HilD, and acetylation of HilD on K297 by Pat was 
suggested to stabilize the protein, which could enhance SPI-1 transcription. The role of Pat in 
virulence was further established by infecting mice with Δpat and ΔcobB mutants. The Δpat 
mutants were hypovirulent and caused reduced mortality, implicating Pat and therefore 
acetylation as necessary for infection (254). However, ΔcobB mutants had little effect. Like S. 
enterica, a ΔyfiQ mutant of Yersinia pestis, the causative agent of plague, is attenuated in mice 
(171), but unlike S. enterica, a ΔcobB mutant is equally attenuated. 
The above examples demonstrate how mechanistically similar machinery has evolved in 
different organisms to suit their specific niches. In many cases, Pat/YfiQ and CobB act 
antagonistically to reversibly acetylate a specific lysine. However, in response to certain stresses, 
loss of either the KAT or KDAC can be detrimental to the survival of the bacterium, which 
suggests that these enzymes are regulating independent pathways. Thus, dysregulation of 
acetylation in either direction can become detrimental under certain stresses. The pathogenicity 
data from S. enterica and Y. pestis suggest that, while there may be some commonalities between 
the requirements for acetylation in certain scenarios, there are cases where KATs and KDACs do 
not always act in opposition. 
Glucose-Induced Acetylation in E. coli Is Acetyl Phosphate-Dependent 
 Addition of glucose to E. coli grown in buffered tryptone broth was found to potently 
enhance acetylation compared to cells grown without glucose addition (56, 63, 201, 221). 
However, this glucose-induced acetylation was found to be independent of YfiQ, as a ΔyfiQ 
mutant retained this strong acetylation. Instead, glucose-induced acetylation depended on the 
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small high-energy central metabolite AcP, as the acetylation was abolished in a Δpta mutant, 
which cannot synthesize AcP. Taken together, these results showed that AcP-dependent 
acetylation does not depend on YfiQ. However, glucose-induced, AcP-dependent acetylation did 
depend on CRP, which was striking because CRP is usually poorly active in the presence of 
glucose due to low levels of its ligand, cAMP (274, 275). Furthermore, glucose-induced 
acetylation was most prominent in stationary phase and nitrogen-limited cultures (54, 57, 63, 
276). AcP also was found to be responsible for glucose-induced acetylation in B. subtilis, rather 
than the only known acetyltransferase, AcuA (70). Furthermore, acetylation in the spirochete 
Borrelia burgdorferi and in the actinomycete Corynebacterium glutamicum also appears to 
depend on AcP (72, 74). Below, the ability of AcP to acetylate proteins will be discussed. 
Non-Enzymatic Acetylation via AcP and AcCoA 
 Chemical reactions are the basis of all life. While enzymatic catalysis is a primary driver 
in the kinds of substrates used and products formed, the possible chemical reactions of those 
substrates and products greatly exceeds those that are catalyzed (3). Many of these uncatalyzed 
reactions are thought of as deleterious to the cell, causing macromolecular damage such as 
oxidation of DNA or proteins. Often, the damage can be caused by products of the cell’s own 
metabolism, such as reactive oxygen species (277). Indeed, non-enzymatic modification has been 
implicated in multiple human diseases (278). As cells have evolved alongside this damaging 
potential of their own metabolism, it is not surprising that repair pathways exist to mitigate this 
damage. Perhaps cells have evolved ways to utilize these extra-metabolic occurrences as means 
of regulation. Specifically, in this context, we will consider acetylation via two acetyl donors, 
AcCoA and AcP. 
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 The ability of AcCoA and AcP to non-enzymatically modify proteins is not a new idea. 
AcP has been shown to chemically acetylate amine, thiol, and hydroxyl groups (279, 280). It was 
first discovered in the 1970s that AcP could non-enzymatically acetylate histones, albumin, and 
polylysine (281). Due to its high energy nature (ΔG° of -43.1 kJ/mol), which is even greater than 
that of AcCoA (ΔG° of -31.4 kJ/mol), AcP readily hydrolyzes in water and can acetylate without 
the need for an enzyme (282, 283). The concentrations needed to achieve non-enzymatic 
acetylation in vitro are comparable to or below physiological levels, which in E. coli are around 
300 - 500 μM for AcCoA and for AcP between 200 μM in exponential phase to 3 mM in 
stationary phase (284-286). In vitro acetylation reactions are often carried out at basic pH. While 
basic pH promotes deacetylation of lysine, which may prime the lysine for acetylation, this also 
increases the rate at which AcP and AcCoA dissociate (279, 283). The non-enzymatic 
acetylation differs for each lysine and each acetyl donor used. Using bovine serum albumin as an 
example, it was shown that non-enzymatic acetylation on each lysine is not equal. In vitro 
acetylation reactions with AcP and AcCoA showed that acetylation rates can vary by three orders 
of magnitude, suggesting that regulation of acetylation depends on the environment surrounding 
the lysine (287). However, the rate and regulation of acetylation in vivo prior to this manuscript 
was unknown. 
Assessment of non-enzymatic acetylation in vivo for AcCoA is difficult. In most cases, it 
is an essential molecule that if depleted would result in lack of viability. However, attempts to 
recreate the mitochondrial environment have shown that AcCoA could acetylate proteins at 
physiological levels in vivo (288). Furthermore, attempts to reduce the levels of AcCoA, such as 
by draining acetyl groups into an acetyl group polymer like PHB, do not preclude the effects of 
KATs. Work in an organism where AcCoA can be non-essential, like the reduced genome 
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bacterium Borrelia burgdorferi that solely synthesizes AcCoA to generate mevalonate, a 
precursor of cell wall lipid I, might be a useful reductionist system to determine whether this 
truly occurs in vivo (72). Without knowing all possible KATs and eliminating them, it is hard to 
say whether the reaction is truly non-enzymatic in vivo.  
Fortunately for most bacteria, modulation or complete elimination of AcP levels is much 
simpler and less detrimental than elimination of AcCoA, which greatly facilitates studying AcP-
dependent acetylation. In E. coli and many other bacteria, AcP is generated as an intermediate of 
the acetate fermentation pathway catalyzed by the reversible enzymes acetate kinase (AckA) and 
phosphotransacetylase (Pta) (289). Pta catalyzes the conversion of AcCoA and inorganic 
phosphate to AcP and free CoA. AckA then converts AcP into acetate by transferring the 
phosphoryl group to ADP to generate one molecule of ATP. In the presence of high acetate 
concentrations (>10 mM), the pathway can run in reverse, synthesizing AcCoA from acetate, 
ATP, and CoA (172, 290). By genetically manipulating this pathway, the levels of AcP and thus 
acetylation can be altered. For example, if cells are grown on glucose, the cells ferment acetate 
and generate AcP as an intermediate. If one prevents the conversion of AcCoA to AcP by 
deleting Pta or the entire Pta AckA pathway, AcP cannot be generated. When these mutants are 
analyzed by western blot, the intensity of the acetylated proteins is greatly reduced to 
background levels (56, 57). It is worth noting that acetylation can still be detected by mass 
spectrometry in Δpta and Δpta ackA mutants, but the relative amount of acetylation and number 
of acetylated lysines is greatly reduced. On the other hand, by deleting ackA, AcP accumulates to 
10–20 mM (56, 284, 291), which can be seen via western blot as a greatly intensified acetylation 
profile relative to wild-type cells (56, 57). Mass spectrometry confirms that many more unique 
lysines on many more unique proteins become acetylated in this mutant, and the population of 
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those lysines that are detected as acetylated in wild-type become further acetylated as the 
proportion of the total pool of each unique peptide shifts towards acetylated. 
While non-enzymatic acetylation does not require a KAT, it appears that the mechanism 
by which this occurs has many parallels with enzymatic acetylation. While the KAT serves as an 
AcCoA binding protein to properly position the acetyl group near the target lysine, non-
enzymatic acetylation requires that the protein being acetylated coordinates the CoA group for 
AcCoA or the phosphate moiety for AcP. Often, the coordinating amino acids are positively 
charged amino acids (R and K) that make ionic bonds or polar amino acids that can make or 
hydrogen bonds via hydroxyl groups (S, T, Y) or side chain amides (Q and N) (57). In contrast to 
KAT-dependent acetylation, where a glutamate from the KAT typically extracts a proton from 
the lysine to be acetylated, during non-enzymatic acetylation, this process requires an internal 
glutamate or a water molecule (57, 105). It may be expected that lysines acetylated non-
enzymatically may have a reduced pKa, and thus more propensity to lose a proton. However, the 
pKa has not been found to correlate with reactivity (287). Like KATs and KDACs, there is no 
clear motif that is predictive of whether a lysine is susceptible to chemical acetylation. In vitro 
acetylation of peptides with AcP on a SAMDI chip showed almost every peptide could be 
acetylated, but by adding magnesium and salt, selectivity and specificity was achieved (57). The 
SAMDI results indicated adjacent arginines and lysines favored acetylation; in vivo, however, 
there is a propensity for glutamates and aspartates to be adjacent to the lysines acetylated by 
AcP. Similar results were found for AcCoA, where glutamates were found near lysines in vivo 
(287).  For both AcP and AcCoA, there is a tendency for susceptible lysines to be surface-
exposed (57, 287). However, due to their relatively small size, AcP and AcCoA can access 
buried lysines that a KAT could not. Thus, protein structures could have evolved to utilize non-
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enzymatic acetylation to regulate protein functions in locations that are impossible for enzymatic 
acetylation to access. 
A Simplified Overview of Central Metabolism and Overflow Metabolism 
 Acetylation is intimately linked to central metabolism. The two acetyl donors, AcCoA 
and AcP, are produced as a result of these metabolic pathways, while sirtuins depend on NAD+, 
a reporter of cellular carbon and energy status that acts as a cofactor in redox reactions of 
glycolysis and the TCA cycle (190). Thus, acetylation levels may be a way for cells to sense the 
nutritional status of the cell. In this section, I will focus primarily on how E. coli metabolizes 
glucose into AcCoA, whether the fate of that AcCoA is fermentation or the TCA cycle, and then 
review how other organisms can form AcP without fermentation. 
 Glucose is the preferred carbon source of E. coli. This preference is achieved through 
three mechanisms: catabolite repression (292), transient repression (293), and inducer exclusion 
(294). Catabolite repression inhibits the transcription of the enzymes necessary to catabolize a 
carbon source other than the preferred carbon source. Although glucose-dependent repression of 
lactose is the most common association, catabolite repression (CR) is not a glucose-specific 
phenomenon, but rather is related to the flux of carbon into the cell. To understand CR and 
inducer exclusion, we first must discuss the phosphotransferase system (PTS), the 
phosphorylation cascade that mediates uptake of glucose (Fig. 2). In this pathway, glucose enters 
the cytoplasm through the inner membrane transporter EIICBglc (ptsG), where it becomes 
phosphorylated to become glucose-6-phosphate, the molecule that can enter glycolysis. The 
carbon from glucose eventually goes on to form 2 molecules of phosphoenolpyruvate. One of 
these molecules is converted to pyruvate and can be used to make AcCoA, while the other can 
act as a phosphodonor to EI (ptsI), a sugar non-specific phosphotransferase system enzyme. 
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Another sugar non-specific protein, HPr (ptsH), accepts the phosphoryl group from E1, which 
can then phosphorylate the glucose-specific EIIAglc (crr). Phospho-EIIAglc can phosphorylate 
EIICBglc to permit continued glucose uptake, resulting in most of the EIICBglc being in the 
dephosphorylated form. Furthermore, this dephosphorylated form of EIIAglc can interact with 
permeases of the non-preferred carbon sources, preventing transport of those carbon sources into 
the cell and thus subsequent induction of the operons that permit their metabolism (295). When 
glucose is fully consumed, phosphorylated PTS proteins become the dominant forms as there is 
no sugar to phosphorylate. Under these conditions, when glucose is absent, the phospho-EIIAglc 
interacts with and activates adenylate cyclase, while dissociating from the permeases for 
alternate carbon sources. This scenario results in production of cAMP, formation of cAMP-CRP 
transcription factor complex, activation of cAMP-CRP-dependent transcription, and transport of 
alternate carbon sources. 
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Figure 2. The PTS System of E. coli. Glucose is transported and phosphorylated by EIICBglc 
(encoded by the ptsG gene). The carbon from glucose passes through glycolysis to make 
phosphoenolpyruvate (PEP), which can either donate its phosphoryl group to EI or be converted 
into pyruvate by Pyk. The phosphoryl group passes from EI to HPr to EIIA and back to EIICBglc. 
When glucose is abundant, the PTS enzymes remain in a most unphosphorylated form. 
Unphosphorylated EIIAglc binds to permeases for other carbon sources and prevents import of 
these carbon sources. When glucose is depleted, the PTS enzymes are mostly phosphorylated. 
Phosphorylated EIIAglc binds to and activates adenylate cyclase. Adenylate cyclase synthesizes 
cAMP, which can bind CRP to activate transcription. 
 
Once glucose has entered the cytoplasm and become phosphorylated, glucose-6-
phosphate passes through one of three glycolytic pathways: the Embden-Meyerhof-Parnas 
(EMP) pathway, the Entner-Doudoroff (ED) pathway, or the pentose phosphate (PP) pathway 
(Fig. 3). The EMP pathway is that which is commonly thought of as glycolysis. Relative to the 
ED and PP pathways, it has high carbon flux. The common result of each of these pathways is 
the formation of energy and AcCoA. When cells are growing and dividing, the AcCoA is used to 
make fatty acids and enters the TCA cycle to form amino acid precursors and energy. However, 
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the flux of carbon into the AcCoA node can be greater than the outward flux. To permit 
continued consumption of carbon from glycolysis, the cells regenerate CoA by fermenting 
acetate. 
 Fermentation is often thought of as a metabolic program during anaerobic growth; 
however, E. coli cells grown aerobically in the presence of excess extracellular glucose will 
ferment acetic acid (acetate) (296, 297). This phenomenon, called aerobic fermentation or the 
Crabtree Effect, was first described in cancer cells. When exposed to excess glucose, these tumor 
cells perform lactic acid fermentation rather than aerobic respiration even when oxygen is 
present (298, 299). The phenomenon also occurs in yeast; instead of acetic acid or lactic acid, 
Saccharomyces cerevisiae ferments ethanol during growth in the presence of high glucose 
concentrations. In all three cases, the cells excrete the excess carbon as partially oxidized 
metabolites (e.g., acetate, lactate, ethanol) rather than putting the excess carbon into biomass via 
the tricarboxylic acid (TCA) cycle (300, 301). The phenomenon described for yeast appears to be 
close to the one described for E. coli and other bacteria (302). In yeast, a short-term and a long-
term form of the Crabtree Effect have been described, but only a phenomenon like the short-term 
effect has been described in bacteria. The short-term effect is described as the appearance of 
fermentative products upon addition of excess sugar (303). The short-term mechanism is thought 
to be overflow in sugar metabolism based on physiological constraints such as maximum 
velocity of respiration-associated enzymes in yeast (303-305), as well as E. coli (306). 
Essentially, rapid glucose consumption by glycolysis overwhelms the capacity of the TCA cycle, 
thereby forcing the cells to ferment. In E. coli, this is also suspected to be a means of maintaining 
proper NAD/NADH redox balance as fermentation of acetate produces no NADH, while the 
TCA cycle will produce 8 NAD(P)H and 2 FADH2 (307, 308). Additionally, the apparent 
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wasting of resources by fermenting may be due to energy costs. The proteomic demands for 
respiration are high compared to fermentation and, thus in fast growing cells, the efficiency of 
respiration is less cost effective than the less efficient fermentation (309). 
 
 
Figure 3. Central Metabolic Pathways of Escherichia coli. Three glycolytic pathways exist in 
E. coli: Embden-Meyerhof-Parnas (EMP) pathway (blue), Pentose Phosphate pathway (red), and 
Entner-Doudoroff pathway (green). Enzyme gene names are shown with the exception of multi-
protein enzymes complexes: pyruvate dehydrogenase complex (PDHC), oxoglutarate 
dehydrogenase complex (OGDH), and succinate dehydrogenase (SDH). Enzymes described in 
more detail in the text are shown in red. Entry points of glucose, xylose, fructose, and lactate are 
shown. 
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Stationary Phase Cultures of E. coli – Physiological Shifts 
 Glucose-induced acetylation increases and accumulates during stationary phase, a time 
when nutrients are insufficient to maintain steady growth. Under laboratory conditions, bacterial 
growth occurs in five main stages, of which stationary phase is one (310). A culture begins in lag 
phase, during which the cells must adjust to their new environment; this adjustment requires 
metabolic reprogramming and nascent protein biosynthesis. The amount of time in lag phase 
depends on the bacteria, the extent of difference between the old and new environments, and the 
length of time in starvation (311). Once the cells have adjusted to the new environment, they 
enter exponential phase (sometimes erroneously called logarithmic phase or log phase). The 
cells grow at a constant rate that is dictated by the richness of the available (312). Once nutrient 
sources become exhausted, growth is no longer exponential, and the cells transition into 
stationary phase, where no increase in cell number is observed. The depleted nutrient that sets 
off this phase could be any that, in its absence, would cause growth cessation; these depleted 
nutrients could be carbon, nitrogen, or trace elements such as magnesium or iron.  As waste 
products accumulate during this stationary phase, the cells will enter a death phase during which 
viable cell counts dramatically decrease. However, not all the cells die, and the remaining 
survivors enter long-term stationary phase. In this final phase, subpopulations die or grow from 
scavenged nutrients in a balance that results in stable viability of the culture. It should be noted 
that 60% of earth’s biomass is hypothesized to consist of microbes in a stationary phase state 
(313). 
 In terms of morphology and transcription, a great change takes place between those cells 
that grow exponentially from those that are in stationary phase (reviewed in (312).) The cells in 
stationary phase become smaller and more spherical as they undergo reductive division due to 
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insufficient resources to generate full sized daughter cells (314). In E. coli, the spherical shape is 
achieved via regulation of penicillin-binding proteins by the transcriptional regulator BolA, 
whose expression depends on RpoS (also known as σS) (314). The stationary phase cells also 
experience dwarfing, where endogenous resources, cell wall, and inner membrane are degraded 
(314). Interestingly, in E. coli, the size of the outer membrane remains unchanged, resulting in an 
increase in periplasmic space (315). Extensive structural changes do occur in the outer 
membrane, inner membrane, and peptidoglycan (316). These changes make the cell wall become 
more rigid and resistant to stress. Inside the cell, the nucleoid becomes condensed via the Dps 
protein, which acts during starvation (317, 318). 
 The starved cells reduce growth rate drastically, reduce transcription, and reduce protein 
synthesis to 20% that of cells growing exponentially (315). This is done via multiple 
mechanisms. The levels of ribosomal RNA and transfer RNA both decrease in stationary phase 
cells, resulting in less capacity for translation (315). The alarmone ppGpp is produced by the 
proteins RelA and SpoT. RelA binds to the ribosome and becomes activated once an uncharged 
tRNA binds to the ribosomal A site (319). ppGpp can then bind to the beta subunit of RNA 
polymerase, affecting promoter specificity and thus gene transcription (320, 321). 
During this phase of culture, the alternative sigma factor, σS becomes dominant to the 
housekeeping sigma factor, σ70, partially due to the association with ppGpp (322). σS controls up 
to 10% of the genes in E. coli (323, 324), including many genes that respond to osmotic stress 
(325) and temperature stress (326). In addition to σS, the extracytoplasmic sigma factor σ32 
becomes activated and induces the expression of chaperones and proteases to mitigate oxidative 
damage occurring on proteins, such as carbonylation (327-329). The activities of IHF and Lrp, 
two other transcriptional regulators, are also increased when cells experience nutrient limitation 
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(330, 331). Lrp appears to prepare the cell to direct internal nutrient reserves and metabolize 
fermentation products (330). IHF induces expression of chaperones and DNA damage response 
proteins (332, 333). 
 While chaperones and proteases are utilized for protein maintenance in response to 
damage, they also generally have increased activity. During growth, the ClpP protease associates 
with the subunit ClpX to recognize and degrade σS (334). During stationary phase, ClpXP and 
ClpAP complexes facilitate protein turnover, which is increased fivefold in starved cells (335). 
By turning over proteins, the cells can utilize the freed amino acids and peptides to perform de 
novo biosynthesis in the absence of carbon (336). As mentioned above, protein biosynthesis is 
reduced on top of this increased proteolysis. In part, this is due to reductions in tRNA and rRNA. 
There is also a phenomenon that occurs, known as the hibernation stage, wherein ribosomes form 
inactive, 100S dimers (337), which could be a way to store ribosomes until nutrients become 
available again. This hibernation is mediated by the Rmf protein, whose expression is induced by 
ppGpp during stationary phase (338). The combination of reduced biosynthesis and increased 
proteolysis results in a significantly reduced proteome relative to its exponential phase 
counterpart, which means any modifications that occur on these proteins have the propensity to 
have greater effect when there are fewer copies. 
 Metabolically, these stationary phase cells switch from a respiratory metabolism to more 
of a fermentative metabolism. The response regulator complex ArcAB/RssB mediates increased 
synthesis of glycolytic enzymes, while decreasing TCA cycle enzyme synthesis (314). The exact 
rationale for this change is not clear, but it is hypothesized that this may serve to either prevent 
uncontrolled use of endogenous nutrient reserves or as a defense mechanism against damaging 
reactive oxygen species that are produced during respiration (314). Thus, it would be expected 
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that cells limited by a non-carbon resource but with access to glucose would strongly ferment 
acetate and acetylate their proteins with AcP. 
Summary 
When bacteria deplete a nutrient, they will enter stationary phase, during which cell 
division ceases, but metabolism remains active. If carbon remains during stationary phase, the 
cells undergo overflow metabolism and ferment acetate. Production of acetate yields AcP, which 
can acetylate proteins. Since the bacteria cannot help but make AcP when they ferment acetate, 
one must ask whether the cells have evolved to cope with and/or utilize this non-enzymatic 
acetylation.  
Bacterial protein acetylation has become a field with rapidly growing interest. Since the 
first determination that a bacterial protein can be regulated by acetylation, CheY of E. coli (339), 
the number of acetylated bacterial proteins detected has grown to the thousands. While 
acetylation of certain lysines may have a clear output, such as inhibition of enzyme activity due 
to active site Nε-lysine acetylation, the functional importance of many acetyllysine modifications 
are more difficult to discern. To uncover the role of acetylation in these unclear cases, it is 
helpful to use a model bacterium (e.g., E. coli) with a vast knowledgebase of pathways, protein 
structure-function relationships, and physiology. Understanding how AcP-dependent acetylation 
is regulated can give clues as to how this global modification affects cellular physiology. 
In Chapter Three, I investigate the regulation of acetylation by AcP. First, I characterize 
AcP-dependent acetylation and determine how to modulate acetylation through genetic and non-
genetic means. To test the hypothesis that acetylation may serve to differentially regulate 
metabolism, I then asked whether exposure to different carbon sources, the six-carbon compound 
glucose and five-carbon compound xylose, yield different acetylated targets. Next, I test the 
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hypothesis that acetylation could be a means to protect proteins against oxidative damage during 
stationary phase. Finally, I test the hypothesis that AcP-dependent acetylation could be used as a 
carbon source during prolonged survival. 
Furthermore, although we now know two mechanisms by which acetylation can occur, 
additional mechanisms might exist. In Chapter Four, I ask whether these two known mechanisms 
are the only means of acetylation. There are 26 GNATs in E. coli, and only YfiQ has been shown 
to have KAT activity. With the knowledge gained in Chapter Three, I find that four of these 
GNATs have KAT activity. Finally, I assess mutants and overexpression constructs of these 
novel KATs to determine when they are physiologically relevant. 
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CHAPTER TWO 
MATERIALS AND METHODS 
Bacterial Strains, Plasmids, and Primers 
All bacterial strains, plasmids, and primers used in this dissertation are listed in Table 3, 
Table 4, and Table 5, respectively. Mutant strains were constructed by generalized transduction 
using P1kc (for details, see “Generalized P1 Transduction”). Transformants were generated via 
two different methods (for details, see “Transformation”). 
Culture Conditions 
For strain construction, cells were grown in Luria Broth (LB), which contains 10 g/liter 
tryptone, 5 g/liter yeast extract, and 5 g/liter sodium chloride; LB plates also contained 15 g/liter 
agar. Where stated, E. coli strains were aerated at 225 rpm with a flask-to-medium ratio of 10:1 
at 37°C in TB7 (10 g/liter tryptone buffered at pH 7.0 with 100 mM potassium phosphate [61.5 
mM potassium phosphate dibasic, and 38.5 mM potassium phosphate monobasic]) or M9 
minimal medium (11.3 g/liter M9 salts [5×], 0.1 mM CaCl2, 1 mM MgSO4, 2.45 μM ferric 
citrate, and 0.03 mM thiamine). In many instances, TB7 was supplemented with 0.4% glucose, 
0.4% lactate, 0.4% fructose, or 33 mM succinate. M9 was supplemented with 0.4% glucose, 
0.4% xylose, 4% glucose, or 4% xylose. Cell growth was monitored by determining the optical 
density at 600 nm (OD600) via spectrophotometer (DU640; Beckman Instruments, Fullerton, 
CA). 
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Table 3. Bacterial Strains Used in This Study 
Strain Genotype Refs 
AJW2198 AJW678 λ42(acs'-lacZ) Δcrp::frt kn (340) 
AJW2573 BW25113 Δpta ackA (341) 
AJW2922 BW25113 Δpta (342) 
AJW4883 BW25113 λrprA142 ΔrcsB::frt kn (78) 
AJW5070 AJW678 Δ(ackA pta hisJ hisP dhu) zej223-Tn10 ΔyfiQ::frt kn (153) 
AJW5231 BW25113 Δcrp::frt kn (78) 
AJW5384 BW25113 ΔptsG::frt kn (78) 
AJW5389 BW25113 Δcra::frt kn (aka ΔfruR::frt kn) (78) 
AJW5416 BW25113 ΔcsrA::frt kn (78) 
AJW5426 BW25113 Δpta::frt ΔyfiQ::frt Δacs::frt ΔcobB::frt kn (153) 
AJW5433 BW25113 Δcya::frt kn (78) 
AJW5441 BW25113 Δpgi::frt kn (341) 
AJW5493 BW25113 Δpta::frt ΔyfiQ::frt ΔacsA::frt ΔcobB::frt kn + pCA24n-
yiiD 
(153) 
AJW5494 BW25113 Δpta::frt ΔyfiQ::frt ΔacsA::frt ΔcobB::frt kn + pCA24n-
yhbS 
(153) 
AJW5495 BW25113 Δpta::frt ΔyfiQ::frt ΔacsA::frt ΔcobB::frt kn + pCA24n-
speG 
(153) 
AJW5496 BW25113 Δpta::frt ΔyfiQ::frt ΔacsA::frt ΔcobB::frt kn + pCA24n-
yjgM 
(153) 
AJW5497 BW25113 Δpta::frt ΔyfiQ::frt ΔacsA::frt ΔcobB::frt kn + pCA24n-
yfiQ 
(153) 
AJW5498 BW25113 Δpta::frt ΔyfiQ::frt ΔacsA::frt ΔcobB::frt kn + pCA24n-
rimJ 
(153) 
AJW5499 BW25113 Δpta::frt ΔyfiQ::frt ΔacsA::frt ΔcobB::frt kn + pCA24n-
rimI 
(153) 
AJW5500 BW25113 Δpta::frt ΔyfiQ::frt ΔacsA::frt ΔcobB::frt kn + pCA24n-
argA 
(153) 
AJW5501 BW25113 Δpta::frt ΔyfiQ::frt ΔacsA::frt ΔcobB::frt kn + pCA24n-
yiaC 
(153) 
AJW5502 BW25113 Δpta::frt ΔyfiQ::frt ΔacsA::frt ΔcobB::frt kn + pCA24n-
yhhY 
(153) 
AJW5503 BW25113 Δpta::frt ΔyfiQ::frt ΔacsA::frt ΔcobB::frt kn + pCA24n-
yncA 
(153) 
AJW5504 BW25113 Δpta::frt ΔyfiQ::frt ΔacsA::frt ΔcobB::frt kn + pCA24n-
yjaB 
(153) 
AJW5505 BW25113 Δpta::frt ΔyfiQ::frt ΔacsA::frt ΔcobB::frt kn + pCA24n-
yedL 
(153) 
AJW5506 BW25113 Δpta::frt ΔyfiQ::frt ΔacsA::frt ΔcobB::frt kn + pCA24n-aat (153) 
AJW5507 BW25113 Δpta::frt ΔyfiQ::frt ΔacsA::frt ΔcobB::frt kn + pCA24n- (153) 
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elaA 
AJW5508 BW25113 Δpta::frt ΔyfiQ::frt ΔacsA::frt ΔcobB::frt kn + pCA24n-yjdJ (153) 
AJW5509 BW25113 Δpta::frt ΔyfiQ::frt ΔacsA::frt ΔcobB::frt kn + pCA24n-
atoB 
(153) 
AJW5510 BW25113 Δpta::frt ΔyfiQ::frt ΔacsA::frt ΔcobB::frt kn + pCA24n-
yafP 
(153) 
AJW5511 BW25113 Δpta::frt ΔyfiQ::frt ΔacsA::frt ΔcobB::frt kn + pCA24n-
ypeA 
(153) 
AJW5512 BW25113 Δpta::frt ΔyfiQ::frt ΔacsA::frt ΔcobB::frt kn + pCA24n-
yjhQ 
(153) 
AJW5513 BW25113 Δpta::frt ΔyfiQ::frt ΔacsA::frt ΔcobB::frt kn + pCA24n-
phnO 
(153) 
AJW5533 BW25113 ΔglnA::frt kn (341) 
AJW5537 BW25113 Δpta::frt ΔyfiQ::frt ΔcobB::frt kn + pCA24n (153) 
AJW5538 BW25113 Δpta::frt ΔyfiQ::frt ΔcobB::frt kn + pCA24n-yfiQ (153) 
AJW5539 BW25113 Δpta::frt ΔyfiQ::frt ΔacsA::frt ΔcobB::frt kn + pCA24n (153) 
AJW5566 BW25113 ΔgltA::frt kn (341) 
AJW5567 BW25113 ∆glnD::frt kn (341) 
AJW5568 BW25113 ∆glnE::frt kn (341) 
AJW5569 BW25113 ∆phnP::frt kn (341) 
AJW5570 BW25113 ∆phoQ::frt kn (341) 
AJW5614 BW25113 ΔptsG::frt kn + pCA24n This study 
AJW5615 BW25113 ΔptsG::frt kn + pCA24n-crp This study 
AJW5616 BW25113 Δcrp::frt kn + pCA24n This study 
AJW5617 BW25113 Δcrp::frt kn + pPtsG This study 
AJW5852 BW25113 ΔthyA+ pKD46 This study 
AJW5864 BW25113 ΔrimI::frt kn This study 
AJW5865 BW25113 ΔphnO::frt kn This study 
AJW5866 BW25113 ΔyjgM::frt kn This study 
AJW5867 BW25113 ΔyjaB::frt kn This study 
AJW5868 BW25113 ΔyiaC::frt kn (153) 
AJW5874 BW25113 + pCA24n-rimI (153) 
AJW5875 BW25113 + pCA24n-phnO (153) 
AJW5876 BW25113 + pCA24n-yjgM This study 
AJW5877 BW25113 + pCA24n-yjaB (153) 
AJW5878 BW25113 + pCA24n-yiaC (153) 
AJW5882 BW25113 ΔyfiQ::frt kn (153) 
AJW5895 BW25113 Δpta::frt ΔyfiQ::frt ΔacsA::frt ΔcobB::frt kn + pCA24n-
locus 31 (FA-2) 
This study 
AJW5896 BW25113 Δpta::frt ΔyfiQ::frt ΔacsA::frt ΔcobB::frt kn + pCA24n-
locus 876 (FA-3) 
This study 
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AJW5897 BW25113 Δpta::frt ΔyfiQ::frt ΔacsA::frt ΔcobB::frt kn + pCA24n-
locus 1878 (FA-4) 
This study 
AJW5901 BW25113 Δpta::frt ΔyfiQ::frt ΔacsA::frt ΔcobB::frt kn + pCA24n-
locus 241 (1291-2) 
This study 
AJW5902 BW25113 Δpta::frt ΔyfiQ::frt ΔacsA::frt ΔcobB::frt kn + pCA24n-
locus 1685 (1291-4) 
This study 
AJW5925 BW25113 ΔthyA::thyA This study 
AJW5927 BW25113 ΔxylA::xylA K17Q This study 
AJW5928 BW25113 ΔxylA::xylA K17R This study 
AJW5930 BW25113 ΔxylA::xylA K381R This study 
AJW5942 BW25113 cysK::cysK K42R + pCA24n-cysK This study 
AJW5967 BW25113 Δpta::frt lac+ This study 
AJW5968 BW25113 ΔackA::frt lac+ This study 
AJW5970 BW25113 Δpta::frt ara+ This study 
AJW5971 BW25113 ΔackA::frt ara+ This study 
AJW5994 BW25113 + pCA24n (153) 
AJW6000 BW25113 Δpta::frt ΔyfiQ::frt ΔacsA::frt ΔcobB::frt kn + pCA24n-
locus 27 (FA-1) 
This study 
AJW6001 BW25113 Δpta::frt ΔyfiQ::frt ΔacsA::frt ΔcobB::frt kn + pCA24n-
locus 237 (1291-1) 
This study 
AJW6005 BW25113 ΔxylA::xylA K381Q This study 
AJW6030 BW25113 ΔalkA::frt kn This study 
AJW6033 BW25113 ΔyiaC::frt This study 
AJW6034 BW25113 ΔyiaC::frt ΔalkA::frt kn This study 
AJW6049 BW25113 ΔalkA::frt This study 
AJW6052 BW25113 Δtag::frt kn This study 
AJW6053 BW25113 ΔalkA::frt Δtag::frt kn This study 
AJW6055 BW25113 Δtag-yiaC::frt kn This study 
AJW6056 BW25113 alkA::frt tag-yiaC::frt kn This study 
AJW6067 BW25113 + pCA24n-yfiQ (153) 
AJW6068 BW25113 Δtag::frt This study 
AJW6069 BW25113 ΔyiaC::frt ΔalkA::frt This study 
AJW6070 BW25113 ΔalkA::frt Δtag::frt This study 
AJW6126 BW25113 Δpta::frt ΔyfiQ::frt ΔacsA::frt ΔcobB::frt kn + pCA24n-
yjaB Y117F 
(153) 
AJW6130 BW25113 Δpta::frt ΔyfiQ::frt ΔacsA::frt ΔcobB::frt kn + pCA24n-
phnO E78A 
(153) 
AJW6131 BW25113 Δpta::frt ΔyfiQ::frt ΔacsA::frt ΔcobB::frt kn + pCA24n-
phnO Y128A 
(153) 
AJW6132 BW25113 Δpta::frt ΔyfiQ::frt ΔacsA::frt ΔcobB::frt kn + pCA24n-
rimI Y115A 
(153) 
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AJW6136 BW25113 Δpta::frt ΔyfiQ::frt ΔacsA::frt ΔcobB::frt kn + pCA24n-
yiaC F70A 
(153) 
AJW6137 BW25113 Δpta::frt ΔyfiQ::frt ΔacsA::frt ΔcobB::frt kn + pCA24n-
yjaB Y117A 
(153) 
AJW6138 BW25113 Δpta::frt ΔyfiQ::frt ΔacsA::frt ΔcobB::frt kn + pCA24n-
yiaC Y115A 
(153) 
AJW6145 BW25113 + pCA24n-yiaC F70A (153) 
AJW6146 BW25113 + pCA24n-yiaC Y115A (153) 
AJW6163 BW25113 Δpta::frt ΔyfiQ::frt ΔacsA::frt ΔcobB::frt kn + pCA24n-ypfI (153) 
AJW6164 BW25113 Δpta::frt ΔyfiQ::frt ΔacsA::frt ΔcobB::frt kn + pCA24n-
astA 
(153) 
AJW6165 BW25113 Δpta::frt ΔyfiQ::frt ΔacsA::frt ΔcobB::frt kn + pCA24n-rffC (153) 
AJW6166 BW25113 Δpta::frt ΔyfiQ::frt ΔacsA::frt ΔcobB::frt kn + pCA24n-
yhhK 
(153) 
AJW6167 BW25113 Δpta::frt ΔyfiQ::frt ΔacsA::frt ΔcobB::frt kn + pCA24n-
yghO 
(153) 
AJW6168 BW25113 Δpta::frt ΔyfiQ::frt ΔacsA::frt ΔcobB::frt kn + pCA24n-citC (153) 
AJW678 thi-1 thr-1(Am) leuB6 metF159(Am) rpsL136 lacX74 (343) 
BW25113 F- λ- Δ(araD-araB)567 Δ(rhaD-rhaB)568 ΔlacZ4787 rrnB3 rph-1 
hsdR514 
(344) 
BW27422 BW25113 ΔarcA43 (345) 
ES114 Wild type isolate from E. scolopes (346) 
JW0030 Keio ΔcarA::kan (342) 
JW0031 Keio ΔcarB::kan (342) 
JW0162 Keio ΔglnD::kan (342) 
JW0389 Keio ΔphoB::kan (342) 
JW0440 Keio ΔglnK::kan (342) 
JW0474 Keio ΔybaS::kan (342) 
JW0660 Keio ΔasnB::kan (342) 
JW0710 Keio ΔgltA::kan (342) 
JW0715 Keio ΔsucA::kan (342) 
JW0911 Keio ΔaspC::kan (342) 
JW1115 Keio ΔphoQ::kan (342) 
JW1116 Keio ΔphoP::kan (342) 
JW1256 Keio ΔtrpE::kan (342) 
JW1328 Keio Δfnr::kan (342) 
JW1517 Keio ΔyneH::kan (342) 
JW1750 Keio ΔgdhA::kan (342) 
JW2005 Keio ΔhisH::kan (342) 
JW2309 Keio ΔpurF::kan (342) 
JW2408 Keio ΔptsH::kan (342) 
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JW2409 Keio ΔptsI::kan (342) 
JW2410 Keio Δcrr::kan (342) 
JW2491 Keio ΔguaA::kan (342) 
JW2537 Keio ΔglnB::kan (342) 
JW2541 Keio ΔpurL::kan (342) 
JW3025 Keio ΔglnE::kan (342) 
JW3179 Keio ΔgltB::kan (342) 
JW3180 Keio ΔgltD::kan (342) 
JW3789 Keio ΔcorA::kan (342) 
JW3839 Keio ΔglnG::kan (342) 
JW3840 Keio ΔglnL::kan (342) 
JW3841 Keio ΔglnA::kan (342) 
JW3985 Keio Δpgi::kan (342) 
JW4099 Keio ΔaspA::kan (342) 
JW4201 Keio ΔmgtA::kan (342) 
MC4100 F-, [araD139]B/r, Δ(argF-lac)169, lambda-, e14-, flhD5301, Δ(fruK-
yeiR)725(fruA25), relA1, rpsL150(strR), rbsR22, Δ(fimB-
fimE)632(::IS1), deoC1 
(347) 
MG1655 F-, lambda-, rph-1 (348) 
PY79 Bacillus subtilis PY79  (349) 
 
Table 4. Plasmids Used in This Study 
Plasmid Resistance Description Refs 
pBR322 Amp Empty vector (350) 
pCA24n Cm Empty vector (351) 
pCA24n-aat Cm ASKA collection (351) 
pCA24n-argA Cm ASKA collection (351) 
pCA24n-astA Cm ASKA collection (351) 
pCA24n-atoB Cm ASKA collection (351) 
pCA24n-citC Cm ASKA collection (351) 
pCA24n-crp Cm ASKA collection (351) 
pCA24n-cysK Cm ASKA collection (351) 
pCA24n-elaA Cm ASKA collection (351) 
pCA24n-locus 1685 
(1291-4) 
Cm pCA24n carrying phnO homolog from GC 
strain 1291 
This 
study 
pCA24n-locus 1878 
(FA-4) 
Cm pCA24n carrying phnO homolog from GC 
strain FA1090 
This 
study 
pCA24n-locus 241 
(1291-2) 
Cm pCA24n carrying rimI homolog from GC strain 
1291 
This 
study 
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pCA24n-locus 31 (FA-
2) 
Cm pCA24n carrying rimI homolog from GC strain 
FA1090 
This 
study 
pCA24n-locus 876 
(FA-3) 
Cm pCA24n carrying locus 876 from GC strain 
FA1090 
This 
study 
pCA24n-phnO Cm ASKA collection (351) 
pCA24n-phnO E78A Cm SDM of pCA24n-phnO (351) 
pCA24n-phnO Y128A Cm SDM of pCA24n-phnO (351) 
pCA24n-ptsG Cm ASKA collection (351) 
pCA24n-rffC Cm ASKA collection (351) 
pCA24n-rimI Cm ASKA collection (351) 
pCA24n-rimI Y115A Cm SDM of pCA24n-rimI (153) 
pCA24n-rimJ Cm ASKA collection (351) 
pCA24n-speG Cm ASKA collection (351) 
pCA24n-yafP Cm ASKA collection (351) 
pCA24n-yedL Cm ASKA collection (351) 
pCA24n-yfiQ Cm ASKA collection (351) 
pCA24n-yghO Cm ASKA collection (351) 
pCA24n-yhbS Cm ASKA collection (351) 
pCA24n-yhhK Cm ASKA collection (351) 
pCA24n-yhhY Cm ASKA collection (351) 
pCA24n-yiaC Cm ASKA collection (351) 
pCA24n-yiaC F70A Cm SDM of pCA24n-yiaC (153) 
pCA24n-yiaC Y115A Cm SDM of pCA24n-yiaC (153) 
pCA24n-yiiD Cm ASKA collection (351) 
pCA24n-yjaB Cm ASKA collection (351) 
pCA24n-yjaB Y117A Cm SDM of pCA24n-yjaB (153) 
pCA24n-yjaB Y117F Cm SDM of pCA24n-yjaB (153) 
pCA24n-yjdJ Cm ASKA collection (351) 
pCA24n-yjgM Cm ASKA collection (351) 
pCA24n-yjhQ Cm ASKA collection (351) 
pCA24n-yncA Cm ASKA collection (351) 
pCA24n-ypeA Cm ASKA collection (351) 
pCA24n-ypfI Cm ASKA collection (351) 
pCP20 Cm, Amp Temperature sensitive plasmid carrying FLP 
gene 
(352) 
pDCRP Amp pBR322 carrying wild-type crp cloned under 
the control of the crp promoter 
(350) 
pDCRP-H159L Amp pBR322 carrying crp H159L cloned under the 
control of the crp promoter 
(350) 
pDCRP- Amp pBR322 carrying crp H159L,K101E cloned (78) 
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H159L,K101E under the control of the crp promoter 
pDCRP-K101E Amp pBR322 carrying crp K101E cloned under the 
control of the crp promoter 
(350) 
pKD46 Amp Carries lambda Red genes under an arabinose-
inducible promoter 
(344) 
 
Table 5. Primers Used in This Study 
Primer Sequence 
PhnO E78A F 5’-gtcaactggatcggcgcaattcaggagttggtg-3’ 
PhnO E78A R 5’-caccaactcctgaattgcgccgatccagttgac-3’ 
PhnO Y128A F 5’-gacgcgcaccgtttcgctctgcgcgaaggcta-3’ 
PhnO Y128A R 5’-tagccttcgcgcagagcgaaacggtgcgcgtc-3’ 
RimI Y115A F 5’-gctgccgccattgccctggccgaaagtttaggctttaa-3’ 
RimI Y115A R 5’-ttaaagcctaaactttcggccagggcaatggcggcagc-3’ 
YiaC F70A F 5’-cagcattatggaaggccgagctctggcagcgatgtttg-3’ 
YiaC F70A R 5’-caaacatcgctgccagagctcggccttccataatgctg-3’ 
YiaC Y115A F 5’-gtttatcaaaaaaatcaaccggcgataaattttgcccaggcacagggttttc-3’ 
YiaC Y115A R 5’-gaaaaccctgtgcctgggcaaaatttatcgccggttgatttttttgataaac-3’ 
YjaB Y117A F 5’-tgagcaggcggttgggttcgctaagaaggtgggttttaag-3’ 
YjaB Y117A R 5’-cttaaaacccaccttcttagcgaacccaaccgcctgctca-3’ 
YjaB Y117F F 5’-gcaggcggttgggttctttaagaaggtgggtttta-3’ 
YjaB Y117F R 5’-taaaacccaccttcttaaagaacccaaccgcctgc-3’ 
thyA up 5'-ccgacgcgcagttta-3' 
thyA dn 5'-cacgttgtgttttcatgc-3' 
xylA K17 TU 5'-ctattttgaccagctcgatcgcgttcgttatgaaggctcaaaatagacagctgcatgcat-3’ 
xylA K17 TD 5'-gttcgtcgggattgtagtgacggaatgctaacgggtttgaggagtgtaggctggagctg-3’ 
xylA MU 17A 5'-cgttcgttatgaaggctcagcatcctcaaacccgttagca-3’ 
xylA MD 17A 5’-tgctaacgggtttgaggatgctgagccttcataacgaacg-3’ 
xylA MU 17Q 5’-cgatcgcgttcgttatgaaggctcacagtcctcaaacccgt-3’ 
xylA MD 17Q 5’-acgggtttgaggactgtgagccttcataacgaacgcgatcg-3’ 
xylA MU 17R 5’-cgcgttcgttatgaaggctcaagatcctcaaaccc-3’ 
xylA MD 17R 5’-gggtttgaggatcttgagccttcataacgaacgcg-3’ 
xylA K17 F1U 5’-gcgagcgagcgcacacttgt-3’ 
xylA K17 F1D 5’-gttccagcagaaggtgtgccagta-3’ 
xylA K17 F2U 5’-tcttacttttgttgcgcaat-3’ 
xylA K17 F2D 5’-gtggaaaaactcaaatgcgac-3’ 
xylA K381 TU 5’-gaaaattgcagcgcgcatgattgaagatggcgagctggataaatagacagctgcatgcat-3’ 
xylA K381 TD 5’-tggcccaattcgctattccagccggaataacgctgcgcgatgcggtgtaggctggagctg-3’ 
xylA MU 381A 5’-gaagatggcgagctggatgcacgcatcgcgcag-3’ 
xylA MD 381A 5’-ctgcgcgatgcgtgcatccagctcgccatcttc-3’ 
xylA MU 381Q 5’-aagatggcgagctggatcagcgcatcgcgcagc-3’ 
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xylA MD 381Q 5’-gctgcgcgatgcgctgatccagctcgccatctt-3’ 
xylA MU 381R 5’-gaagatggcgagctggatagacgcatcgcg-3’ 
xylA MD 381R 5’-cgcgatgcgtctatccagctcgccatcttc-3’ 
xylA K381 F1U 5’-gtggtctgaacttcgatgcc-3’ 
xylA K381 F1D 5’-tcctggcgaccactctgatg-3’ 
xylA K381 F2U 5’-gtgtggaagagaatgcgctg-3’ 
xylA K381 F2D 5’-tgcccggtatcgctaccgat-3’ 
CRP AR1 H159L - F 5'-caaaacaaccagacgctatgactctgccggacggtatg-3' 
CRP AR1 H159L - R 5'-cataccgtccggcagagtcatagcgtctggttgttttg-3' 
CRP AR2 K101E - F 5'-gtgaagtggctgaaatttcgtacaaagaatttcgccaattgattca-3' 
CRP AR2 K101E - R 5'-tgaatcaattggcgaaattctttgtacgaaatttcagccacttcac-3' 
pCA24n Up 5’-gccctttcgtcttcacctc-3’ 
pCA24n Dn 5’-ggcagatcgtcagtcagtca-3’ 
ackA fwd 5’-gcgctacgctctatggct-3’ 
ackA rev 2 5’-cgttccattgcacggatcac-3’ 
pta fwd 2 5’-gcggtggttatcccaacc-3’ 
pta rev 2 5’-gcaaagtgggatggcgc-3’ 
acsA fwd 2 5’-gttgctgaccttcaaaaattaccc-3’ 
acsA rev 2 5’-cccgctcccttatgggag-3’ 
yfiQ fwd 5’-aacgcaacatctgggtagc-3’ 
yfiQ rev 5’-cctctgtgcaatgcagacg-3’ 
tag::frtkn deletion F 5’-cgatcgggtacatagcgagggaaagtatgattccggggatccgtcgacc-3’ 
yiaC::frtkn deletion R 5’-gaactgacacttacagcgtttgaaccaccggtgtaggctggagctgcttcg-3’ 
 
To determine the effect of magnesium on growth, a volume of MgSO4 stock (1 M) was 
added to cells grown in TB7 or TB7 supplemented with 0.4% glucose to achieve the final 
concentrations indicated in the text. 
Antibiotics were prepared as a stock solution 1000 times the working concentration. 
Working concentrations were as follows: ampicillin, 100 μg/mL; kanamycin, 40 μg/mL; 
tetracycline, 15 μg/mL; and chloramphenicol, 25 μg/mL. Stock solutions of ampicillin and 
kanamycin were dissolved in water and filter sterilized. Stock solutions of tetracycline and 
chloramphenicol were dissolved in 50% and 100% ethanol, respectively, and filter sterilized. All 
antibiotic stocks were stored at -20°C. To induce expression from the pCA24n plasmid, IPTG 
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(Isopropyl β-D-1-thiogalactopyranoside) was added to a final concentration of 50 μM or 100 
μM. 
Generalized P1 Transduction 
To generate lysates, a donor strain (often from the KEIO collection (342)) was aerated 
until 0.3 OD600 in 5 mL TBT (TB with 0.2% [w/v] glucose, 10 mM calcium chloride, 10 mM 
magnesium sulfate, 0.04 mM ferric chloride) with antibiotic, if appropriate. Upon reaching this 
density, 100 μL of a P1kc phage lysate was added and aeration resumed for another three to five 
hours until complete lysis. This lysate was treated with 100 μL chloroform, vortexed, and 
centrifuged at 3000 rpm for 15 minutes. The supernatant was transferred to a new tube, treated 
with 100 μL chloramphenicol and stored at +4°C in the dark. 
To transduce a recipient strain, the recipient was grown overnight in LB and diluted into 
5 mL TBT to an OD600 of 0.02-0.04.  The recipient was aerated until 0.5-1.0 OD500, and 1 mL 
of culture was transferred into 1.5 mL tubes. 100 μL of donor phage lysate was added to the 
recipient and the mixture was incubated statically for 30 minutes at 37°C. 200 μL of 1 M sodium 
citrate, pH 5.5 was added to the infected cells to prevent further infection. The infected cells 
were pelleted and suspended in 500 μL LB, then 200 μL of 1 M sodium citrate, pH 5.5 was 
added to the suspension. The cells were incubated statically at 37°C for 70 minutes. The cells 
were pelleted and suspended in 100 μL sodium citrate, pH 5.5. The entire 100 μL of transduced 
cells was plated onto LB plates containing the appropriate antibiotics and incubated at 37°C for 
24 hours, or until colonies appeared. Note that, if the marker was chloramphenicol, half the 
normal working concentration was used, while if the marker was kanamycin, double the normal 
working concentration was used. 
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Elimination of Kanamycin Cassettes Flanked by FRT Sites 
 The KEIO collection replaces each non-essential gene of E. coli with a kanamycin 
cassette flanked by FRT sites that can permit elimination of the cassette upon expression of Flp 
recombinase. To achieve this, a mutant carrying an FRT-kanamycin-FRT cassette was 
transformed via the TBF protocol (see “Transformation”) with the pCP20 plasmid carrying the 
flp gene. Cells were plated on LB/ampicillin, and recovery of the strain was carried out at 30°C 
or below due to the temperature-sensitive origin of replication of pCP20. To ensure loss of the 
kanamycin cassette, individual colonies that arose were struck on LB and LB/kanamycin and 
were grown at 30°C. To eliminate pCP20, kanamycin sensitive colonies were struck on LB and 
grown at 42°C. Loss of pCP20 was confirmed by replica streaking on LB and LB/ampicillin. The 
resultant kanamycin-sensitive, ampicillin-sensitive strains were checked for kanamycin cassette 
elimination by PCR. 
Site-Directed Mutagenesis 
Site-directed mutagenesis of crp in pDCRP and of phnO, rimI, yiaC, and yjaB in pCA24n 
was performed using the QuikChange II Site-Directed Mutagenesis Kit (Agilent Technologies, 
Santa Clara, CA) per the manufacturer’s instructions. Primers used for site-directed mutagenesis 
can be found in Table 5. Mutations were confirmed by sequence analysis of the purified 
mutagenized plasmid (ACGT, inc, Wheeling, IL). 
FRUIT: Flexible Recombineering Using Integration of thyA 
To introduce mutant alleles of xylA into the chromosome, lambda Red-based technique, 
FRUIT, was employed (353). Briefly, a ΔthyA strain carrying the temperature sensitive plasmid 
pKD46 that encodes the lambda Red recombination genes was grown to 0.6 OD600 in 50 mL 
LB supplemented with 100 μg/mL thymine, 100 μg/mL ampicillin, and 0.15% arabinose. Cells 
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were pelleted at 4000 rpm for 7 minutes. The pellet was washed with 50 mL ice cold water three 
times. After the last wash, the water was decanted, and the pellet was resuspended in any 
remaining water. Cells were transformed with a PCR product containing a thyA cassette flanked 
by homology to the gene to be mutated. Cells that successfully recombined the thyA cassette into 
the chromosome were grown in LB supplemented with 100 μg/mL ampicillin and 0.15% 
arabinose. These cells were pelleted and transformed as described above. However, the PCR 
product contains the replacement allele of interest with regions of homology around the thyA 
cassette. Transformants were plated on M9 minimal medium supplemented with 0.4% glucose, 
0.2% casamino acids, 100 μg/mL ampicillin, 100 μg/mL thymine, and 20 μg/mL trimethoprim, 
such that only cells that successfully replace the thyA cassette can grow. Finally, the thyA 
cassette was restored to the native site in the chromosome via the steps described above. 
Transformation 
Two transformation methods were used: transformation buffers (TBF) and electroporation. 
TBF 
To generate chemically competent cells, overnight cultures grown in LB (with antibiotic, 
if appropriate) were subcultured into 100 mL LB (with antibiotic, if appropriate) and aerated at 
225 rpm at 37°C until the OD600 reached 0.4-0.6. The culture was cooled on ice for 5 minutes 
and then pelleted. The supernatant was removed, and the pellet was suspended with 7.5 mL cold 
TBF1 (30 mM potassium acetate, 100 mM potassium chloride, 10 mM calcium chloride, 50 mM 
manganese chloride, 15% glycerol, pH to 5.8 with acetic acid) and incubated for one hour on ice. 
The cells were pelleted, supernatant removed, then the pellet suspended with 2 mL cold TBF2 
(10 mM MOPS, 75 mM calcium chloride, 10 mM potassium chloride, 15% glycerol, pH to 6.5 
with potassium hydroxide). The cells were chilled on ice for 30 minutes before use.  
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1 μL plasmid DNA was added to 50 μL chemically competent cells and chilled on ice for 
10 minutes. The cell-DNA mixture was heat shocked in a water bath for 45 seconds at 42°C, 
then chilled on ice for 2 minutes. 1 mL LB was added to the transformed cells, and the cells were 
shaken at 225 rpm at 37°C for one hour. 100 μL of the transformed cells were plated onto LB 
plates containing the appropriate antibiotics and incubated at 37°C overnight, or until colonies 
appeared. 
Electroporation 
Overnight cultures grown in LB (plus antibiotic if appropriate) were subcultured into 50 
mL LB (plus antibiotic if appropriate) and shaken at 225 rpm at 37°C until the OD600 reached 
0.4-0.6. The culture was transferred into a 50 mL conical tube and incubated on ice for 30 
minutes. The tube was centrifuged at 4000 rpm for 7 minutes at +4°C. The supernatant was 
removed, and each pellet was suspended in 1 mL cold water. An additional 49 mL cold water 
was added to each cell suspension, bringing the volume to 50 mL. These washes were repeated 
three more times; after the last wash, the pellet was suspended in the liquid remaining after 
decanting. 1 μL plasmid DNA was added to 50 μL electrocompetent cells, which were then 
transferred to a chilled electroporation cuvette with a 0.2 cm gap and electroporated at 25 μF, 
200 Ω, and 2.5 kV. 1 mL LB was added to the transformed cells, and the cells were shaken at 
225 rpm at 37°C for one hour. 150 μL of the transformed cells were plated onto LB plates 
containing the appropriate antibiotics and incubated at 37°C overnight, or until colonies 
appeared. 
Measurement of Glucose and Acetate in Media 
At the indicated time points, culture supernatants were harvested. Supernatants were 
diluted 1:150 in 50 mM sodium acetate buffer. 50 μL of the diluted samples and standards were 
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added to a 96-well plate. To each well, 50 μL of reaction mix (48 mM sodium acetate [Sigma 
241245], 320 μM o-Dianisidine [Sigma D3252], 4U/mL horseradish peroxidase [Sigma P8250], 
0.8U/mL glucose oxidase [Sigma G2133]) was added. Reactions were incubated for 30 minutes 
and were stopped with 12N H2SO4. Color change was measured spectrophotometrically at 
OD540. Concentration of glucose in samples was determined using the standards. 
Acetate measurements were performed using Acetate Colorimetric Assay Kit (Biovision, 
Milpitas, CA) per the manufacturer’s instructions. Briefly, culture supernatants were harvested as 
above. 5 μL sample was added to 45 μL assay buffer. Diluted samples and standards were added 
to a 96-well plate. 50 μL of reaction mix was added to each well and allowed to proceed for 40 
minutes at room temperature. OD450 was determined spectrophotometrically and standards were 
used to calculate acetate concentrations in the samples. 
Western Immunoblot Analysis 
E. coli cells were grown in TB7 overnight at 225 rpm at 37°C. The cultures were diluted 
to 0.05 OD600 in either TB7 or TB7 supplemented with 0.4% glucose. Cells were harvested and 
pelleted at the indicated times. Per 1 mL culture, pelleted cells were lysed with agitation for 30 
minutes using 46 μL BugBuster protein extraction reagent (Novagen, Merck Millipore, Billerica, 
MA, USA) with 4 μL DNase/RNase mix (1 mg/mL DNase, 0.3 mg/mL RNase). The lysate was 
centrifuged, and the cleared lysate was separated from cell debris. The amount of cell lysate to be 
loaded on the gel was normalized to the total protein concentration (15 μg), as determined by the 
bicinchoninic acid (BCA) assay (Thermo Scientific Pierce, Waltham, MA, USA). After 
normalization, the lysates were boiled in a 1:5 mixture with NuPage LDS sample buffer 
supplemented with 10% beta-mercaptoethanol. Proteins were separated by sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) at 125V until the dye front left the gel. 
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Normalization was verified by Coomassie staining. Transfer to nitrocellulose membrane was 
carried out for 1.5 hours at 100V at +4°C. The membrane was blocked with 5% milk. Protein 
acetylation was determined using a rabbit polyclonal anti-acetyllysine antibody (Cell Signaling 
#9441) at a dilution of 1:1,000 in 5% BSA with a secondary goat-anti-rabbit IgG HRP-linked 
antibody (Cell Signaling #7074) at a dilution of 1:2,000 in 5% milk. His-tagged proteins were 
detected using mouse anti-His tag (27E8) antibody at a dilution of 1:1,000 (Cell Signaling, 
Danvers, MA) and an anti-mouse IgG HRP-linked antibody at a dilution of 1:2,000 (Cell 
Signaling, Danvers, MA). To detect CRP, monoclonal mouse primary antibodies against CRP 
(BioLegend 664304) were used at a dilution of 1:2,000 and HRP-conjugated goat anti-mouse 
secondary antibody (Millipore AP503P) were used at a dilution of 1:2,500. 
Detection of His-tagged KATs was carried out as above with slight modifications. His-
tagged KATs were detected with crude lysates. One milliliter of 1 OD600 culture was harvested, 
pelleted, and suspended in 200 μL sample loading buffer. The samples were boiled for 10 
minutes and 15 μL were loaded directly onto SDS-PAGE gels. His-tagged proteins were detected 
with mouse anti-His tag (27E8) antibody at a dilution of 1:1,000 (Cell Signaling, Danvers, MA) 
and an anti-mouse IgG HRP-linked antibody at a dilution of 1:2,000 (Cell Signaling, Danvers, 
MA). 
Isolation and Qualitative Assessment of Protein Aggregates 
E. coli cells were aerated overnight in TB7 at 225 rpm at 37°C. The cultures were diluted 
to 0.05 OD600 in TB7 supplemented with 0.4% glucose and aerated for 10 hours or 24 hours. 
After 10 or 24 hours, a 10 mL sample of the culture with lowest OD600 value and the equivalent 
cell number of the other cultures were harvested and pelleted. Cell pellets were suspended in 1 
mL PBS and pelleted again. Cell pellets were suspended in 300 μL Lysis Buffer (10 mM Tris-
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HCl pH 8.0, 1 mM EDTA pH 8.0, 1.4 mM PMSF) and were incubated on ice for 10 minutes. 
From here on, cells or cell components were kept on ice or at 4°C for centrifugation steps. Pellets 
were disrupted by sonication (10 bursts of 10 seconds each with 30 seconds rest in between). 
Cell suspensions were centrifuged at 2000 × g for 15 minutes to remove intact cells. Supernatant 
was removed and centrifuged at 15,000 × g for 20 minutes to collect the insoluble fraction. The 
insoluble pellet was suspended in 400 μL of Lysis Buffer with 2% NP40 to separate proteins 
from membranes. Aggregated proteins were centrifuged at 15,000 × g for 30 minutes, and the 
resultant pellets were suspended in Lysis Buffer with 2% NP40 twice. Pelleted proteins were 
suspended in 40 μL Gel Loading Buffer (62.5 mM Tris-HCl pH 6.8, 10% glycerol, 179 mM 
beta-mercaptoethanol, 0.2% SDS, 0.002% Bromophenol blue). Proteins were separated by SDS-
PAGE at 125V until the dye front left the gel. Proteins were visualized by Coomassie staining. 
Carbonylation Analysis 
 Carbonylated proteins were assessed via the OxyBlot™ Protein Oxidation Detection Kit 
(MilliporeSigma, Darmstadt, Germany) per the manufacturer’s instructions. Cells were grown 
and harvested as described in the text. Cell lysis was performed with either sonication (10 bursts 
of 10 seconds each with 30 seconds rest in between) or with BugBuster protein extraction 
reagent. During cell lysis, 1% beta mercaptoethanol and 50 mM DTT were added to inhibit 
oxidation after lysis and 1 mM PMSF was added to inhibit proteolysis. 15 μg of isolated proteins 
were denatured by adding an equivalent volume of 12% SDS and derivatized by treatment with a 
1× 2,4-dinitrophenylhydrazine (DNPH) solution or a control solution for 15 minutes. 3 μL of 
LDS sample buffer was added and volumes were normalized to 30 μL with water. Proteins were 
separated via SDS-PAGE and were transferred to a nitrocellulose membrane as described in 
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“Western Immunoblot Analysis”. Derivatized proteins were detected via anti-DNP primary 
antibody with an HRP-linked secondary antibody. 
Purification of His-Tagged Proteins 
 QIAexpress® Ni-NTA Fast Start kit (Qiagen, Hilden, Germany) was used to purify His-
tagged proteins per the manufacturer’s instructions. Briefly, cells carrying a plasmid encoding a 
His-tagged protein were aerated in 250 mL LB supplemented with chloramphenicol. Upon 
achieving an OD600 of 0.6, IPTG was added to a final concentration of 500 μM. After 5 hours, 
cells were pelleted, resuspended in 10 mL Native Lysis Buffer supplemented with 1 mL 
DNase/RNase mix and 40 μL lysozyme (25 mg/mL), and agitated for 30 minutes on ice. Cell 
debris was removed by centrifugation at 14,000 × g at 4°C. His-tagged proteins were purified 
using the supplied Ni-NTA column. Flow through, wash fractions, and elutions were collected at 
each step to monitor the His-tagged protein purity and loss.  
In Vitro Acetylation Assays 
Enzymatic 
 Acetylation reactions of CysK (20 μM) were carried out with YiaC (2 μM) in reaction 
buffer (50 mM Tris pH 8.0 or 50 mM Tris pH 7.0, 250 mM NaCl, 10% glycerol, 1 mM DTT, 10 
mM sodium butyrate, 10 mM MgCl2) with concentrations of AcCoA varying from 10 μM to 5 
mM. Control reactions were carried out in the absence of YiaC or AcCoA. The reactions were 
allowed to proceed for 1 hour at 37°C. To stop the reactions, loading dye was added, and either 
samples were boiled for 5 minutes at 100°C or they were immediately loaded into the SDS-
PAGE gel. Anti-acetyllysine western blots were performed as described above. 
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Non-Enzymatic 
 Acetylation reactions were carried out in reaction buffer (150 mM Tris pH 7.3, 150 mM 
NaCl, 10% glycerol, 10 mM MgCl2) with varying concentrations of AcP or AcCoA. Reactions 
were incubated at 37°C for 2 hours. Reactions were stopped by adding an equivalent volume of 
LDS sample buffer. Samples were loaded on an SDS-PAGE gel, and anti-acetyllysine western 
blots were performed as described above. 
Starvation Survival Assay 
 From a parent strain (BW25113) that could not grow on arabinose or lactose, two sets of 
Δpta and ΔackA strains were generated such that they could grow on either arabinose or lactose 
by performing three backcrosses initially using a lysate of strain MG1655 (lac+, ara+). All 
strains were aerated overnight in M9 minimal medium with 0.4% glucose (M9/gl) as the sole 
carbon source. The cultures were diluted into fresh M9/gl and aerated until stationary phase (~9 
hours). Equivalent cell numbers were harvested from each flask. Cell pellets were resuspended in 
M9 without a carbon source and either maintained as a monoculture or combined with the cell 
suspension containing the opposing deletion and marker. These M9 cultures were aerated for 9-
16 days. At the indicated days, serial dilutions were performed, and cells were plated on M9 agar 
supplemented with 0.4% arabinose or 0.4% lactose to enumerate colony forming units. 
DNA Alkylation Survival Assay 
 Cells were aerated in LB until an OD600 of 0.4 – 0.6, whereupon they were harvested 
and pelleted. Cell pellets were resuspended in an equivalent volume of M9 without a carbon 
source. A volume of MNNG (1 mg/mL) was added to each cell suspension to achieve the desired 
concentration, and treatment was allowed to proceed for 20 minutes. After 20 minutes, two 
equivalents of PBS were added to stop the treatment. Then, cells were pelleted and resuspended 
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in fresh PBS. 10-fold dilutions were made in PBS, and dilutions were spotted on LB plates to 
determine cell survival. 
Mucoidy Assay 
 Cells were grown overnight in LB with appropriate antibiotic. Equivalent cell numbers 
were spotted onto M9 minimal glucose plates. Plates were incubated at 28°C overnight. Colonies 
were assessed for visual mucoid phenotype. 
Motility Assay 
 Cells were grown in tryptone broth medium (10 g/liter tryptone, 5 g/liter NaCl) overnight 
supplemented with antibiotics or 50 μM IPTG when appropriate. 5 μL spots containing 
equivalent cell numbers were spotted onto semisolid agar plates (10 g/liter tryptone, 5 g/liter, 2 
g/liter agar) supplemented with antibiotics or 50 μM IPTG when appropriate. Alternatively, 
overnight cultures were diluted to 0.05 OD600 and aerated until exponential phase (~0.5 
OD600). Then, equivalent cell numbers were spotted onto semisolid agar plates. Plates were 
incubated at 30°C. Diameters of the colonies were measured hourly. 
Mass Spectrometry 
Preparing Samples 
 In all experiments described, each sample described was obtained in triplicate biological 
samples. To determine how acetylation changed over time in response to glucose, wild-type E. 
coli was grown overnight in TB7 and then diluted into TB7 alone or into TB7 supplemented with 
0.4% glucose. At the time points mentioned in the text, cultures were harvested. To identify 
proteins acetylated by YiaC, YjaB, PhnO, RimI, and YfiQ, the Δpta yfiQ acsA cobB (gutted) 
strains overexpressing each putative KAT were aerated in TB7 supplemented with 0.4% glucose, 
50 μM IPTG, and chloramphenicol for 10 hours. To identify acetylated proteins in response to 
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glucose or xylose, wild-type E. coli were grown overnight in M9 minimal medium with either 
0.4% glucose (M9/glucose) or 0.4% xylose (M9/xylose) as the sole carbon source. The cells in 
M9/glucose were diluted into M9 minimal medium supplemented with 0.4% or 4% glucose, 
while the cells in M9/xylose were diluted into M9 minimal medium supplemented with 0.4% or 
4% xylose. These cultures were aerated for 12 hours and harvested. In each experiment, the cells 
were pelleted, rinsed in 6 mL PBS, pelleted again, and frozen at -80°C until shipment to Dr. 
Birgit Schilling (Buck Institute for Research on Aging). 
Proteolytic Digestion of Protein Lysates and Enrichment of Acetylated Peptides 
The firm cell pellet was suspended and denatured in a final solution of 6 M urea, 100 mM 
Tris, 75 mM NaCl, and the deacetylase inhibitors tricostatin A (1 mM) and nicotinamide (3 
mM). Samples were sonicated on ice (5× each for 15 sec), cellular debris was removed by 
centrifugation, and the supernatants were processed for proteolytic digestion. Lysates containing 
1.5 mg of protein were reduced with 20 mM DTT (37°C for 1 h), and subsequently alkylated 
with 40 mM iodoacetamide (30 min at RT in the dark). Samples were diluted 10-fold with 100 
mM Tris (pH 8.0) and incubated overnight at 37°C with sequencing grade trypsin (Promega) 
added at a 1:50 enzyme:substrate ratio (wt/wt). In parallel, separate 1.5 mg protein aliquots were 
digested using endoproteinase Glu-C (Roche, Indianapolis, IN) by adding Glu-C at a 1:50 
protease to substrate protein ratio (wt:wt), and incubating overnight at 37 °C. Subsequently, 
samples were acidified with formic acid and desalted using HLB Oasis SPE cartridges (Waters) 
(354). Proteolytic peptides were eluted, concentrated to near dryness by vacuum centrifugation, 
and suspended in NET buffer (50 mM Tris-HCl, pH 8.0, 100 mM NaCl, 1 mM EDTA). A small 
aliquot of each protein digestion (∼ 10 μg) was saved for protein-level identification and 
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quantification. The remaining proteolytic peptide samples were used for affinity purification of 
acetylated peptides (Kac).  
Acetylated peptides were enriched using 1/4 tube of anti-acetyl lysine antibody-bead 
conjugated ‘PTMScan Acetyl-Lysine Motif [Ac-K]’ Kit (Cell Signaling Technologies) for each 
of the 1 mg protein lysate samples according to the manufacturer’s instructions. Prior to mass 
spectrometric analysis, the acetylated peptide enrichment samples were concentrated and 
desalted using C-18 zip-tips (Millipore, Billerica, MA). 
Mass Spectrometric Analysis 
Samples were analyzed by reverse-phase HPLC-ESI-MS/MS using the Eksigent Ultra 
Plus nano-LC 2D HPLC system (Dublin, CA) combined with a cHiPLC System, which was 
directly connected to a quadrupole time-of-flight SCIEX TripleTOF 6600 mass spectrometer 
(SCIEX, Redwood City, CA) (78). After injection, peptide mixtures were transferred onto a C18 
pre-column chip (200 µm x 6 mm ChromXP C18-CL chip, 3 µm, 300 Å, SCIEX) and washed at 
2 µl/min for 10 min with the loading solvent (H2O/0.1% formic acid) for desalting. 
Subsequently, peptides were transferred to the 75 µm x 15 cm ChromXP C18-CL chip, 3 µm, 
300 Å, (SCIEX), and eluted at a flow rate of 300 nL/min with a 3 h gradient using aqueous and 
acetonitrile solvent buffers (78). 
Data-dependent acquisitions: To build a spectral library for protein-level quantification, 
the mass spectrometer was operated in data-dependent acquisition (DDA) mode where the 30 
most abundant precursor ions from the survey MS1 scan (250 msec) were isolated at 1 m/z 
resolution for collision induced dissociation tandem mass spectrometry (CID-MS/MS, 100 msec 
per MS/MS, ‘high sensitivity’ product ion scan mode) using the Analyst 1.7 (build 96) software 
with a total cycle time of 3.3 sec as previously described (57, 78, 355).   
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Data-independent acquisitions: For quantification, all peptide samples were analyzed by 
data-independent acquisition (DIA, e.g. SWATH) (356), using 64 variable-width isolation 
windows (57, 357, 358). The SWATH cycle time of 3.2 sec included a 250 msec precursor ion 
scan followed by 45 msec accumulation time for each of the 64 variable SWATH segments. 
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CHAPTER THREE 
EXPERIMENTAL RESULTS 
Characterizing the Timing and Dynamics of Glucose-Dependent Acetylation 
Introduction 
Our group and others have determined that acetylation can globally modify proteins in E. 
coli. Acetylation in E. coli depends on two mechanisms. First, the only known lysine 
acetyltransferase (KAT) in E. coli, YfiQ, can enzymatically acetylate proteins using the 
metabolite Acetyl-CoA (AcCoA) (126, 166, 359, 360). Second, acetyl phosphate (AcP), an 
intermediate of the acetate fermentation pathway, can acetylate lysines in the absence of an 
enzyme (56, 57). Western blot analysis with confirmation by mass spectrometry showed that the 
majority of acetylation in wild-type (WT) E. coli cells depends on the synthesis of AcP, while 
YfiQ plays a relatively small role (56, 57). Structural analyses of the lysines sensitive to AcP 
revealed that the molecular determinants of an AcP-sensitive lysine must be able to bind the 
phosphoryl group, properly position the acetyl group, and deprotonate the target lysine (57). The 
proteins modified in an AcP-dependent manner are predominantly central metabolic enzymes, 
often on lysines known to be metabolically active. Thus, we hypothesize that AcP may be a 
signal used to control central metabolism through acetylation. While this hypothesis remains to 
be tested, the physiological effects of AcP-dependent acetylation are unknown. 
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Furthermore, the only known mechanism of deacetylation in E. coli is via CobB, a lysine 
deacetylase (KDAC) of the NAD+-dependent sirtuin family. However, our determination of 
CobB-sensitive lysines by mass spectrometry only found 24 lysines were susceptible to both 
CobB and AcP (205). The disparity between these regulatory mechanisms raises the question:
how do cells regulate AcP-dependent acetylation? Understanding this regulation may provide 
necessary insights into how cells have evolved to utilize this global PTM.  
Thus, I sought to better characterize how AcP-dependent acetylation was regulated. I 
hypothesized that since AcP is an intermediate of acetate fermentation, AcP-dependent 
acetylation could be a mechanism to sense the metabolic status of the cell.  Therefore, AcP-
dependent acetylation may be regulated in a manner similar to fermentation, or it may be further 
regulated based on which lysines are acetylated at a given time. To address any of these 
questions, first we needed to describe the phenomenon more fully. I set out to better establish the 
timing of acetylation and to determine whether I could modulate acetylation by modulating 
exposure to carbon. 
Carbon-Induced, AcP-Dependent Acetylation Accumulates during Stationary Phase 
 Previous work demonstrated that addition of 0.4% glucose (4 g/L or 22.2 mM) to 
tryptone broth buffered to pH 7 (TB7/gl) induced global acetylation in WT E. coli in an AcP-
dependent manner (57). Broad time points indicated that this induction occurred between 
exponential growth and stationary phase, as assessed by anti-acetyllysine western blot. This 
phenomenon depended on glucose because the intensity of the acetylation profile was 
consistently low throughout exponential phase and stationary phase for cells grown in TB7 
alone. In our efforts to determine how AcP-dependent acetylation is regulated, I sought to more 
fully characterize the timing of this phenomenon. 
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To more precisely determine when induction occurs, I repeated this experiment while 
taking more time points across the growth curve. Thus, I monitored the growth of WT cells in 
TB7/gl and harvested cells every hour for ten hours and again at 24 hours (Fig. 4A). Lysates 
were normalized for protein concentration (Fig. 4B) and analyzed by anti-acetyllysine western 
blot (Fig. 4C). The signal intensity of the global acetylation profile increased steadily, but the 
vast majority of that increase occurred after the cells had entered stationary phase (after 4 hours 
post-inoculation) and continued until a point between 10 and 24 hours. 
Furthermore, a single band appeared at 24 hours that was also present in cells grown in 
TB7 alone. As described in Appendix A, this band corresponds to the YfiQ-dependent 
acetylation target, AcCoA synthetase (Acs). Since Acs expression depends on CRP, it is only 
produced when glucose is depleted, and thus it serves as a diagnostic marker for whether the 
cells are no longer experiencing catabolite repression. 
I then asked whether this was a phenomenon exclusive to glucose or whether other 
carbon sources could induce acetylation. I grew cells in TB7 supplemented with 0.4% lactate and 
found the same trend, indicating that this is not a glucose-specific phenomenon but rather that 
acetylation is carbon-induced (Fig. 5). 
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Figure 4. Glucose-Induced Acetylation. Wild-type cells of E. coli (strain BW25113) were 
aerated at 37°C in TB7 (gray circles) or in TB7 supplemented with 0.4% (w/v) glucose (black 
circles), harvested every hour up to 10 h, growth measured at OD600 and the filtered culture 
medium assessed for glucose (black squares) and acetate (black diamonds) concentrations (A). 
The whole cell protein lysate was normalized to protein concentration, separated by 1D-SDS 
PAGE and stained with Coomassie blue stain (B) and assessed for protein acetylation by anti-
acetyllysine (α-acK) Western immunoblot analysis. This blot is representative of three 
experiments (C). In panels B and C, cells grown in TB7 and TB7 plus glucose were also 
harvested at 24 hours. Also, cells were grown in TB7 supplemented with 0.4% (w/v) lactate for 
24 hours before harvesting. The band at the asterisk (*) corresponds to acetylated Acs. 
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Figure 5. Lactate Induces Acetylation. Wild-type cells of E. coli (strain BW25113) were 
aerated at 37°C in TB7 supplemented with 0.4% (w/v) lactate. Samples were harvested every 
hour up to 10 h and again at 24 h. The whole cell protein lysate was normalized to protein 
concentration, separated by 1D-SDS PAGE and assessed for protein acetylation by anti-
acetyllysine (α-acK) western immunoblot analysis. Two additional lanes with the 10 h glucose 
(Glu) and TB7 sample from 3.1C were included for reference. The band at the asterisk (*) 
corresponds to acetylated Acs. 
 
Glucose Is Not Consumed until Stationary Phase in TB7 
 The finding that glucose-induced, AcP-dependent acetylation could occur in stationary 
phase was perplexing. In M9 minimal medium with glucose as the sole carbon source, glucose is 
consumed during exponential growth, and only once glucose is depleted does the culture enter 
stationary phase (361). Because AcP is generated as a consequence of glucose metabolism and 
acetate fermentation, this would mean one of two possibilities. First, glucose is metabolized 
during exponential phase, and AcP is stored/sequestered until stationary phase when it can 
acetylate proteins. Alternatively, glucose is not consumed until stationary phase in the rich, 
amino acid-based TB7 medium. To determine when glucose was consumed, I repeated the above 
experiment and measured the glucose in the medium via a colorimetric assay. This assay utilizes 
glucose oxidase to oxidize glucose to D-glucono-δ-lactone and hydrogen peroxide that can be a 
substrate for peroxidase, resulting in a color change of o-Dianisidine. Using this assay, I found 
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that cells grown in TB7/gl only appreciably depleted glucose once the cells had entered 
stationary phase (>4 hours) (Fig. 4A), in contrast to those grown in M9 minimal medium with 
glucose as the sole carbon source; in the latter condition, glucose depletion and entry into 
stationary phase co-occurred (Fig. 6). These data were independently confirmed by our 
collaborator James Orr (University of Illinois Urbana-Champaign), who used liquid 
chromatography to monitor glucose concentrations (341). These data further solidified the 
connection between consumption of glucose and induction of acetylation. 
 
 
Figure 6. Glucose Is Consumed Prior to Stationary Phase in Minimal Medium. Wild-type 
cells of E. coli (strain BW25113) were aerated at 37°C in M9 minimal medium supplemented 
with 0.4% glucose, harvested hourly for 10 h, growth measured at OD600 (black line) and the 
filtered culture medium assessed for glucose (red line) concentration. 
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Continuous Carbon Exposure Is Required for Induction of Acetylation 
 To confirm that continuous metabolism of glucose in stationary phase is required for 
accumulation of acetylation, I asked whether removal of the excess carbon source could abrogate 
the accumulation of acetylation. Because glucose cannot be removed from the medium directly, I 
performed media swaps between parallel cultures of WT cells grown in TB7 or TB7/gl. I aerated 
cultures for three hours until just before the cells began to rapidly consume glucose. Then, every 
hour from three to eight hours, I swapped the media by pelleting cultures from TB7 and TB7/gl, 
filtering the supernatants, and then resuspending the pellets in the opposite medium from which 
they had begun growth. The swapped cultures were continually aerated until ten hours after 
initial inoculation and analyzed by anti-acetyllysine western blot. With this experimental design, 
cells that had been exposed to glucose from the beginning (0 hours) were further incubated in the 
media that had never contained glucose and vice versa. Consistent with the hypothesis that 
metabolism of glucose in stationary phase is required to achieve strong acetylation, cells that 
were exposed to glucose longer before the media swap had stronger acetylation intensity than 
those that had been swapped sooner (Fig. 7). Strangely, the cultures that received glucose after 
the swap at 3 hours never looked like cells exposed to glucose from the beginning of growth, 
though there should be plenty of glucose (Fig. 7, compare lane 9 to lane 8). Thus, exposure to 
glucose in exponential phase may induce a regulatory program that causes E. coli to accumulate 
acetylation in stationary phase. 
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Figure 7. Continuous Glucose Exposure Is Required for Accumulation of Acetylation in 
Stationary Phase. Wild-type cells of E. coli (strain BW25113) were aerated at 37°C in TB7 or 
TB7 supplemented with 0.4% glucose (Starting medium). At the indicated hours (h), the cells 
were pelleted and resuspended in the opposite medium. Ten hours after inoculation, cells were 
harvested. Protein lysates were normalized to protein concentration, separated by 1D-SDS 
PAGE, and assessed for protein acetylation by anti-acetyllysine (α-acK) western immunoblot 
analysis. The band at the asterisk (*) corresponds to acetylated Acs. 
 
Carbon Must be Added during Exponential Growth to Induce Acetylation 
Since acetylation occurs in stationary phase and depends on glucose, I wondered whether 
timing of glucose addition could alter timing of acetylation or whether addition of glucose to 
cultures during stationary phase is sufficient to induce acetylation. To determine this, I grew WT 
cells in TB7. At each hour, I added 0.4% glucose. Ten hours after inoculation, I harvested the 
cells and performed anti-acetyllysine western blot analysis (Fig. 8A). Acetylation was strongest 
if I added glucose prior to the transition to stationary phase (prior to three hours after 
inoculation), and the signal intensity was further reduced with longer delays before glucose 
addition. Using 0.8% lactate, I was able to achieve the same results, which confirmed that this is 
not exclusively a glucose phenomenon (Fig. 8B). 
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Because the cells with later glucose addition had been exposed to glucose for less time, I 
ensured this weak acetylation was not due to insufficient exposure to glucose by growing the 
cells for an additional ten hours after the addition of glucose. Indeed, the acetylation intensity 
was strong when glucose was added during exponential phase (prior to three hours after 
inoculation), but weak when glucose was added after three hours (Fig. 8C). 
 
Figure 8. Acetylation in Stationary Phase Requires Carbon to Be Added During 
Exponential Phase. (A) Wild-type cells of E. coli (strain BW25113) were aerated at 37°C in 
TB7, and at the hour indicated, glucose was added to a final concentration of 0.4%. 10 or 24 
hours after inoculation, cells were harvested. Protein lysates were normalized to protein 
concentration, separated by 1D-SDS PAGE, and assessed for protein acetylation by anti-
acetyllysine (α-acK) western immunoblot analysis. (B) Instead of glucose, cells were 
supplemented with 0.8% lactate. (C) Glucose was added at the indicated hours. 10 hours after 
addition of glucose, cells were harvested and subjected to α-acK western immunoblot analysis. 
The band at the asterisk (*) corresponds to acetylated Acs. 
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A simple explanation for the lack of acetylation could be that cells do not consume 
glucose in cultures that received glucose after three hours. However, using the colorimetric assay 
described above, I found that all cultures rapidly consumed glucose at a rate comparable to the 
cells exposed to glucose from the start of the experiment (Fig. 9A). Western blot analysis of the 
cells from this experiment were consistent with the findings above (Fig. 9B). 
 
Figure 9. Glucose Is Readily Consumed by Stationary Phase Cells. (A) Wild-type cells of E. 
coli (strain BW25113) were aerated at 37°C in TB7, and at the hour indicated in the legend, 
glucose was added to a final concentration of 0.4%. Growth was measured at OD600 (solid 
lines), and filtered culture medium was assessed for glucose concentration (dashed lines). (B) 
Samples from (A) were harvested at 24 hours after inoculation. Protein lysates were normalized 
to protein concentration, separated by 1D-SDS PAGE, and assessed for protein acetylation by 
anti-acetyllysine (α-acK) western immunoblot analysis. The band at the asterisk (*) corresponds 
to acetylated Acs. 
 
80 
 
The most obvious explanation for the consumption of glucose but lack of acetylation is 
the enzyme pyruvate oxidase (PoxB), an enzyme expressed in stationary phase. PoxB catalyzes 
the oxidative decarboxylation of pyruvate to form acetate and CO2; thus, PoxB consumes 
glucose without producing AcP. Furthermore, PoxB is known to be the main acetate production 
pathway during stationary phase (362). Preferential consumption of glucose via PoxB could 
easily explain why exposure to glucose only during stationary phase (after the first three hours 
incubation) does not lead to accumulation of acetylation. It does not, however, explain why 
exposure to glucose during exponential phase (following the first three hours incubation) results 
in acetylation during stationary phase. One possibility is that exposure to glucose during the first 
three hours of growth might somehow favor glucose metabolism via the Pta-AckA pathway over 
that of PoxB during stationary phase. Thoughts on this an unanswered question will be covered 
in the Discussion section. 
Mass Spectrometric Analysis of Acetylated Targets over Time 
 Western blot analysis gives general information as to how acetylation changes over time, 
but to get a more detailed understanding of acetylation dynamics on specific lysines, as well as 
identify modified proteins, we sent samples to our collaborators at the Buck Institute for Aging 
for tandem mass spectrometry (MS/MS) analysis. The samples came from triplicate biological 
samples of cultures grown in TB7 for 12 hours or TB7/gl for 2, 5, 8, and 12 hours. Thus, we 
could determine how acetylation changes over time in TB7/gl and how glucose induces 
acetylation by comparing TB7/gl to TB7 alone. Please note that all of these data can be found in 
Schilling et al. (78). 
 From the MS spectra of all samples, we identified a total of 2813 unique acetylated 
lysines on 780 unique acetylated proteins. Most acetylated proteins were acetylated on one, two 
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or three lysines; however, 30% of proteins were acetylated on more than 3 lysines. There was 
only a slight correlation between the number of lysines on a protein and number of acetyllysines 
detected and no correlation with size of the protein. Growth for 12 h in TB7/gl resulted in 
substantially more protein acetylation (2338 acetylated lysines on 705 proteins) than growth for 
12 h in TB7 without glucose (451 acetylated lysines on 216 proteins), which is consistent with 
the western blot data. During growth in TB7/gl, the number of unique acetylated lysines (1068, 
1658, 2226 and 2338 at 2, 5, 8 and 12 hours, respectively) and proteins (395, 540, 671, and 705 
at 2, 5, 8, and 12 hours, respectively) increased over time. Interestingly, most of the lysines 
detected as acetylated at 12 hours were already detected at 2 hours. This implies that acetylation 
occurs at a basal level and the accumulation of acetylation observed by western blot is a result of 
new sites being acetylated and increased occupancy on already acetylated lysines. 
 Next, quantification was performed by our collaborators on these acetylated lysines to 
determine relative fold-increases of acetylation over time. These changes were normalized to the 
protein levels detected to ensure we determined changes in acetylation and not protein 
abundance. Approximately half of all sites met the criteria as significantly increased (>2-fold, P-
value ≤ 0.05). Comparing the two extremes, 1081 lysines on 406 lysines were significantly 
increased (median increase of 7.5-fold) in the 12-hour culture in TB7/gl compared to the 12-hour 
culture in TB7 alone. Over the glucose time course, acetylation of 1091 lysines on 420 proteins 
increased significantly with a median relative acetylation change of 2.7-fold (5 h/2 h), 5.7-fold (8 
h/2 h) and 6.6-fold (12 h/2 h). The vast majority (∼ 90%) of these regulated acetyllysine sites 
were both time- and glucose-dependent, which suggests that the increase in acetylation over time 
is a response to glucose. Supporting the hypothesis that glucose-regulated sites are AcP-sensitive 
sites, in the linear motif surrounding the glucose-regulated acetyllysines, the lysine is often 
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flanked by negatively charged amino acids at the +1 and -1 positions, which is similar to that of 
acetyllysines regulated by AcP (57). 
 We next determined whether the dynamics on glucose-regulated lysines are consistent 
between lysines by asking how the fold changes vary over time. This was performed on >400 
proteins on >1000 lysines. For example, we assessed 10 lysines on malate dehydrogenase and 
found that while some lysines experienced gradual increases in acetylation over time, other 
lysines increased rapidly (Fig. 10). In most cases, acetylation peaked after 8 hours and changed 
very little by 12 hours, which was consistent with the western blot data. In some cases, the 
relative acetylation level decreased between 8 and 12 hours. This may suggest that specific 
lysines are susceptible to deacetylation, while others are not. Alternatively, acetylation of certain 
lysines may be a signal for degradation, which could result in the apparent reduction of 
acetylation. 
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Figure 10. Differential Acetylation Rates. Wild-type cells of E. coli were grown in 
TB7/glucose for 12 hours with samples harvested at 2, 5, 8, and 12 hours. Mass spectrometry to 
detect acetylated lysines across the proteome was performed on pooled bacteria with 3× 
biological and 3× technical (MS injection) replicates. Fold changes were determined relative to 
the 2 hour time point. All Kac fold changes were normalized for protein level changes. 
Significance of the Kac site fold changes was assessed using two-tailed Student’s t-test and 
requiring P-values < 0.05.  Dynamic change of acetylation is displayed for MDH with 10 
significantly changing Kac sites shown (K54, K56, K99, K107, K133, K140, K272, K279, K300 
and K301). 
 
 As we are seeking to understand whether cells can use global, glucose-induced 
acetylation as a means of sensing their own metabolism, identification of acetylated enzymes is 
critical. The proteins with acetylated lysines are primarily involved in central metabolism 
including pathways responsible for glycolysis, gluconeogenesis, and fatty acid biosynthesis, as 
well as the TCA cycle and glyoxylate bypass. Comparing the sites that we detected as acetylated 
by AcP (57) to those we consider regulated by glucose, we observed a great overlap (Fig. 11), 
especially in central metabolism (Fig. 12). The overlap was not 100%, however. An explanation 
of this discrepancy most likely results from these experiments being carried out in two different 
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strain backgrounds; MG1655 was used in Kuhn et al. (57) but BW25113 was used in my work. 
Additionally, genetic manipulation of the AcP levels (i.e., deletion of ackA) could lead to 
aberrant metabolic flux, which could result in changes to gene expression that would either 
directly or indirectly affect acetylation targets. Furthermore, by not forcing AcP to accumulate, 
the lysines that reach the threshold for regulation in a ΔackA mutant may not be acetylated at a 
sufficiently high level in wild-type cells. 
 
 
Figure 11. Overlap in Sites and Proteins Regulated by Glucose and AcP. After mass 
spectrometry analysis was performed as described in Figure 10, lysines were considered 
regulated by glucose if they were upregulated at least 2-fold in TB7/gl compared to TB7. A 
protein was considered regulated if it contained a lysine that met this criteria. This dataset was 
compared to the previously generated dataset from Kuhn et al. 2014 that used the same criteria 
when comparing a ΔackA mutant to WT. 
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Figure 12. Proteins of Central Metabolism Regulated by AcP and/or Glucose. Proteins 
containing lysines that were regulated by either AcP (green) or glucose (red) are marked by 
asterisks. 
 
Summary 
Our group had previously established that AcP-dependent acetylation begins to 
accumulate somewhere between exponential phase and stationary phase. My initial contribution 
was to obtain a more granular view of acetylation dynamics over time. In doing so, I found that 
acetylation accumulates primarily after the culture transitions from exponential phase into 
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stationary phase. Surprisingly, this delay of acetylation appears to be due to a delay in glucose 
consumption in TB7 that is not observed when glucose is the sole carbon source in a minimal 
medium. The importance of glucose consumption was confirmed because by removing the 
glucose, acetylation failed to accumulate. This phenomenon is not exclusive to glucose as these 
findings were extended to lactate. Taken together, these data support a hypothesis in which 
acetylation is tightly linked to carbon metabolism, specifically through excess carbon flux via 
acetate fermentation. As such, acetylation by AcP may serve as a feedback to monitor the flux of 
carbon through central metabolism. 
Consistent with that hypothesis, glucose-induced acetylation was found to be 
predominantly detected on central metabolic proteins and, as predicted, many of the lysines that 
were acetylated in a glucose-dependent manner were previously found to be AcP-dependent 
(57). With continued exposure to glucose, proteins became more acetylated, which matched the 
pattern seen via western blot. Interestingly, many of the proteins detected as acetylated over this 
time course were detected as acetylated as early as 2 hours after growth in glucose, which by 
western blot, looks comparable to cells grown in TB7 alone. Thus, we propose a model where 
acetylation accumulates due to i) new lysines becoming acetylated and ii) greater occupancy 
(stoichiometry) of previously acetylated lysines, i.e., an increasing fraction of a given lysine 
becomes acetylated over time. 
Rate of Carbon Flux Dictates Glucose-Induced, AcP-Dependent Acetylation 
Introduction 
Overflow metabolism (also called aerobic fermentation) is a phenomenon whereby cells 
growing aerobically ferment acetate. This occurs because the flux of carbon into the AcCoA 
node of central metabolism is too rapid (Fig. 3). At this node, carbon from glycolysis is added 
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onto CoA to generate AcCoA, which can be used for fatty acid biosynthesis or biomass 
formation and/or energy production via the TCA cycle. However, the flux through glycolysis can 
exceed the metabolic capacities of the TCA cycle and fatty acid biosynthesis, resulting in an 
accumulation of AcCoA. Since CoA is a limiting factor, glycolysis would experience a backup 
that could cause toxic buildup of sugar phosphates (363). To regenerate CoA and keep glycolysis 
running, the cell removes the acetyl group from AcCoA and ferments acetate. 
Because there is an intimate link between AcP-dependent acetylation and glucose 
metabolism, I hypothesized that AcP-dependent acetylation could simply be a consequence of 
fermentation. If this hypothesis were correct, I could modulate global acetylation by reducing 
flux into the AcCoA node to prevent overflow metabolism. To test this hypothesis, I used both 
genetic and non-genetic means to reduce fermentation and assessed the effect on AcP-dependent 
acetylation. 
Rapid Carbon Flux through the Major Glucose Transporter, EIICBglc, Is Required for 
Glucose-Induced Acetylation 
 For glucose to be consumed by E. coli, it must first pass through the porins OmpF, 
OmpC, and LamB in the outer membrane to enter the periplasm (364-367) (Fig. 3). In the 
periplasm, glucose preferentially is transported in the cytoplasm by the phosphotransferase 
system (PTS), specifically though the EIICBglc transporter (also called PtsG), where it becomes 
phosphorylated and directly enters glycolysis. In the absence of EIICBglc, glucose can still enter 
the cytoplasm through alternative transporters, such as the galactose permease, GalP (368, 369). 
However, the glucose is not phosphorylated and must become phosphorylated through 
glucokinase. This alternative process is relatively slow and inefficient (370, 371). To determine 
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whether acetylation required rapid flux through glycolysis, I started by slowing glucose 
consumption into the cytoplasm. 
 I grew WT E. coli alongside a mutant lacking EIICBglc (ΔptsG) in TB7/gl and 
TB7/lactate for ten hours, harvested proteins, verified normalization via Coomassie-stained SDS-
PAGE gel, and performed an anti-acetyllysine western blot. With the knowledge that the ΔptsG 
mutant would have reduced flux of glucose into the cytoplasm and thus into glycolysis (372), I 
hypothesized that this mutant should have reduced overflow metabolism and thereby reduced 
glucose-induced acetylation compared to WT. While the WT experienced glucose-induced 
acetylation, the ΔptsG mutant appeared as though it was grown in the absence of glucose and 
only showed one acetylated band, Acs (Fig. 13, compare lanes 1 and 5). However, lactate 
bypasses the need for EIICBglc, and thus I expected that the acetylation intensity of the ΔptsG 
mutant would be comparable to WT in TB7/lactate. Indeed, the acetylation pattern in both strains 
looked comparable (Fig. 13, compare lanes 6 and 10). These data show that the ΔptsG mutant 
is not generally defective for carbon-induced acetylation; instead, as I hypothesized, glucose-
induced acetylation requires rapid flux of carbon via EIICBglc. 
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Figure 13. CRP Is Required for Glucose-Induced Acetylation and Lactate-Induced 
Acetylation. Wild-type and isogenic mutants of E. coli (strain BW25113) were aerated at 37°C 
in TB7 supplemented with 0.4% glucose or 0.4% lactate. Those strains carrying pCA24n-CRP, 
pCA24n-PtsG, or pCA24n vector control (VC) were also supplemented with 25 μg/mL 
chloramphenicol and 50 μM IPTG. After 10 hours, cells were harvested. Protein lysates were 
normalized to protein concentration, separated by 1D-SDS PAGE, and assessed for protein 
acetylation by anti-acetyllysine (α-acK) western immunoblot analysis. 
 
Rapid Carbon Flux through the Embden-Meyerhof-Parnas Pathway Is Required for 
Glucose-Induced Acetylation 
 Glycolysis is traditionally thought of as the passage of glucose-derived carbon through 
what is known as the Embden-Meyerhof-Parnas (EMP) pathway. However, this carbon can enter 
two other pathways, the pentose phosphate (PP) pathway or the Entner-Doudoroff (ED) pathway. 
The flux through these pathways is slower than the flux through the EMP pathway. By deleting 
certain enzymes of the EMP pathway, the cell can be forced to metabolize glucose using these 
slower pathways. Slowing flux of carbon through glycolysis should reduce overflow metabolism, 
90 
 
and I hypothesized that a mutant of the EMP pathway would have reduced acetylation relative to 
WT. I chose phosphoglucose isomerase (Pgi) as this enzyme converts the first committed step of 
the EMP pathway, the conversion of glucose-6-phosphate into fructose-6-phosphate (Fig. 3). 
Furthermore, I can bypass the need for Pgi by supplementing the Δpgi mutant with fructose, 
which can directly enter the EMP pathway. 
 I performed an endpoint analysis of WT and Δpgi mutant cells after ten hours of growth 
in TB7/gl and TB7 supplemented with 0.4% fructose (Fig. 14A). Consistent with my hypothesis, 
deletion of pgi reduced acetylation relative to WT cells in the presence of glucose (Fig. 14B). 
The Δpgi mutant did not produce an acetylated Acs band, as opposed to a ΔptsG mutant, which 
indicates that these cells were still important and sensing glucose. Supplementing Δpgi mutant 
with fructose restored global acetylation; indeed, the acetylation profile of the Δpgi mutant was 
more intense than that of the WT cells exposed to either glucose or fructose. Since the Pgi 
reaction is reversible, these results may suggest that conversion of fructose-6-phosphate into 
glucose-6-phosphate occurs in WT cells, causing less carbon overflow and thus less AcP-
dependent acetylation. 
 To ensure that the Δpgi mutant was truly defective in glucose-induced acetylation and 
that the time point chosen did not mislead our interpretation, I performed a time course and 
monitored acetylation over time in TB7/gl. While the WT cells experienced carbon-induced 
acetylation, there was little change in acetylation intensity of the Δpgi mutant over the entire 24-
hour period (Fig. 15). 
 Together, these data support the model carbon-induced acetylation requires that carbon 
must rapidly enter the AcCoA node to promote overflow metabolism and generate the acetyl 
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donor, AcP. These data further confirm that glucose-induced acetylation is actually carbon-
induced acetylation, as shown by induction with glucose, lactate, and now fructose. 
 
Figure 14. Acetylation Is Enhanced When Carbon Flux Is Rapid. Wild-type cells and an 
isogenic Δpgi mutant of E. coli (strain BW25113) were aerated at 37°C in TB7 supplemented 
with 0.4% glucose or 0.4% fructose. (A) Growth measured at OD600. (B) Cells were harvested 
after 10 hours of aeration. Protein lysates were normalized to protein concentration, separated by 
1D-SDS PAGE, and assessed for protein acetylation by anti-acetyllysine (α-acK) western 
immunoblot analysis. 
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Figure 15. Acetylation Does Not Significantly Change Over Time in a Δpgi Mutant. Wild-
type cells and an isogenic Δpgi mutant of E. coli (strain BW25113) were aerated at 37°C in TB7 
supplemented with 0.4% glucose. Cells were harvested at the indicated time points. Protein 
lysates were normalized to protein concentration, separated by 1D-SDS PAGE, and assessed for 
protein acetylation by anti-acetyllysine (α-acK) western immunoblot analysis. 
 
Major Transcription Factors Can Regulate Acetylation 
If glucose- and, by extension, carbon-induced acetylation was a response to carbon flux, 
then this acetylation should be influenced by regulators of carbon flux. Therefore, I constructed 
an isogenic set of mutants defective for the carbon regulators ArcA, Cra, CsrA, and CRP. I also 
used a ΔptsG mutant as a negative control and a ΔrcsB mutant as a control for a mutant that 
should not affect central metabolism. ArcA primarily represses operons involved in respiratory 
metabolism under anaerobic conditions, and I hypothesized that deletion of arcA may decrease 
acetylation by causing a loss of repression of these genes, driving carbon flux away from 
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fermentation. Cra is reported to be an activator of gluconeogenic enzymes and a repressor of 
glycolytic enzymes. I expected a Δcra mutant to lose repression of glycolytic enzymes and 
perhaps increase the amount of fermentation and therefore acetylation. CsrA negatively 
influences transcription of gluconeogenic and glycogen synthesis enzymes while activating 
glycolytic enzymes. Thus, a ΔcsrA mutant should lower acetylation as it would no longer be able 
to activate glycolytic enzymes and would decrease carbon flux to fermentation. CRP, or the 
catabolite activator protein, is important for activating gene transcription in the absence of 
glucose, and thus I would expect CRP to have little effect on glucose-induced acetylation. 
Endpoint western blot analysis was performed on the ΔarcA, Δcra, ΔcsrA, Δcrp, ΔptsG, 
and ΔrcsB mutant strains grown in TB7/gl for ten hours (Fig. 16A). Acetylation in the ΔptsG 
mutant was significantly reduced compared to WT, consistent with what I had observed 
previously. The ΔarcA and ΔcsrA mutants behaved like WT and the ΔrcsB control. Consistent 
with my hypothesis, the Δcra mutant had a small reproducible increase in acetylation relative to 
WT. Strikingly, the Δcrp mutant looked comparable to a ΔptsG mutant, indicating that CRP 
plays a major role in carbon-induced acetylation. This corroborated data found by former 
members of the lab Robert Davis, PhD (373) and Arti Walker (170), and will be discussed 
below. From these data, I conclude that carbon regulators can regulate acetylation, and I 
hypothesize that this would be due to control of carbon flux through central metabolism. 
CRP-Dependent Transcriptional Activation Is Required for Carbon-Induced Acetylation 
 Arti Walker and Robert Davis found that a Δcrp mutant lost glucose-induced acetylation 
in the presence of exogenous cAMP, a small molecule produced in the absence of glucose that, 
with transcription factor CRP, forms a cAMP-CRP complex that activates transcription. CRP 
increases the rates at which glucose is consumed and acetate is produced, which should increase 
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the rate at which AcP is produced (374). Through epistasis analysis, Robert Davis showed that 
AcP was required for CRP-dependent, glucose-induced acetylation, and the loss of crp could be 
bypassed by overproducing AcP (in a ΔackA mutant) (78). As described above, I was able to find 
that CRP played a role even in the presence of glucose, which should significantly reduce CRP-
dependent transcription. Thus, I sought to determine the mechanism by which CRP controls 
acetylation. 
 
Figure 16. Effect of CRP and Other Carbon Regulators on Acetylation. (A) Wild-type cells 
and isogenic ΔarcA, Δcra, ΔcsrA, Δcrp, ΔptsG, and ΔrcsB mutants of E. coli (strain BW25113) 
were aerated at 37°C in TB7 supplemented with 0.4% glucose. Cells were harvested after 10 
hours. Protein lysates were normalized to protein concentration, separated by 1D-SDS PAGE, 
and assessed for protein acetylation by anti-acetyllysine (α-acK) western immunoblot analysis. 
(B) Triplicate cultures of Wild-type cells and an isogenic Δcya mutant were aerated in TB7 
supplemented with 0.4% glucose. Cells were harvested after 10 hours and analyzed by anti-
acetyllysine western blot as in (A). 
 
 To determine the mechanism by which CRP regulates glucose-induced, AcP-dependent 
acetylation, I began by asking whether CRP required formation of the cAMP-CRP complex to 
regulate acetylation. I made a Δcya mutant that lacks adenylate cyclase, the enzyme necessary to 
form cAMP. I performed an anti-acetyllysine western blot of this mutant grown in TB7/gl for ten 
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hours and found that it behaved like the Δcrp mutant (Fig. 16B). This indicated to me that CRP 
was probably exerting its effect through its canonical function, activating transcription. 
 CRP can bind to two sites on DNA, called Class I and Class II sites. A Class I site is 
characterized by being positioned at -60.5, -70.5, -81.5, or -91.5 relative to the transcription start 
site (TSS), while Class II sites are centered at -41.5 relative to the TSS. Activation of 
transcription from a Class I site depends on the interaction between a surface region called 
Activating Region 1 (AR1) on CRP with the C-terminal domain of the α-subunit (α-CTD) of 
RNA polymerase. In contrast, Class II sites depend on an interaction between both AR1 with the 
α-CTD and Activating Region 2 (AR2) of CRP with the α-subunit N-terminal domain. Thus, by 
disrupting AR1 and/or AR2, one can lose activation of Class I-dependent promoters, Class II-
dependent promoters, or both. 
 To determine whether either or both activating regions are required for CRP-dependent 
acetylation, I complemented the Δcrp mutant strain in the AJW678 background with pDCRP 
carrying the wild-type CRP isoform, CRP variants lacking AR1 (H159L), AR2 (K101E), both 
AR1 and AR2 (H159L/K101E), or the vector control (pBR322). Each strain was grown in 
TB7/gl or TB7 alone for ten hours, harvested, and analyzed by anti-acetyllysine western blot 
(Fig. 17A). Complementation with the WT crp allele on the pDCRP plasmid restored glucose-
induced acetylation to the Δcrp mutant, while the strain carrying the vector control did not. 
Complementation with mutant alleles carrying intact AR1 or AR2 alone was sufficient to 
promote glucose-induced acetylation. However, complementation with the AR1/2 double mutant 
allele produced a result similar to the Δcrp mutant. To generalize this effect, I recapitulated these 
data in another background of E. coli, BW25113 (Data not shown). 
96 
 
 
Figure 17. CRP Requires Both Activating Regions for Acetylation. (A) Δcrp mutants of E. 
coli (strain AJW678) carrying pDCRP (WT), vector control pBR322 (VC), or variants defective 
for AR1 (H159L), AR2 (K101E), both AR1 and AR2 (in duplicate) were aerated in TB7 alone or 
supplemented with 0.4% glucose (TB7/glucose). Cells were harvested after 10 hours. Protein 
lysates were normalized to protein concentration, separated by 1D-SDS PAGE, and assessed for 
protein acetylation by anti-acetyllysine (α-acK) western immunoblot analysis. (B) Lysates from 
cells grown in TB7/glucose in (A) were probed by anti-CRP western immunoblot analysis. 
 
 In TB7, each strain only varied in acetylation of one band, Acs. The acetylated Acs band 
was strong in WT and AR2, weak in AR1, and absent in AR1/2 and the vector control. In 
TB7/gl, the Acs band could be visualized in the AR2 defective variant. The reason for the 
variation in acetylation of Acs is most likely the expression levels of Acs. The Acs promoter is 
AR1-dependent, and thus inactivation of AR1 would reduce expression of Acs (375). 
Additionally, the Acs promoter is repressed in an AR2-dependent manner (340); thus, it makes 
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logical sense that mutating AR2 could relieve some of this repression even in the presence of 
glucose. Finally, since Acs depends on CRP, mutation of both activating regions and deletion of 
crp results in poor and no expression of Acs, respectively. 
To ensure these constructs were properly expressed, I determined the protein levels of 
these CRP variants from the same lysates using an anti-CRP antibody (Fig. 17B). This confirmed 
the Δcrp mutant did not express CRP. While the AR2 and AR1/2 variants had similar protein 
levels to WT, AR1 protein levels were significantly reduced. However, since the AR1 CRP 
variant was still capable of promoting glucose-induced acetylation, while the AR1/2 mutant was 
not, this implies that the CRP protein levels do not correlate with acetylation. I conclude that 
CRP utilizes both AR1 and AR2 to promote acetylation by activating transcription. 
CRP-Dependent Activation of EIICBglc Is Required for Acetylation 
One of the promoters that CRP regulates is that of ptsG, the gene that encodes the major 
glucose transporter EIICBglc. The ptsG promoter is regulated in a Class I- and Class II-dependent 
manner (376, 377). I hypothesized that the reason a Δcrp mutant lacked acetylation was due to 
low EIICBglc expression. To test this, I performed an epistasis experiment to determine whether 
CRP and EIICBglc acted in the same pathway to promote glucose-induced acetylation. I first 
transformed a ΔptsG mutant with a plasmid carrying CRP or vector control. In a WT strain, 
overexpression of CRP enhanced acetylation (78). However, overexpression of CRP in the 
ΔptsG mutant had no effect, and the only visible acetylated band was Acs, which indicates that 
any effect of CRP must require EIICBglc (Fig. 13, compares lanes 1 and 2). Next, I transformed 
a Δcrp mutant with a plasmid carrying ptsG or vector control with the expectation that if a Δcrp 
mutant poorly expresses EIICBglc, overexpressing EIICBglc would restore proper glucose 
utilization and acetylation. My hypothesis was partially correct. While the Δcrp mutant with 
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vector control had no induction of acetylation, overexpression of EIICBglc was able to partially 
suppress the defect (Fig. 13, compare lanes 3 and 4). Thus, the reduced acetylation of a Δcrp 
mutant is, in part, due to poor EIICBglc expression, which supports the previous findings that 
Δcrp mutants poorly consume glucose at a third of the rate of WT cells (374). 
However, overexpression of EIICBglc in the crp mutant does not completely restore the 
acetylation to WT levels. Why not? While the exact mechanism is not known, the paper from 
Perrenoud and Sauer provides further insights (374). In addition to the reduced rate of glucose 
consumption of a Δcrp mutant, they also found that CRP enhances flux through the EMP 
glycolytic pathway while diminishing flux through the PP pathway. However, the exact EMP 
and PP enzymes that CRP regulates to direct flux remain unclear. Fitting the findings of 
Perrenoud with my data from the Δpgi mutant indicates that CRP may have a dual role in 
managing carbon flux both into the cell and through glycolysis and thus to promote acetylation. 
Directing Carbon to Biomass Reduces Protein Acetylation 
 Overflow metabolism is a consequence of flux through the TCA cycle being too slow to 
meet demand from the AcCoA node. Further compounding this problem for the cells, in our 
conditions, glucose is mostly consumed after entry into stationary phase due to exhaustion of 
some other nutrient, which reduces the need for new biomass (see Glucose Is Not Consumed 
until Stationary Phase in TB7). Thus, TCA cycle intermediates are not being used as 
precursors for biomass, which further reduces the capacity of the TCA cycle to receive carbon 
from AcCoA. Instead, most of this carbon is fermented as acetate. In the Appendix, I describe 
my finding that cell growth is limited by magnesium in the standard medium we used to study 
acetylation, TB7/gl. I hypothesize that the accumulation of protein acetylation induced by excess 
carbon is a result of overflow metabolism (as described in Rate of Carbon Flux Dictates 
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Glucose-Induced, AcP-Dependent Acetylation) in combination with an “aging” proteome, due 
to reduced nascent protein synthesis in stationary phase. 
 Since addition of magnesium to cultures of E. coli extends exponential phase growth and 
can triple their final biomass (341), if my hypothesis is correct, this would mean that there would 
be a resultant reduction in acetylation due to more carbon being used to generate biomass and 
greater dilution of acetylated isoforms into nascent proteins. I added varying concentrations of 
magnesium (from 10 μM to 1 mM) to cultures of WT E. coli grown in TB7/gl, which resulted in 
a dose-dependent increase in biomass as measured by final OD600 measurements at 10 and 24 
hours (Fig. 18). Anti-acetyllysine western blot showed that cells supplemented with up to 25 μM 
magnesium experienced carbon-induced acetylation comparable to unsupplemented TB7/gl (Fig, 
19A). Cells exposed to 50 to 100 μM magnesium saw the expected decrease in acetylation. 
Unexpectedly, between 100 μM and 500 μM up to 1 mM, the acetylation increased but remained 
slightly below unsupplemented TB7/gl culture. Finally, if I restored carbon to excess over 
magnesium by increasing the concentration of glucose from 0.4% to 4%, addition of magnesium 
no longer reduced acetylation (Fig. 19B). 
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Figure 18. Magnesium Extends Exponential Phase and Increases Final Optical Density. 
Wild-type cells of E. coli (strain BW25113) were aerated at 37°C in TB7 supplemented with 
0.4% glucose alone (Solid lines) or with 1 mM MgSO
4
 
(Dashed lines). Growth was measured at 
OD600 (Black lines) and the filtered culture medium was assessed for glucose (Dark gray lines) 
and acetate (Light gray lines) concentrations. 
 
 While my hypothesis that shifting carbon to biomass would reduce acetylation held true 
during supplementation with certain concentrations of magnesium, clearly something else was 
happening at the higher concentrations of magnesium. The reason remains unknown. However, 
metal ions like Ca2+ and Mg2+ promote AcP hydrolysis in vitro because they make the phosphate 
a better leaving group (283, 378). Also, addition of magnesium promotes selectivity and 
specificity of in vitro acetylation with AcP (57). Perhaps these characteristics of AcP explain 
how the high concentrations of magnesium promote acetylation when lower concentrations 
reduce acetylation. 
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Figure 19.  Magnesium Reduces Acetylation in TB7/glucose.  (A) Wild-type cells of E. coli 
(strain BW25113) were aerated at 37°C in TB7 or TB7 supplemented with 0.4% glucose. To 
each culture, magnesium sulfate was added to the indicated final concentrations. (B) Wild-type 
cells of E. coli (strain BW25113) were aerated in 37°C in TB7 supplemented with 0.4% glucose 
or 4% glucose. To each culture, magnesium sulfate was added to the indicated final 
concentrations. Cells were harvested after 10 hours. Protein lysates were normalized to protein 
concentration, separated by 1D-SDS PAGE, and assessed for protein acetylation by anti-
acetyllysine (α-acK) western immunoblot analysis.  
 
Summary 
 Prior to this work, we knew that glucose could induce global acetylation in an AcP-
dependent manner. The physiological consequences of widespread acetylation are unknown but 
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understanding how the cell regulates acetylation could direct our studies. Since AcP is produced 
as a result of fermentation, which is caused by overflow metabolism under our growth 
conditions, I hypothesized that by modulating overflow metabolism I could reduce or enhance 
acetylation. 
 Overflow metabolism is characterized by excessive carbon flux through glycolysis with a 
bottleneck at the AcCoA node that is relieved by fermentation of acetate. I therefore asked 
whether reducing flux into the cell or into the AcCoA node could reduce acetylation. Using a 
carbon source like glucose whose utilization by E. coli has been studied in great depth allowed 
me to make predictions about how certain mutants should influence acetylation. As I predicted, 
acetylation was reduced by slowing entry of glucose into the cell by deleting the major glucose 
transporter or by forcing cells to use the slower glycolytic pathways by deleting Pgi. Under the 
conditions used in our experiments, I found that CRP was required for AcP-dependent 
acetylation. The requirement for CRP depended on its ability to form a cAMP-CRP complex and 
activate transcription via either AR1 or AR2. At least one mechanism by which CRP controls 
acetylation is through expression of EIICBglc, thus increasing flux of carbon into the cell. 
However, the literature suggests CRP is also required for driving flux into the EMP pathway and 
away from the PP pathway. Therefore, glucose-induced acetylation is caused by overflow 
metabolism, but this phenomenon is not exclusive to glucose and should be more correctly 
described as carbon-induced acetylation. 
In addition to reducing flux through glycolysis, I also found that acetylation could be 
reduced by preventing carbon from becoming excessive by adding the limiting nutrient 
magnesium. I hypothesize that this attempt to balance carbon and magnesium results in more 
carbon entering biomass and any proteins that become acetylated are rapidly diluted into nascent 
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proteins. Thus, when magnesium is limiting and thus depleted before full consumption of 
glucose or some other fermentable carbon source, the cells cease exponential phase growth 
ferment the excess carbon as acetate. Any proteins with a lysine in the proper molecular 
environment (57) will be able to bind AcP and become acetylated. Together, these data support a 
model in which acetylation cannot help but occur on permissive lysines when AcP is produced 
via fermentation. 
Global Acetylation Occurs in a Carbon Source Agnostic Manner  
Introduction 
 Our current model suggests that acetylation occurs as a result of fermentation and that the 
only factors that dictate acetylation are production of the acetyl donor AcP and the proper 3D 
structure/molecular environment to facilitate acetylation. Therefore, regardless of carbon source, 
we should observe the same targets acetylated as long as the cells ferment. To further test our 
model, I chose the hexose sugar, glucose, and the pentose sugar, xylose, as the sole carbon 
sources. These two sugars are relevant because (i) E. coli grows faster on glucose than on xylose 
and thus may have different lysine acetylation patterns and (ii) their metabolism requires 
different enzymes, which may also be differentially acetylated. Furthermore, by making these 
sugars the sole carbon sources, I avoid any complications with other carbon sources coming from 
the tryptone broth of TB7. In addition to the usual 0.4% carbon source, I also grew the cells in 
4% carbon to ensure that the cells experience carbon excess and thus ferment via overflow 
metabolism. 
Neither Carbon Source nor Amount Cause Major Changes to Protein Abundance 
 I grew cells in M9 minimal medium supplemented with xylose or glucose at a final 
concentration of 0.4% or 4%. After 12 hours, I harvested samples and submitted them to our 
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collaborators for mass spectrometric analysis. Comparing the protein expression levels between 
conditions, only 61 proteins exhibited significant differences in expression. The abundance of 
many of these proteins was reduced, especially during growth at 4% sugar, presumably through 
catabolite repression, as many of these are CRP-regulated.  Four of the proteins that were 
increased in 4% carbon are members of the NtrC regulon that controls genes in response to high 
carbon-to-nitrogen ratio (379), suggesting these cells are experiencing nitrogen limitation. 
During growth on xylose, members of the XylR regulon were induced; this regulon includes 
genes that encode proteins required for the uptake and metabolism of xylose and arabinose (380). 
Acetylation Modifies the Same Targets Independent of Carbon Source 
 To determine whether glucose and xylose induce acetylation of the same proteins, we 
identified lysines acetylated under all four conditions. Through this analysis, we identified 3840 
unique acetylated lysines that corresponded to 978 proteins. Using the above protein abundances, 
we were able to calculate the relative fold-change between conditions. Comparing 4% to 0.4% 
glucose, 278 lysines on 157 proteins increased acetylation by at least 2-fold in 4% glucose. 
Similarly, 256 sites on 147 proteins had at least a 2-fold increase in acetylation comparing 4% 
xylose to 0.4% xylose. In neither case was acetylation observed to decrease between 4% and 
0.4% carbon. Anti-acetyllysine western blot confirmed these findings, where more carbon 
resulted in a stronger acetylation pattern, although not as strikingly as expected (Fig. 20). 
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Figure 20. Xylose and Glucose Induce Acetylation. Triplicate cultures of wild-type cells of E. 
coli (strain BW25113) were aerated at 37°C in M9 minimal medium supplemented with glucose 
or xylose at a final concentration of 0.4% or 4%. Cells were harvested after 10 hours. Protein 
lysates were normalized to protein concentration, separated by 1D-SDS PAGE, and assessed for 
protein acetylation by anti-acetyllysine (α-acK) western immunoblot analysis.  
 
 When comparing both carbon sources of the same concentration to one another, most of 
the acetylations were regulated independent of the identity of the carbon source. In other words, 
the proteins that were acetylated in the presence of glucose were the same proteins acetylated in 
the presence of xylose. In one interesting case, xylose isomerase (XylA) was found to be 
differentially acetylated on two lysines. Specifically, the relative abundance of acetylation for 
one lysine, K17, increased, while the other, K381, decreased during growth on 4% glucose 
versus 4% xylose. The acetylation of K17 also increased during growth on 4% versus 0.4% 
xylose, suggesting that it is sensitive to the energy state of the cells. I hypothesized that the 
differential acetylation in response to the different carbon sources could be a regulatory 
modification to adjust metabolism of xylose. 
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Lysines 17 and 381 Acetylation Mimics of XylA Do Not Affect Growth on Xylose 
 To determine whether acetylation of either lysine affects XylA activity, I asked whether 
E. coli strains carrying xylA alleles mimicking acetylated lysines would hinder growth in medium 
with xylose as the sole carbon source. Into the native xylA gene in the chromosome, I 
recombined xylA alleles that encoded variants of XylA with lysine to glutamine substitutions that 
mimic and acetylated lysine (K17Q and K381Q) or variants of XylA with lysine to arginine 
substitutions that mimic an unacetylatable lysine (K17R and K381Q). To ensure that the cells 
would grow initially, I aerated cultures overnight in M9 minimal medium supplemented with 
0.4% glucose. Normalized cell numbers were harvested, washed three times in PBS, and 
resuspended in 0.4% xylose or 4% xylose with 0.4% glucose and 4% glucose serving as controls 
where XylA should not have an effect on growth (Fig. 21). As a further control, a ΔxylA mutant 
was unable to grow in xylose, and thus confirmed that XylA is required for growth on xylose 
(381). The rate of growth was reduced in the xylose cultures compared to their glucose 
counterparts, while the final densities achieved were comparable between the two sugars. 
However, there was no significant difference in growth between WT cells or the cells carrying 
the XylA variants. Thus, these lysine residues do not appear to be required for growth of E. coli 
on xylose.  
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Figure 21. Comparison of Growth for Different XylA Mutants During Growth in 0.4% 
Xylose or 4% Xylose. Wild-type E. coli (strain BW25113) or strains carrying the indicated 
mutant variants of XylA K17 or K381 were aerated in M9 minimal medium supplemented with 
0.4% or 4% of glucose or xylose as the sole carbon source. 
 
Summary 
 To conclude this section, we found that independent of the carbon source, the identities of 
acetylated proteins did not change. This finding is consistent with the hypothesis that the major 
factors that regulate acetylation are the synthesis of AcP and a molecular environment that 
facilitates acetyl transfer. Indeed, the only factor that meaningfully altered acetylation was the 
concentration of carbon. Increased carbon caused an increase in acetylation, which is not 
surprising since this should cause more AcP to be generated and be available for protein 
modification. One of the targets that was differentially acetylated in the two carbon sources was 
XylA. However, neither lysine appears to regulate XylA activity.  
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Assessing Phenotypes for Global AcP-Dependent Acetylation 
Introduction 
 The evidence thus far suggests that acetylation by AcP is simply a consequence of 
fermentation. This raises the question: has E. coli evolved to cope with or utilize this 
unavoidable modification? AcP accumulates when cells are exposed to excess carbon and 
increases greatly during stationary phase. AcP may serve one or many functions for the cell. As 
many of the proteins acetylated by AcP are in central metabolism, acetylation could be a 
regulator of carbon flux.  
Stationary phase is a time when individual cells in a culture adjust their physiology, 
shifting from a program of growth and division to one in which the cell prepares defenses against 
stresses that may cause macromolecular damage. Many amino acids are subject to damage via 
reactive oxygen species or products of oxidation. Lysine can be oxidized by at least 8 different 
chemical oxidations (277), one of which, carbonylation, has been found to readily occur in 
stationary phase cultures of E. coli (327, 382). Carbonylation results in protein misfolding and 
aggregation, which can be lethal to the cell if not mitigated by proteolytic degradation. Thus, I 
hypothesized that AcP is a preventative non-enzymatic modification of lysines against more 
deleterious non-enzymatic modifications like carbonylation. In the first part of this section, I will 
test the hypothesis that cells containing high acetylation will have reduced carbonylation and/or 
reduced protein aggregates. 
Another hypothesis that is independent of the previous two is that acetylation may serve 
as carbon storage. Across the phylogenetic tree, cells store excess carbon in glycogen, a glucose 
polymer, as a carbon source for use during starvation. Perhaps acetylation could similarly be a 
way for cells to stockpile two-carbon subunits on proteins. When grown in 2XYT medium, a rich 
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medium but without glucose, Baeza et al. estimated there may be approximately 1.7 – 2.8 mM 
acetate stored on proteins as acetylation (77). Thus, cells that accumulate AcP, such as a ΔackA 
mutant or cells grown in glucose may have even higher amounts of acetate stored on proteins. In 
the second part of this section, I will test the hypothesis that acetylation can serve as a carbon 
source to permit survival in starvation conditions. 
Carbonylation and Acetylation Are Not Inversely Related 
 To test the hypothesis that acetylation protects proteins against carbonylation, I began by 
comparing aggregated proteins of cells with low acetylation (e.g. Δpta or Δpta ackA mutants that 
cannot generate AcP) to those with higher acetylation (WT). To obtain the aggregated proteins, I 
grew the WT cells, Δpta, and Δpta ackA mutants in TB7/gl for 10 hours, harvested samples, and 
isolated the insoluble fractions to obtain protein aggregates as described in the Methods section. 
These insoluble proteins were visualized by Coomassie-stained SDS-PAGE. Contrary to the 
hypothesis, the aggregation observed in wild-type cells and AcP-deficient mutants was not 
visually different in three independent replicates of three biological replicates each (a 
representative image is found in Fig. 22).  
To directly determine whether acetylation of a lysine could protect proteins against 
carbonylation, I utilized a carbonylation detection assay. Δpta, Δpta ackA, and WT cells were 
grown in TB7/gl for 10 hours, and lysates were generated.  Carbonylation could be measured by 
reaction of protein lysates with DNPH reagent, which reacts with carbonyl groups and labels 
them for subsequent detection with an anti-DNPH antibody. Again, in data that contradicted my 
hypothesis, the carbonylation was indistinguishable between the low acetylation strains and the 
WT cells (Fig. 23). While both of these experiments yielded negative data under these 
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conditions, it may yet be possible that acetylation may have an effect under more stressful 
conditions like hydrogen peroxide stress. 
 
Figure 22. AcP-Dependent Acetylation Mutants Do Not Affect Protein Aggregation. 
Triplicate cultures of wild-type cells, Δpta mutants, and Δpta ackA mutants of E. coli (strain 
BW25113) were aerated at 37°C in TB7 supplemented with 0.4% glucose. After 10 hours, 
equivalent numbers of cells were harvested, and protein aggregates were isolated. Aggregated 
proteins were separated by 1D-SDS PAGE and stained by Coomassie Brilliant Blue to visualize. 
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Figure 23. Loss of AcP Does Not Alter Carbonylation. Triplicate cultures (A-C) of wild-type 
cells, Δpta mutants (Left panels), and Δpta ackA mutants (Right panels) of E. coli (strain 
BW25113) were aerated at 37°C in TB7 supplemented with 0.4% glucose. Cells were harvested 
after 10 hours. Protein lysates were normalized to protein concentration and treated with or 
without DNPH to detect carbonylated proteins. The lysates were separated by 1D-SDS PAGE 
(Top panels) and assessed for protein acetylation by anti-DNP western immunoblot analysis 
(Bottom panels).  
 
Acetylation Does Not Promote Survival under Starvation Conditions 
 To determine whether acetylation could serve as a carbon source, I began by asking 
whether carbon from acetylation was sufficient to promote colony formation in the absence of a 
carbon source. To do this, I grew WT cells in TB7 (low acetylation) or TB7/gl (high acetylation) 
overnight. I made serial dilutions and spread an aliquot of cells onto M9 minimal medium plates 
without a carbon source, such that the cells could only grow based on their carbon stores. 
However, no colonies developed indicating that the amount of carbon from glycogen and 
acetylation is insufficient to promote colony formation. 
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 To further test this hypothesis, I performed competition experiments of Δpta (low 
acetylation) and ΔackA (high acetylation) mutants in liquid media without a carbon source. Each 
mutant contained a marker that permitted utilization of either arabinose (Ara+) or lactose (Lac+). 
Thus, I paired Δpta Ara+ with ΔackA Lac+ and vice versa. The mutants were initially cultured in 
M9 minimal medium supplemented with 0.4%glucose for 9 hours to ensure the cells had entered 
stationary phase and fully consumed all of the glucose. Then, equivalent cell numbers of each 
culture were pelleted in duplicate, one pellet for a monoculture control and one pellet for the 
competition assay. The pellets were resuspended in M9 minimal medium without a carbon 
source. Then, the resuspended pellets of the complementary Δpta and ΔackA mutants were 
combined. The colony forming units (CFUs) from the monocultures and competitions were 
measured over the course of approximately two weeks (a representative graph is shown in Fig. 
24). No difference was detected in the monocultures of the Δpta and ΔackA mutants with either 
marker. While slight variations could be detected between the mutants in competition, the 
differences were not significant. 
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Figure 24. Carbon from Acetylation Does Not Promote Starvation Survival. Δpta (Red lines) 
and ΔackA (Blue lines) mutants of E. coli (strain BW25113) able to grow on either lactose (lac+) 
or arabinose (ara+) were aerated at 37°C in M9 minimal medium supplemented with 0.4% 
glucose for 9 hours. Equivalent cell numbers were spun down and resuspended in M9 minimal 
medium without carbon. To perform the competitions, Δpta and ΔackA mutants with opposing 
markers were cultured together. Survival was measured by plating for CFUs every three days for 
nine days. 
 
Summary 
 In summary, I was unable to find a phenotype for AcP-dependent acetylation. The 
hypothesis that acetylation could serve as a protective modification is still sound. I only tested 
AcP-dependent as a protection against endogenous carbonylation, but it is possible that a 
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phenotype for acetylation may arise after treatment of cells with hydrogen peroxide to cause 
further oxidative stress. Furthermore, carbonylation can occur on other amino acids beyond 
lysine, so it is possible that a western blot would not be sensitive enough to determine the 
contribution of carbonylated lysines to the total carbonylation of proteins.  
Acetylation was unable to sustain survival in starvation conditions. This could be because 
the hypothesis is incorrect, and acetylation is insufficient to provide carbon for starving cells. 
Alternatively, it could be that the contribution of glycogen to survival under starvation conditions 
obscures any contribution by acetylation. Thus, the exact phenotype for global, AcP-dependent 
acetylation remains elusive. However, recent reports studying the effect of AcP-dependent 
acetylation on specific lysines have found that acetylation may play a role in the function of 
certain proteins, including some proteins found in central metabolism (Table 2). 
These studies lay the groundwork for future researchers to further investigate these 
hypotheses but under different conditions. I only assessed carbonylation under a single condition, 
but many chemicals can promote oxidative damage, which may exacerbate protein damage in the 
absence of acetylation. Importantly, I have generated differentially marked ΔackA and Δpta 
mutants. These stains can be used to perform competition experiments to assess how AcP-
dependent acetylation affects a given phenotype with the caveat that the markers promote growth 
on either arabinose or lactose. 
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CHAPTER FOUR 
EXPERIMENTAL RESULTS 
Identification of GNATs in E. coli That Have KAT Activity and Their Targets 
Introduction 
 Prior to this work, two mechanisms were known to acetylate proteins in E. coli. As 
described in Chapters One and Three, AcP is produced as an intermediate of the Pta-AckA 
acetate fermentation pathway and readily acetylates proteins non-enzymatically. The other 
mechanism is the canonical enzymatic mechanism where a KAT, YfiQ, catalyzes the transfer of 
the acetyl group of AcCoA onto the target lysine side chain. Data obtained by Alaa 
AbouElfetouh suggested that these may not be the only means of acetylating proteins in E. coli. 
She showed that a strain lacking AcP and YfiQ (Δpta ackA yfiQ) could still produce acetylation 
detected by anti-acetyllysine western blot (Fig. 25). 
 I hypothesized that this acetylation could result from at least one of three possible 
sources. First, acetylation could be catalyzed by an uncharacterized KAT. Second, AcCoA could 
serve as a non-enzymatic acetyl donor, like AcP. Finally, there could be another non-AcP, non-
AcCoA compound that could serve as an acetyl donor. I chose to focus on the first two 
hypotheses. In the following chapter, I assess the KAT activity of proteins encoded by E. coli 
predicted to be members of the Gcn5-related N-acetyltransferase (GNAT) family, of which YfiQ 
is a member, identifying four of these GNATs as KATs. We then identified the proteins that 
were acetylated in a KAT-dependent manner.
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Figure 25. A Strain Lacking Known Mechanisms of Acetylation Contains Residual Lysine 
Acetylation. Triplicate cultures of wild-type cells and Δpta ackA yfiQ mutants of E. coli (strain 
AJW678) were aerated at 37°C in TB7 supplemented with 0.4% glucose. After 8.5 hours, cells 
were harvested. Protein lysates were normalized to protein concentration, separated by 1D-SDS 
PAGE, and assessed for protein acetylation by anti-acetyllysine (α-acK) western immunoblot 
analysis (Left panel). Coomassie-stained SDS-PAGE gel (Right panel) to confirm protein 
normalization is shown. 
 
PhnO, RimI, YiaC, YjaB, and YjgM Enhance Acetylation of One or More Proteins 
 Within the E. coli genome, 26 genes are annotated as GNATs, one of which is YfiQ (113, 
126, 162). This family of enzymes catalyzes the donation of an acetyl group from AcCoA onto a 
molecule. When the molecule acetylated is a lysine on a protein, these enzymes are called KATs. 
The existence of these other GNATs may explain YfiQ-independent, AcP-independent 
acetylation. Thus, I wanted to determine whether, in addition to YfiQ, any of the gene products 
annotated as GNATs have KAT activity. 
 To determine whether these GNATs have KAT activity, I compared acetylation profiles 
of strains overexpressing each of the GNATs via anti-acetyllysine western blotting. I used a Δpta 
yfiQ acs cobB background to enhance the signal-to-noise ratio, which I refer to as the acetylation 
“gutted” strain. This strain reduces background acetylation levels from AcP and YfiQ (Δpta 
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yfiQ), while ensuring that the residual acetylation that occurs is not reversed by the CobB 
deacetylase (ΔcobB). Acs was also deleted, as it has been reported to acetylate the chemotaxis 
response regulator CheY (339). Furthermore, YfiQ regulates Acs activity and loss of that control 
can have a detrimental effect on growth due to energy depletion (383). As with a Δpta ackA yfiQ 
mutant, the gutted strain (Δpta yfiQ acs cobB) exhibited only limited acetylation (Fig. 26). To 
validate that this strain behaved as expected and hyperacetylated specific lysine sites with the 
known KAT YfiQ, I first compared YfiQ overexpression in a gutted strain that expresses the 
known YfiQ substrate Acs (Δpta yfiQ cobB, Acs+) to that in a gutted strain that does not express 
Acs (Δpta yfiQ cobB, Acs-). Indeed, by anti-acetyllysine western blot analysis, I observed an 
acetylated band in the gutted Acs+ strain that was absent in the gutted Acs- strain (Fig. 27, 
denoted by an asterisk). Upon induction of each of the 25 GNAT family members in the gutted 
strain, I found that overexpression of four GNATs (Aat, ElaA, YiiD, and YafP) inhibited growth. 
For the 21 strains that did grow, only 8 of the putative GNATs - plus YfiQ - resulted in the 
appearance of one or more acetylated protein band(s) (Fig. 28). Induction of YncA (17 kDa) and 
AstA (38.5 kDa) each produced a single acetylated band that migrated consistent with its 
expected molecular mass, suggesting acetylation of the proteins themselves. Induction of RimI, 
YiaC, YjaB, YjgM, and PhnO expression reproducibly produced acetylated protein band(s) 
across multiple replicates; in contrast, induction of RimJ did not (data not shown). Thus, I 
selected RimI, YiaC, YjaB, YjgM, and PhnO for further assessment of their ability to function as 
KATs. However, the subsequent mass spectrometry studies described below were unable to 
identify any targets of YjgM, so it will not be discussed further. 
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Figure 26. Gutted Strain of E. coli Has Low Background Acetylation. Wild-type cells and 
Δpta yfiQ cobB acs (Gutted) mutant of E. coli (strain BW25113) were aerated at 37°C in TB7 
supplemented with 0.4% glucose. After 10 hours, cells were harvested. Protein lysates were 
normalized to protein concentration, separated by 1D-SDS PAGE, and assessed for protein 
acetylation by anti-acetyllysine (α-acK) western immunoblot analysis (Left panel). Coomassie-
stained SDS-PAGE gel (Right panel) to confirm protein normalization is shown. 
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Figure 27. Overexpressing YfiQ Results in Increased Acetylation. BW25113 Δpta yfiQ cobB 
cells (Acs+) or Δpta yfiQ acs cobB (Acs-) were transformed with pCA24n-YfiQ or the empty 
vector (VC). The resultant strains were aerated in TB7 supplemented with 0.4% glucose and 25 
μg/ml chloramphenicol for 10 hours. IPTG was added to a final concentration of 50 μM where 
indicated. Whole cell lysates were analyzed by Coomassie blue-stained SDS-PAGE gel (Bottom 
panel) to ensure equivalent loading and by anti-acetyllysine (α-acK) western blot (Top panel). 
The acetylated Acs band is indicated by an asterisk (*). Note, leaky expression of YfiQ results in 
acetylation of Acs in the absence of IPTG. 
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Figure 28. Overexpression of Five GNAT Family Members Results in Altered Lysine 
Acetylation Patterns by Anti-Acetyllysine Western Blot. The gutted strain (BW25113 Δpta 
yfiQ acs cobB) was transformed with the pCA24n vector control (negative (-) control) or 
pCA24n containing the indicated genes under an IPTG inducible promoter (69). As a positive (+) 
control, an isogenic strain that retained the WT allele of acs (Δpta yfiQ cobB) was transformed 
with pCA24n containing YfiQ. The resulting strains were aerated in TB7 supplemented with 
0.4% glucose, 50 μM IPTG, and 25 μg/mL chloramphenicol for 10 hours. Whole cell lysates 
were analyzed by Coomassie blue-stained SDS-PAGE gel (Right panels) to ensure equivalent 
loading and by anti-acetyllysine western blot (Left panels). Note that the band in RimJ was not 
reproducible. The positive control contains one additional YfiQ-dependent band around 72 kDa, 
which corresponds to Acs. YncA and AstA each produce an acetylated band that can be observed 
in the Coomassie stained gel at the expected molecular weight of these proteins. 
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Mutation of Conserved Catalytic Residues Inactivates PhnO, RimI, YiaC, and YjaB 
 The enzymatic acetylation mechanism is catalyzed in three steps 1) deprotonation of the 
target lysine via a general base like glutamate or via a “proton wire”-type mechanism, 2) 
nucleophilic attack of the lysine on the carbonyl carbon of the acetyl group of AcCoA, and 3) 
protonation of CoA via a general acid like tyrosine. Thus, I hypothesized that if I could identify 
and mutate these residues in the putative KATs, I could prevent acetylation by them in vivo. I 
compared their sequences and utilized the protein structure prediction tool Phyre2 to identify 
residues that would be required for catalysis. I was able to identify the catalytic tyrosine that 
should protonate CoA for each of the four putative KATs (PhnO Y128, RimI Y115, YiaC Y115, 
and Yjab Y117). I was only able to identify a catalytic glutamate in PhnO (E78), suggesting 
these other three enzymes may use a “proton wire”-type mechanism (131).  Additionally, Phyre2 
suggested that a phenylalanine (F70) of YiaC could affect activity.  
I made alanine substitutions at each of these residues and repeated the western blot with 
these variant proteins (Fig. 29). Each of the variants lost all acetylation detected in the WT 
isoforms, except YiaC F70A. The YiaC F70A variant produced the same pattern as WT YiaC 
but at a reduced intensity. This is not surprising since this residue was predicted to be important 
for function, but not necessarily catalysis. Because these plasmids encoded proteins carrying an 
N-terminal His-tag, I could ensure that the loss of acetylation in these variant proteins was due to 
a loss of activity rather than unstable proteins. Thus, I performed an anti-His-tag western blot, 
and found that protein levels of the variant proteins were equivalent to the WT protein in every 
case, except YjaB Y117A. I hypothesized that this may be due to the tyrosine having a role in the 
structure of YjaB, and mutation of that tyrosine destabilized the protein. However, since the role 
of tyrosine in catalysis is hypothesized to be for the donation of the proton from the hydroxyl 
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group to CoA, I expected that if I mutated tyrosine to phenylalanine, the protein should be 
structurally identical but lack the hydroxyl group needed for catalysis. As I predicted, the YjaB 
Y117F mutant produced a stabilized protein that could not produce the YjaB-dependent band on 
an anti-acetyllysine western blot (Fig. 30). 
 
Figure 29. Mutation of Conserved Catalytic Amino Acids Prevents RimI, PhnO, YjaB, and 
YiaC-Dependent Acetylation. The gutted strain (BW25113 Δpta yfiQ acs cobB) was 
transformed with the pCA24n vector control, pCA24n carrying the wild-type allele for each 
putative KAT, or mutant alleles for each putative KAT with alanine substitutions of the indicated 
residues. The resulting strains were grown in TB7 supplemented with 0.4% glucose, 100 μM 
IPTG, and 25 μg/mL chloramphenicol for 8 hours. Crude lysates harvested after 4 hours were 
analyzed for expression of the KAT proteins. Whole cell lysates harvested after 8 hours were 
analyzed for acetylation. Coomassie stained SDS-PAGE gels (A, C) served as loading controls 
for anti-His (B) and an anti-acetyllysine (D) western blots. 
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Figure 30. The Hydroxyl Group of Tyrosine 117 Is Required for the KAT Activity of YjaB. 
The gutted strain (BW25113 Δpta yfiQ acs cobB) was transformed with the pCA24n vector 
control, pCA24n carrying the wild-type YjaB or the indicated YjaB mutants. The resultant strains 
were grown in TB7 supplemented with 0.4% glucose, 100 μM IPTG, and 25 μg/mL 
chloramphenicol for 8 hours. Crude lysates harvested after 4 hours were analyzed for expression 
of the KAT proteins. Whole cell lysates harvested after 8 hours were analyzed for acetylation. 
Coomassie stained SDS-PAGE gels (left) served as loading controls for anti-His (top right) and 
an anti-acetyllysine (bottom right) western blots. 
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We next confirmed that the amino acids I chose to mutate were active site residues. The 
sequence identity between these KATs is low (<30%), but since GNATs share a common 
structural fold, our collaborator at San Francisco State University, Misty Kuhn, performed a 
structural comparison of these KATs. The goal was to confirm that the chosen residues were in 
the correct location within the 3D structure (Fig. 31). An E. coli crystal structure of RimI (5isv) 
and an NMR structure of YjaB (2kcw) have been deposited into the Protein Data Bank (PDB); 
however, PhnO, YfiQ, and YiaC lack crystal structures. Thus, Dr. Kuhn built homology models 
for these three KATs. All of their active sites, with the exception of YfiQ, contained a conserved 
tyrosine known to act as a general acid in other GNAT homologs (384, 385), which were the 
same tyrosines that I mutated. However, as Phyre2 indicated, the identity/presence of the general 
base that deprotonates the lysine shows lower conservation than the general acid. RimI E103 acts 
as the general base in S. enterica serovar Typhimurium (386) and is conserved in the E. coli 
RimI and YiaC. In contrast, YjaB and PhnO have N105 and S116 in this position, respectively. 
Since I found PhnO E78 was required for acetylation dependent upon PhnO, E78 may be 
required for catalysis, which may suggest the general base may be found in a different 3D 
location for the different KATs. 
The requirement for conserved catalytic amino acids for production of the PhnO-, RimI-, 
YiaC-, and YjaB-dependent bands suggests that these putative GNATs have KAT activity. 
However, the best evidence that an enzyme is a KAT would be demonstration that the enzyme 
can acetylate a target in vitro. Therefore, we needed to determine what proteins are acetylated by 
these putative KATs. 
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Figure 31. Sequence and Structural Comparison of KAT Proteins and Their Key Catalytic 
Residues. (A) Sequence alignment of all five E. coli KATs. Only the GNAT portion of the 
sequence for YfiQ is shown. The structural elements above the sequences are based on the 5isv 
RimI structure. Red highlighting represents 100% identity, whereas yellow highlighting shows a 
global score of 70% identity based on ESPript 3.0 parameters. Black arrows beneath the 
sequences indicate the residues selected for structural comparison in panel C. (B) Comparison of 
overall structures and homology models of E. coli YfiQ (pink), YiaC (orange), YjaB (yellow), 
126 
 
RimI (green; full C-terminus not shown in the figure), and PhnO (blue) proteins in a ribbon 
representation. 3D structures of YjaB and RimI were determined previously (PDB IDs 2kcw and 
5isv, respectively). We built homology models of the remaining KATs using the following 
structures as templates: 4nxy for YfiQ, 2kcw for YiaC, and 1z4e for PhnO. Only the GNAT 
portion of the YfiQ protein sequence was used for the homology model. Further details regarding 
parameters for building and selecting representative homology models for these proteins are 
described in Materials and Methods. (C) Comparison of select active site residues potentially 
important for substrate recognition and catalysis in GNATs. The crystal structure of RimI (5isv) 
has the C-terminus of one monomer bound in the active site of the second monomer. A surface 
representation of this portion of the protein that encompasses the AcCoA donor (gray) and 
peptide acceptor (purple) site are shown. Each of the KAT homology models and structures were 
aligned using TopMatch and Pymol. Four active site residues are shown. A table beneath the 
structures shows the specific residue numbers for each KAT. Residues that were mutated are 
shown in red. This figure was generated by Dr. Misty Kuhn (SFSU) and published in (153). 
 
Identification and Gene Ontologies of Proteins Acetylated by the KATs 
  To identify proteins whose acetylation depended on these putative KATs, I grew the 
“gutted” E. coli strains overexpressing RimI, YiaC, YjaB, and PhnO, as well as the known 
acetyltransferase YfiQ as a positive control and the empty vector as a negative control. I 
harvested pellets and submitted them to our collaborator Birgit Schilling for mass spectrometric 
analysis. We identified a total of 1539 unique acetylation sites on 668 unique proteins across all 
samples (see (153) for the published data). To determine the set of acetylation sites regulated by 
these novel KATs and YfiQ, we applied stringent filters to the quantitative comparisons between 
the overexpression samples and control (q-value < 0.01 and log2 [FC] ≥ 2, which is a ≥4-fold 
increase over vector control), resulting in a total of 818 acetylation sites on 434 proteins whose 
acetylation increased with overexpression of at least one KAT. YfiQ, acetylated the most lysines, 
with a total of 649 sites with significantly enhanced acetylation on 364 proteins. YiaC and YjaB 
overexpression resulted in lower, yet substantial, numbers of significantly increased acetylation 
of sites/proteins (391/251 and 171/128, respectively). Overexpression of RimI and PhnO elicited 
the fewest changes, each acetylating fewer than 20 sites. It should be noted that we observed 
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many more acetylated proteins by mass spectrometry than the number of bands we obtained via 
Western blot analysis. Mass spectrometry will detect site-specific acetylated peptides with 
greater sensitivity than western blotting, as previously shown (57, 78). Additionally, different 
acetylated proteins may migrate together on a gel and result in the appearance of only one band 
on a western blot. 
 To further explore the specificity of these KATs, we compared the sites acetylated by 
KAT overexpression with sites that we previously found to be sensitive to deletion of ackA, 
which causes accumulation of the highly reactive acetyl donor AcP and therefore results in non-
enzymatic protein acetylation (57). Remarkably, of the 592 AckA-regulated sites, only 29 
overlapped the 818 sites acetylated by PhnO, RimI, YiaC, YjaB, or YfiQ, further reinforcing 
their specificity and thus likely distinct functions. We also analyzed the primary amino acid 
sequences surrounding lysines that were acetylated by these novel KATs and found no specific 
neighboring residue preference. This suggests that substrate specificity cannot be determined by 
primary sequence alone and that three-dimensional analysis of protein structures should be 
considered. 
 To determine what pathways or functions these novel KATs may regulate, we assessed 
the gene ontologies of the KAT-regulated targets. Translation proteins and central metabolic 
enzymes were the most heavily acetylated cellular function. Almost all ribosomal protein 
subunits were acetylated (51 of 55 proteins); some were acetylated by AcP only (8/55) and some 
were acetylated by one or more KATs but not AcP (11/55), but most were acetylated by at least 
one KAT and AcP (32/55). Of the lysines on those ribosomal proteins, one-quarter (46/184) of 
them were targeted by more than one KAT, with as many as 3 KATs acetylating the same lysine. 
Acetylation by a KAT and AcP only occurred in 9/184 lysines. In addition to the ribosome itself, 
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amino acid tRNA ligases (16/23 proteins) were acetylated; some were acetylated by AcP only 
(6/23), some by KATs only (5/23), and some by both (5/23). Three of the 7 elongation factors 
were acetylated; these acetylations were largely dependent on AcP (13/15). All of the initiation 
factors were acetylated, and these acetylations were almost entirely KAT dependent (7/8). These 
data support a hypothesis where acetylation by AcP and by KATs have distinct roles. 
 Twenty-seven proteins comprise the three glycolytic pathways in E. coli (Embden-
Meyerhof-Parnas [EMP], Entner-Doudoroff [ED],and pentose phosphate [PP]). Of these 27 
proteins, 20 were detected as acetylated: 2 strictly by KAT(s), 7 by KAT(s) and AcP, and 11 by 
AcP alone (Fig. 32). A total of 97 lysines were acetylated: 9 by KAT(s) alone, 86 by AcP alone, 
and only 2 by both AcP and a KAT. Intriguingly, the majority of KAT-dependent acetylations 
(7/11) were found on proteins responsible for either the early or late steps of glycolysis, i.e., prior 
to the formation ofglyceraldehyde 3-phosphate (GAP) or on enzymes responsible for aerobic 
AcCoA synthesis. In contrast, the majority of AcP-dependent acetylations (66/88) were found on 
proteins that all glycolytic pathways share. In support of the concept that KAT-dependent 
acetylation helps direct flux, 3 other proteins relevant to glycolysis are exclusively acetylated by 
KAT(s). YfiQ and YiaC acetylated the transcription factor GntR,which controls expression of 
the enzymes (Eda [2-keto-4-hydroxyglutarate aldolase]and Edd [phosphogluconate dehydratase]) 
that comprise the ED pathway. LipA synthesizes lipoate, whereas LipB transfers a lipoyl group 
onto a lysine in the E2 subunit (AceF) of the pyruvate dehydrogenase complex (PDHC). The 3 
subunits of PDHC, whose activity requires lipoylation, are highly acetylated, but almost entirely 
by AcP. Incontrast, LipA and LipB are entirely acetylated by KATs (7 lysines on LipA by YfiQ, 
YiaC,and YjaB and 1 lysine on LipB by YfiQ). These observations are consistent with the 
hypothesis that KAT-dependent acetylation helps direct flux through the 3 different glycolytic 
129 
 
pathways and regulates the transition from glycolysis to AcCoA-dependent pathways, such as 
the TCA cycle, fatty acid biosynthesis, and different forms of fermentation. 
 
Figure 32. Most of Central Metabolism Is Differentially Acetylated by AcP and/or KATs.  
The three glycolytic pathways, Embden-Parnas-Meyerhof (EMP), Entner-Dourdoroff (ED), and 
Pentose Phosphate (PP) are shown with metabolites and enzymes indicated. Some enzymes are 
not acetylated (gray), while others are acetylated by acetyl-P alone (blue), KATs alone (red), or 
both (orange). Enzymes with boxes were modified by at least one KAT (as indicated); some were 
also acetylated by acetyl-P (AcP). The size of the dot indicates the fold upregulation for each 
lysine by either a KAT or AcP. 
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In Vitro Acetylation with YiaC 
 To determine whether these KATs truly have lysine acetyltransferase activity, I sought to 
demonstrate that incubation of a KAT with a target protein in the presence of AcCoA would 
yield an acetylated target protein. I chose a representative target protein that met the following 
criteria of having i) a high chance of being purified, ii) a lysine in a provocative location, and iii) 
an established assay to assess the effect of acetylation. I found that the YiaC target, cysteine 
synthase A (CysK), met my criteria. CysK catalyzes the second step in cysteine biosynthesis. 
CysK activity can be assessed in vitro, and a ΔcysK mutant is a cysteine auxotroph. Furthermore, 
I found that CysK was acetylated on a critical lysine that normally is covalently bound to the 
catalytic cofactor pyridoxal-5’-phosphate (PLP). Therefore, I hypothesized that acetylation of 
CysK would inactive the enzyme by preventing PLP from binding, which could be assessed by 
in vitro or in vivo assays. 
 To begin, I obtained purified YiaC from our collaborator Ekaterina Filippova, then at 
Northwestern Unviersity. I then purified His-tagged CysK encoded on a plasmid from the ASKA 
collection, an overexpression library containing most E. coli genes. I incubated CysK in the 
presence of YiaC, AcCoA, or both with the expectation that I should only see acetylation 
catalyzed in the presence of both YiaC and AcCoA. However, I consistently found that CysK 
was acetylated by AcCoA in the absence of YiaC, indicating that AcCoA non-enzymatic 
acetylation can occur in vitro (Fig. 33). This is consistent with other findings that histones (387), 
mitochondrial proteins (288), and bacterial proteins (232, 339, 388) can be acetylated by AcCoA 
non-enzymatically in vitro. 
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Figure 33. Non-Enzymatic AcCoA-Dependent Acetylation. Purified His-tagged CysK protein 
(0.6 μg) was incubated with YiaC (0.26 μg) and/or the indicated concentrations of AcCoA for 1 
hour at 37°C. Reaction was stopped by heating at 100°C for 5 minutes. Proteins were resolved 
by SDS-PAGE and assessed for protein acetylation by anti-acetyllysine (α-acK) western 
immunoblot analysis. 
 
 I attempted to disfavor non-enzymatic acetylation by manipulating the reaction 
conditions. First, I boiled the samples prior to loading onto the SDS-PAGE gel for Coomassie 
staining and anti-acetyllysine western blotting. However, this might have enhanced hydrolysis of 
AcCoA and perhaps drive acetylation. Thus, I compared acetylation between samples that had 
and had not been boiled (Fig. 34A). Boiling resulted in more acetylation than the samples that 
were not boiled. However, this modification to the procedure still did not demonstrate any effect 
of YiaC on CysK acetylation. 
 To further modify the reaction conditions to disfavor non-enzymatic acetylation, I did not 
boil my samples and reduced the pH from 8 to 7 with the hypothesis that a less basic pH would 
result in fewer lysines becoming becoming spontaneously deprotonated. As expected, pH 8 
promoted increased acetylation intensity more than pH 7 (Fig. 34B). Unfortunately, there was no 
visible effect of YiaC beyond that of AcCoA alone. Misty Kuhn is continuing to optimize 
conditions so that she can test the other KATs and targets for in vitro acetylation. Reasons for the 
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prevalence of non-enzymatic acetylation and caveats of this approach will be covered in the 
Discussion section. 
 
Figure 34. Non-Enzymatic AcCoA-Dependent Acetylation Is Enhanced by Boiling, High 
pH. (A) Purified His-tagged CysK protein (0.37 μg) was incubated with YiaC (0.26 μg) and/or 
the indicated concentrations of AcCoA for 1 hour at 37°C. (A) Reactions were either stopped by 
boiling at 100°C for 5 minutes or by adding loading buffer. Proteins were resolved by SDS-
PAGE and assessed for protein acetylation by anti-acetyllysine (α-acK) western immunoblot 
analysis. (B) Reactions were buffered to pH 7 or pH 8 and carried out as described in A. 
Reactions were stopped by adding loading buffer and not boiling. 
 
Conservation of the KATs across Bacteria Phylogeny 
 I wondered whether these novel KATs are present in other bacteria, and thus whether 
anything we learn about these KATs in E. coli may apply to other organisms. Unfortunately, 
these KATs are generally small (~145 amino acids / 16-17 kD) and tend to have low sequence 
homology. This proved to be troublesome for BLAST analysis. Thus, we reached out to our 
collaborators William Nelson and Samuel Payne. To find orthologs of these KATs, William 
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Nelson generated Hidden Markov Models for each KAT gene and searched against 5,589 
genomes from Refseq (389, 390). To ensure we were looking at orthologs and not paralogs, strict 
cutoffs were used to ensure each genome contained at most only one match. As a highly 
conserved gene, rimI was identified in 4,459 genomes. The yiaC and yjaB genes were all broadly 
distributed across bacterial taxa and found in 421 and 692 genomes, respectively. However, 
phnO was found to have a very limited distribution, identified in only 22 genomes, and appears 
to belong exclusively to the gammaproteobacteria. 
The Gutted Strain as a Tool 
 The “gutted strain” used to identify these E. coli KATs could be utilized as a tool to 
identify KATs from other bacteria. The low signal-to-noise ratio and knowledge about how to 
manipulate E. coli to favor and disfavor acetylation could allow for relatively high-throughput 
analysis of many genes for KAT activity. This also bypasses the requirement to purify the 
enzyme and know a target. A downside, however, is that there must be a protein encoded by E. 
coli that can be acetylated by the heterologously expressed KAT. Additionally, if a target is 
detected as acetylated in E. coli, it may not be the same protein acetylated in the native host. 
Thus, this should be used as an exploratory system and followed up with further study in the 
organism of interest. 
 To test this concept, I received 12 plasmids from John Kirby and David Payne that 
encoded GNAT family members from two strains of Neisseria gonorrhoeae and transformed 
them into the gutted strain. Of these 12 genes, 7 GNATs proteins were represented with two of 
their sequences identical between the two strains and the other five with divergent sequences 
between the two strains. Using the same protocol that I used to identify the novel KATs of E. 
coli, I observed that the RimI homolog of each Neisseria strain was capable of acetylating a band 
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around 40 kD (Fig. 35, lanes FA-2 and 1291-2), which appeared to be the same band acetylated 
by E. coli RimI (Fig. 28). These data confirm that the system can work. However, for the 
heterologously expressed proteins for which I was unable to detect acetyltransferase activity, 
these results suggest that they are either not KATs or that their native targets are distinct from the 
proteins present in E. coli. 
 
Figure 35. RimI Homologs FA-2 and 1291-2 from Neisseria gonorrhoeae Acetylate a Protein 
in E. coli. The gutted strain (BW25113 Δpta yfiQ acs cobB) was transformed with the pCA24n 
vector control (VC) or pCA24n containing the indicated genes under an IPTG inducible 
promoter. The genes come from either the FA 1090 strain or 1291 strain of Neisseria 
gonorrhoeae. Each strain was aerated at 37°C for 10 hours in TB7 supplemented with 0.4% 
glucose, 50μM IPTG, and 25 μg/mL chloramphenicol. The whole cell protein lysate was 
normalized to protein concentration, separated by 1D-SDS PAGE and assessed for protein 
acetylation by anti-acetyllysine (α-acK) western immunoblot analysis. 
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Summary 
 In this section, I have demonstrated that E. coli appears to have at least four KATs in 
addition to the one known KAT, YfiQ. These KATs are single domain proteins that share a 
common GNAT fold and correspond to Class II (Type IV) GNAT classification. The proteins 
acetylated by the KATs were distinct from those proteins acetylated by AcP, suggesting that 
KATs have evolved distinct regulatory roles from AcP. 
 While I was unable to show that one of these KATs, YiaC, could acetylate CysK in vitro, 
mutation of residues suspected to be catalytic based on structural predictions inactived each 
enzyme. Based on prior structures and modelling, each KAT has a catalytic tyrosine that acts as a 
general acid to protonate CoA to regenerate the enzyme. The KATs appear to be highly 
conserved across bacterial phylogeny, which may suggest that what we learn in E. coli also can 
be applied to other bacteria. Indeed, I was able to identify a homolog of RimI from Neisseria 
gonorrhoeae that was capable of acetylating a protein at a molecular weight comparable to the 
band acetylated by E. coli RimI. 
Phenotypic Assessment of the Novel KATs 
Introduction 
 In the above section, I described the discovery of four E. coli proteins that appear to have 
KAT activity. Of these, non-KAT activities of RimI and PhnO have already been described. 
RimI from both E. coli and Salmonella Typhimurium is known to function as an N-terminal 
alanine acetyltransferase that has but one known target, the ribosomal protein S18 (32, 384, 391). 
PhnO is an aminoalkylphosphonate acetyltransferase in both E. coli and S. enterica (392, 393). 
PhnO is part of a gene cluster involved in the utilization of phosphonate under inorganic 
phosphate starvation conditions. While PhnO is not absolutely required for phosphonic acid 
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utilization, it does acetylate (S)-1-aminoethylphosphonate and aminomethylphosphonate (393, 
394). In all cases, however, a role for KAT activity is unknown.  
 To find a role for acetylation, I utilized the E. coli gene expression database 
(https://genexpdb.okstate.edu/databases/genexpdb/) to find conditions under which these KATs 
may be expressed and, thus, when they may be relevant. I also searched for genomic context for 
nearby genes that may suggest a role for these KATs. Finally, I analyzed the targets of each KAT 
to determine whether there were any clear phenotypes that acetylation by a KAT would affect. In 
the following section, I will describe my attempts at uncovering a phenotype for deletion or 
overexpression of these KATs. 
Assessing Growth and Survival of KAT Mutants and Overexpression strains in Various 
Stresses 
 To begin, I searched the genomic neighborhood in which these KATs are located and 
found RimI, YiaC, and PhnO are encoded in polycistronic operons, while YjgM and YjaB are 
monocistronic. The yiaC gene is directly downstream and overlaps four nucleotides of the tag 
gene that encodes 3-methyl-adenine DNA glycosylase I. The product of the tag gene is important 
for removing potentially mutagenic alkylation damage from DNA, but it is not induced through 
the adaptive response. As mentioned previously, the phnO gene is located with the other genes 
necessary for phosphonate utilization. RimI overlaps with DNA polymerase III subunit ψ, which 
is known to form a dimer with subunit χ to enhance affinity of DNA polymerase III preinitiation 
complex for DNA to stabilize the complex (395, 396). Since RimI is known to acetylate the 
ribosome, perhaps linking these genes coordinates replication and translation in some way. 
 The simplest hypothesis from the above information was that YiaC may help cells 
respond to DNA damage. Thus, I hypothesized that deletion of yiaC could reduce or enhance 
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cellular survival against a mutagenic chemical, N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), 
an alkylating agent that methylates DNA. The cell encodes DNA glycosylase I (encoded by the 
tag gene) and DNA glycosylase II (encoded by the alkA gene) to remove the mutagenic lesion. 
Deletion of tag results in impaired survival to MNNG, while deletion of tag and alkA results in 
extreme sensitivity to MNNG (397). Thus, I performed an epistasis analysis between tag, alkA, 
and yiaC to determine whether YiaC contributes to survival against alkylating agents. I began by 
optimizing the protocol to determine killing of the ΔalkA tag mutant compared to WT, and I 
found that treatment with 50 μg/mL MNNG for 20 minutes showed the greatest difference in 
survival between WT and the ΔalkA tag mutant. With the established protocol, I tested the single 
mutants Δtag, ΔalkA, and ΔyiaC, the double mutants ΔalkA yiaC and Δtag yiaC, ΔalkA tag, and 
the triple mutant ΔalkA tag yiaC for survival in MNNG. Consistent with the literature, Δtag 
mutants were more sensitive to MNNG compared to WT, while the ΔalkA mutant was more 
sensitive than the Δtag mutant, and ΔalkA tag mutant was the most sensitive (Fig. 36). However, 
deletion of yiaC alone or in combination with any other deletion survived as well as the 
respective parent strain. Thus, under these conditions, YiaC does not appear to play a role in 
survival against MNNG. 
 Next, I analyzed microarray data that has been collected on the E. coli gene expression 
database to get a sense for conditions under which these KATs are expressed. The microarray 
datasets suggest that conditions that might upregulate KAT expression include heat shock and 
cold shock. To test this hypothesis, I performed growth curves at different temperatures, 
choosing a low temperature (24°C) and a high temperature (46°C) to compare to the standard 
temperature of 37°C. However, neither overexpression nor deletion of any of the KATs affected 
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growth at any temperature in LB (Fig. 37). Thus, while these KATs may affect growth at these 
temperatures, they do not under the conditions tested here. 
 
Figure 36. YiaC Does Not Play a Role in Survival Against MNNG. Mutants of E. coli (strain 
BW25113) or the WT strain were aerated at 37°C to 0.5 OD600. Each strain was treated with 50 
μg/mL N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) or left untreated (control). Cultures were 
incubated for 20 minutes at 37°C. Treatment was stopped by adding 2 volumes of PBS, and 
serial dilutions were plated to enumerate CFUs. Percent survival of the MNNG treated CFUs 
relative to the control CFUs are shown above the bars. 
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Figure 37. KAT Deletion or Overexpression Does Not Affect Growth at Different 
Temperatures. WT cells, KAT deletion mutants, and KAT overexpression (OE) strains of E. coli 
(strain BW25113) were aerated in LB at 24°C, 37°C, and 46°C in LB or LB supplemented with 
50μM IPTG and 25 μg/mL chloramphenicol for the overexpression strains and vector control 
(VC). 
 
Overexpression of YiaC and YfiQ Inhibits Migration 
 Additional conditions under which all of these KATs were found expressed were 
stationary phase and biofilm. Thus, I tested overexpression constructs of the four novel KATs 
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and YfiQ in a mucoidy assay as a readout of capsule formation, which is a characteristic of 
biofilm formation in E. coli (398). but we did not observe any difference relative to wild-type 
cells. The multicellular lifestyle of the biofilm is often contrasted by the planktonic lifestyle 
where the cells are free swimming and migrate towards various chemoattractants or away from 
repellants. Therefore, KAT-dependent acetylation may be a way E. coli shuts down planktonic 
phenotypes like motility to prepare for biofilm formation. I asked whether overexpressing the 
KATs would affect the swimming motility of E. coli in a soft-agar motility assay. We found that 
overexpression of YiaC and YfiQ consistently reduced migration in a soft agar motility assay 
(Fig. 38A and B). The inhibition of migration was not due to a reduction in growth rate as the 
overexpression strains grew as well as their vector controls (Data not shown). 
 To determine whether this reduction required the acetyltransferase activity of YiaC, we 
tested overexpression of YiaC F70A, which had reduced acetyltransferase activity, and YiaC 
Y115A, which lost activity as shown in Fig. 29. Overexpression of YiaC YF70A inhibited 
migration similarly to overexpression of wild-type YiaC (Fig. 38C). In contrast, YiaC Y115A 
was unable to inhibit migration. This suggests that acetyltransferase activity is required for the 
YiaC phenotype. To ensure this was not a strain-specific phenomenon, I recapitulated these data 
for YiaC in another E. coli strain background, MG1655 (Data not shown). While, the YiaC data 
were reproducible, overexpression of YfiQ caused a growth defect in MG1655, which 
confounded any effect of YfiQ on motility. Finally, since YiaC and YfiQ overexpression reduced 
migration, I hypothesized that deleting yiaC or yfiQ would enhance migration. However, neither 
a ΔyiaC nor a ΔyfiQ mutant showed the expected enhancement of migration (Fig. 38D). The 
reasons for this lack will be covered in the Discussion. 
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Figure 38. YiaC and YfiQ Inhibit Migration. Cultures of E. coli (strain BW25113) were grown 
overnight in TB medium supplemented with chloramphenicol and 50 μM IPTG. 5 μL of each 
normalized culture was spotted on low percentage TB plates supplemented with chloramphenicol 
and 50 μM IPTG. The diameter of the cell spot was measured hourly. (A) Final diameter relative 
to vector control (VC) after 12 hours is shown for WT strains carrying the indicated plasmids. 
(B) Representative motility plates of WT strains carrying VC, pYiaC, or pYfiQ. (C) Hourly 
migration of WT strains carrying pCA24n encoding YiaC, YiaC mutants, or vector control (VC). 
(D) Hourly migration of WT strain or isogenic deletion mutants on low percentage TB plates 
without supplement. 
 
Summary 
 While I have identified four new KATs in E. coli, the phenotypes associated with their 
acetyltransferase activity are still unknown. Those who wish to take up this project in the future 
have many tools at their disposal. I have generated an isogenic set of deletion mutants of these 
KATs and the corresponding complementation constructs for some of them. Furthermore, I 
produced a set of overexpression constructs of WT and catalytically inactive isoforms of the 
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KATs that can be used to determine whether a KAT phenotype truly depends on the 
acetyltransferase activity. 
 I was successful in showing that overexpression of either YfiQ or YiaC inhibits migration 
of E. coli, and that phenotype this required the acetyltransferase activity of YiaC. However, I 
was unable to show a phenotype for deletion mutants of these KATs. This may suggest that they 
are not expressed under these conditions or the overexpression phenotype is artifactual. Another 
student in the lab, Sarah Feid, has generated fusions of the KAT promoters to beta-galactosidase. 
With these promoter constructs, we will be able to definitively say whether the KATs are 
expressed and under what conditions. Indeed, Sarah has recently found that yiaC is not 
transcribed under the conditions tested above. In the future, this knowledge will be able to better 
inform phenotypic assays to test these KAT mutants.
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CHAPTER FIVE  
DISCUSSION 
Overall Summary: Chapter Three 
The evidence presented in Chapter Three, in combination with previously published data, 
supports a model in which non-enzymatic, AcP-dependent acetylation is an unavoidable 
consequence of fermentation that accumulates on an aging proteome. Since AcP is made as an 
intermediate of fermentation, the only means of regulating acetylation would be by regulating 
fermentation, deacetylating acetyllysines with a KDAC, and/or evolving protein structures to 
optimally favor/disfavor acetylation of specific lysines. Because acetate fermentation has 
evolved as a key mechanism that allows many bacteria to regenerate the limiting pool of CoA, 
this would suggest that E. coli has evolved to cope with or utilize this global modification over 
millions of years. What is this global, unavoidable modification doing to the cell? Multiple 
studies have shown that acetylation by AcP can modulate protein activity (Table 2); but often, 
these studies fall short of physiological relevance due to the assumption that 100% of the enzyme 
being studied is acetylated or unacetylated at a given lysine, which is rarely if ever the case (77, 
81). Therefore, I sought to find physiologically relevant phenotypes that would explain how E. 
coli has evolved to utilize acetylation, i.e., as a carbon source or protection against oxidative 
damage. Though I was unsuccessful in identifying an effect of acetylation on these phenotypes, 
perhaps other conditions or experimental designs are necessary to test these hypotheses.
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Carbon Overflow Induces AcP-Dependent Acetylation 
 When glucose consumption rate depletes free CoA faster than it can be recycled, E. coli 
will ferment acetate from AcCoA via the Pta-AckA pathway in a process called overflow 
metabolism to regenerate the limiting pools of CoA (296, 297). However, the production of AcP 
by Pta is faster than the conversion of AcP to acetate by AckA, leaving a pool of the intermediate 
AcP (284, 399). AcP stores carbon and phosphate, as well as energy via its anhydride bond. This 
high energy bond makes it a very reactive molecule. Initially, this property prompted studies that 
identified AcP as a non-enzymatic phosphoryl donor and subsequently encouraged studies that 
explored the physiological consequences of AcP-dependent phosphorylation (291).  
Later, AcP was shown to be the predominant acetyl donor in E. coli, and mass 
spectrometry confirmed the existence of thousands of lysines on hundreds of proteins that are 
sensitive to AcP metabolism (56, 57). For most acetylated lysines, the increase in acetylation was 
uniformly low, yet certain hotspots were identified whereby a lysine was more frequently 
acetylated by AcP. Anti-acetyllysine western blot analysis confirmed the correlation between 
AcP and excess carbon by showing that glucose-induced acetylation depended on the ability of 
cells to synthesize AcP (56, 57). In addition to glucose, I demonstrated that global acetylation 
could be induced by two other fermentable sugars, fructose (Fig. 14B) and xylose (Fig. 20), as 
well as the organic acid, lactate (Fig. 5), Thus, I hypothesized that AcP-dependent acetylation 
was primarily the result of overflow metabolism. If this hypothesis were correct, a few 
predictions could be made. I would expect the same lysines should be susceptible to both 
glucose-induced acetylation and AcP-dependent acetylation. Similarly, acetylation of these 
lysines should not depend on the source of carbon, but simply the capacity of the carbon to enter 
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the Pta-AckA pathway. Finally, by preventing overflow metabolism, acetylation should be 
reduced. 
In my work, I showed that glucose-induced acetylation modified ~30% of the lysines and 
~45% of the proteins sensitive to AcP (Fig. 11), especially in central metabolism (Fig. 12) (57, 
78). Though the overlap was not 100%, this discrepancy could be explained by the fact that these 
two experiments were carried out in two different strain backgrounds, which could express 
different proteins under the same conditions. Also, AcP-dependent acetylation was determined 
by studying a ΔackA mutant, while glucose-dependent acetylation was determined with a WT 
strain. Deletion of ackA could lead to a metabolic imbalance that might alter gene expression, 
which could directly or indirectly affect which acetylated targets we would detect. The metabolic 
imbalance in a ΔackA mutant is exemplified by the 3- to 5-fold increase in AcP levels compared 
to WT cells (56, 284, 399), and an ackA mutation is known to cause phenotypic differences from 
WT cells that, in some cases, can be attributed to altered expression (221, 223, 398, 400). For the 
mass spectrometric studies, a lysine was determined to be sensitive to glucose or AcP based on a 
threshold value of >2-fold increase relative to a control. Since the AcP levels are higher than 
physiologically relevant in a ΔackA mutant, it is possible that the increased concentration of AcP 
permitted the fold increase of certain lysines to exceed the threshold value, which was not 
possible in WT cells. Additionally, improvements in workflow and software in the time between 
these two studies also may have contributed to these differences. I conclude that, while the mass 
spectrometry data do not perfectly correlate glucose-induced acetylation with AcP-sensitive 
acetylation, these data along with western blot data strongly imply that most glucose-induced 
acetylation is AcP-dependent and vice versa.  
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Though the work above was performed with glucose, I suspected that the AcP-dependent 
acetylation would overlap with acetylation induced by other fermentable carbon sources. Indeed, 
I have shown that cells grown on lactate, fructose, and xylose promote acetylation in a similar 
manner to glucose. Additionally, I tested whether acetylated lysines that were induced by 
glucose were the same acetylated lysines induced by xylose. Indeed, mass spectrometry showed 
that most lysines that were acetylated in response to glucose were also acetylated in response to 
xylose. Additionally, western blot analysis showed that glucose and xylose induced very 
comparable acetylation profiles (Fig. 20). Indeed, the only protein whose acetylation was 
sensitive to the choice of growth sugar was xylose isomerase, the first enzyme in xylose 
catabolism. Since xylA requires active cAMP-CRP and xylose-XylR for transcriptional 
activation, it is surprising that it was detected in the glucose conditions at all. While acetylation 
was similar regardless of sugar identity, the variable that significantly altered acetylation was 
concentration of the sugar. High sugar (4%) produced more acetylation than low sugar (0.4%), 
but again, the acetylation differences between glucose and xylose at each concentration were 
small. 
 Finally, I provided evidence that supports the model that AcP-dependent acetylation is a 
response to overflow metabolism. I prevented rapid carbon flux both into the cell and through 
glycolysis by making targeted mutants at different stages of glucose metabolism. In each case, I 
observed a reduction in acetylation in these mutants compared to WT cells. I prevented rapid 
carbon flux into the cell by deleting the major glucose transporter EIICBglc, which is known to 
reduce acetate excretion (371). I found that acetylation in the ΔptsG mutant was comparable to 
that in cells grown in the absence of glucose (Fig. 13 lane 1 and 16A), but I could avoid the need 
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for EIICBglc by supplementing the medium with lactate, a carbon source that does not require 
EIICBglc for its uptake (Fig. 13 lane 6). Similarly, preventing rapid carbon flux through the 
glycolytic EMP pathway and forcing the cells to use alternative glycolytic pathways by deleting 
phosphoglucose isomerase has been shown to reduce acetate excretion (401-403). Though not as 
defective as the ΔptsG mutant, I showed that a Δpgi mutant had reduced acetylation compared to 
WT cells (Fig. 14 and 15). The defect could be suppressed by using fructose instead of glucose, 
which bypasses the need for phosphoglucose isomerase (Fig. 15). Interestingly, the Δpgi mutant 
grown in fructose achieved stronger acetylation than WT cells in glucose. In part, this may be 
due to the ability of fructose, through fructose 1,6-bisphosphate, to activate pyruvate kinase, one 
of the three rate-limiting enzymes of glycolysis (404). Also, the Δpgi mutant achieved stronger 
acetylation in fructose than WT cells grown in fructose. I suspect that this may be due to an 
inability of a Δpgi mutant to convert fructose-6-phosphate into glucose-6-phosphate, which 
directs all carbon through glycolysis towards pyruvate by removing the final step of 
gluconeogenesis catalyzed by Pgi. 
 I predict that the reason a Δpgi mutant has reduced acetylation is two-fold. First, by 
blocking the EMP pathway, E. coli is forced to use the less preferred PP and ED glycolytic 
pathways (Fig. 3) (405). Second, to enter the PP pathway, glucose-6-phosphate must be 
converted to 6-phosphogluconolactone via the rate-limiting enzyme glucose-6-phosphate 
dehydrogenase (406). Thus, a bottleneck formed at the entry into the PP pathway would slow 
further glucose consumption. Therefore, one might expect that carbon sources using the PP 
pathway would induce less acetylation compared to glucose. However, xylose is catabolized via 
the PP pathway, but readily promotes acetylation to levels comparable to glucose (Fig. 20). I 
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predict that acetylation is reduced in cells catabolizing glucose through the PP pathway (Δpgi 
mutant) versus WT cells catabolizing xylose because the Δpgi mutant requires 5 steps for 
glucose to enter the EMP pathway, one of which is rate-limiting, while xylose can enter the EMP 
in only 2 steps, neither of which are rate-limiting (406). 
AcP-Dependent Acetylation Accumulates in Stationary Phase 
Previously, our group had shown that acetylation increased in E. coli cells growing in 
TB7/glucose compared to those grown in TB7 alone when analyzed by anti-acetyllysine western 
blot (57). The most striking increase in this glucose-induced acetylation occurred in stationary 
phase cells, while only minor changes could be observed during exponential phase. Thus, one of 
the major questions prior to my work was understanding why acetylation occurred in stationary 
phase. By harvesting more samples over this time course, I showed more finely that acetylation 
noticeably increased after the cells transitioned from exponential phase to stationary phase and 
that acetylation continued to accumulate for hours after cessation of growth (Fig. 4C). Strikingly, 
the reason acetylation accumulated was because much of the glucose in the medium was not 
consumed until the cells entered stationary phase (Fig. 4A). Mass spectrometry data of select 
time points along this growth curve showed that many (~39%) of the lysines that we detect as 
acetylated in stationary phase (12 hours) are already acetylated when the bacteria are in 
exponential phase (2 hours). Additionally, the population of those lysines that were detected as 
acetylated at 2 hours became more acetylated over time. Thus, the increase in acetylation 
observed in stationary phase by western blot is a result of two major changes to the acetylome: 
unique lysines/proteins become acetylated and acetylation occurs on unacetylated isoforms. 
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 Compared to exponential phase, two facets of stationary phase make it the perfect growth 
phase to promote acetylation when excess carbon is present: reduced protein synthesis and 
reduced respiration. In stationary phase, rates of growth cannot be sustained due to depletion of a 
limiting nutrient (315). Thus, cells reduce rates of transcription and translation, which greatly 
reduces the generation of new proteins (312). Since the rate of protein biosynthesis is reduced, 
fewer TCA cycle intermediates are used to make new biomass. This will cause a bottleneck at 
the TCA cycle, and carbon must enter other pathways. In conjunction with reduced translation, 
total cellular protein becomes further reduced due to increased protein turnover. When E. coli 
enters stationary phase, aerobic metabolism is repressed (312, 314). As such, the carbon flux is 
driven towards fermentation. The combination of a reduced proteome in stationary phase and the 
continued metabolism of a fermentable carbon source increases the probability that any 
susceptible lysine will become acetylated.  
My data appears to support this model. Continual exposure to carbon was required for E. 
coli cells to accumulate acetylation because removal of glucose prior to complete depletion (Fig. 
4A) prevented further acetylation (Fig. 7). Supplementing TB7/glucose with magnesium 
extended exponential growth and increased the biomass of the cultures (Fig. 18). This 
magnesium addition permitted complete glucose consumption prior to entry into stationary phase 
(Fig. 18) and reduced acetylation (Fig. 19). I hypothesize that magnesium reduces acetylation 
through two mechanisms. Magnesium makes more carbon available for biomass, which results in 
less carbon available for fermentation. Additionally, any proteins that become acetylated in 
magnesium-supplemented cultures would be diluted into nascent proteins during the extended 
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exponential phase. However, once the culture enters stationary phase, there is no glucose 
remaining in the medium that can be fermented and therefore acetylation does not accumulate. 
Acetylation Does Not Always Increase on Individual Lysines 
While acetylation accumulates globally over time in stationary phase, the same is not 
necessarily true for individual lysines on proteins. In our time course experiment, we determined 
that the dynamics of acetylation varied across different lysines (78). Acetylation of some lysines 
increased over time, others diminished over time, and yet others had a constant basal level of 
acetylation. Intriguingly, many acetylations that diminished only did so between 8 and 12 hours 
(Fig. 10). This is a period well after the culture has transitioned into stationary phase. For certain 
proteins, perhaps acetylation reveals degradation signals or perhaps acetylation itself is a 
degradation signal. Thus, the isoforms carrying these acetylated lysines in the population would 
diminish. For CRP, the opposite appears to be true; CRP is stabilized by the loss of the K100 
positive charge by substituting a glutamine residue mimicking acetylation (218). Additionally, 
acetylation has been linked to protein aggregation, but whether this leads to increased 
degradation of acetylated proteins remains to be tested (407-409). 
Nutrient Limitation Promotes Acetylation When Carbon Is in Excess 
As described in the previous section, magnesium limitation in the TB7/glucose medium 
commonly used in our experiments promotes acetylation. However, this phenomenon is not 
exclusive to magnesium. In most cases, a nutrient that becomes limiting while carbon remains 
abundant would be expected to promote acetylation. In each case, nutrient limitation would favor 
fermentation and/or cause the culture to enter stationary phase. In the case of the facultative 
anaerobe E. coli, oxygen is a nutrient that, when limiting, would favor fermentation, and 
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therefore promote synthesis of AcP, but would not cause the culture to enter stationary phase. As 
described above, stationary phase is a time when the proteome becomes relatively stagnant due 
to increased proteolysis and reduced translation. Therefore, continued carbon metabolism would 
cause acetylation to accumulate on this stagnant proteome. Below, I will discuss how certain 
nutrient limitations would promote acetylation. 
In the case of magnesium, the cation is found throughout the cell, often as a counterion to 
stabilize membrane phospholipids, lipopolysaccharide, polyphosphate compounds like DNA and 
RNA, and the ribosome (410-412). Magnesium is also required to make ATP biologically active. 
If cells continue to divide without consideration of available magnesium, cellular activity would 
cease to function. One mechanism that cells appear to use to sense this magnesium depletion is 
through ribosomes. Without sufficient magnesium, translation will nearly cease due to 
dissociation of ribosomes (413). Thus, when magnesium concentration is insufficient for 
proliferation, carbon flux would be directed away from generating biomass like amino acids or 
lipids, and instead would be directed towards acetate fermentation. 
In addition to magnesium, nitrogen limitation has also been shown to promote acetylation 
(56). Weinert et al. found that acetylation increased when cells were artificially forced into 
stationary phase by transferring exponential phase cells into glucose replete minimal medium 
lacking nitrogen. In contrast, nitrogen replete minimal medium lacking carbon did not promote 
acetylation. In E. coli, ammonia is the preferred nitrogen source, but nitrogen also can come 
from amino acids (379, 414). Ammonia assimilation primarily produces glutamate and 
glutamine, two of the major sources of cellular nitrogen used to synthesize purines, pyrimidines, 
and many amino acids (379). If cells deplete nitrogen, glutamine and glutamate would diminish, 
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which would cause the precursor molecule α-ketoglutarate to accumulate. Since α-ketoglutarate 
is an intermediate of the TCA cycle, accumulation of α-ketoglutarate would slow flux of carbon 
from AcCoA into the TCA cycle, drive carbon flux into fermentation, and thus promote 
acetylation. 
I highly expect that oxygen limitation will promote acetylation. Though the effect of 
oxygen on acetylation has not been shown directly, low oxygen increases acetate production 
(415, 416). While magnesium and nitrogen are required to make new cells, oxygen is not 
required. Oxygen allows E. coli to use the electron transport chain with oxygen as the terminal 
electron acceptor, which increases growth rate and biomass yield (415). In anaerobic conditions, 
the TCA cycle becomes a branched pathway rather than a cyclic pathway and flux through these 
branches is reduced due to anaerobic repression (417). In this branched form, these pathways 
satisfy the biosynthetic requirements for proliferation, while fermentative pathways generate 
cellular energy. In anaerobic conditions like during overflow metabolism, E. coli will produce 
acetate, ethanol, and formate as well as some lactate and succinate in order to maintain redox 
balance (418, 419). Thus, I would expect that anaerobiosis would increase acetylation because of 
increased acetate production. However, the amount of carbon converted into the other non-
acetate fermentation products may siphon carbon away from acetate fermentation, and thus the 
acetylation of anaerobic cells may be comparable to aerobically grown E. coli. In either case, I 
would predict that anaerobically grown E. coli would have stronger acetylation in stationary 
phase compared to exponential phase due to the reasons outlined in the previous section. 
Production of AcP via Pta depends on both carbon and free inorganic phosphate. Also, 
the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase requires inorganic phosphate 
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to convert glyceraldehyde-3-phosphate into 1,3-bisphosphoglycerate. Thus, phosphate starvation 
may be one of the starvation conditions besides carbon limitation that would reduce rather than 
enhance acetylation. Phosphorous compounds are the major building blocks of various molecules 
and are critical for many signal transduction pathways (420). Due to the importance of 
phosphate, E. coli has evolved a regulon designed to sense and respond to low phosphate 
conditions (421). One of the mediators of the response to phosphate limitation is ppGpp, the 
alarmone responsible for the stringent response to amino acid starvation that slows transcription, 
translation, and replication (422, 423). This suggests that when cells starve for phosphate, they 
behave like they are starving for amino acids. However, recent data suggests that ppGpp levels 
are directly correlated to AcP levels (424). Furthermore, in Pseudovibrio, phosphate limitation 
decreased citrate synthase gene expression and increased Pta-AckA gene expression (425). 
Therefore, the hypothesis that phosphate starvation would reduce acetylation could be incorrect 
and, instead, it may promote acetylation. Determining which hypothesis is correct could provide 
insight into how E. coli senses and responds to phosphate starvation. 
Early Glucose Exposure Is Required for AcP-Dependent Acetylation 
While most of my data support the model that carbon-induced, AcP-dependent 
acetylation is a consequence of acetate fermentation, there are a few pieces of data that do not fit 
this model. Because I hypothesized that acetylation accumulates on a relatively unchanging 
proteome during stationary phase, I thought that adding glucose later in growth, and thus having 
more carbon to ferment, would result in stronger acetylation than when glucose is used for 
biomass during growth. However, this was not the case (Fig. 8A and 8C). If I supplemented 
cultures with glucose at 0, 1, or 2 hours after inoculation, then acetylation was strong. However, 
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adding glucose after 2 hours resulted in a significantly weaker pattern, comparable to cells that 
had never been exposed to glucose. I suspected that perhaps these stationary phase cells were not 
consuming glucose; however, these cultures readily consumed glucose (Fig. 9A). I confirmed 
that lactate-induced acetylation also requires the carbon source to be added early, although the 
timing was slightly different (Fig. 8B). Thus, something was different between these 
exponentially growing cells and their stationary phase counterparts. 
The most plausible explanation for the lack of acetylation when carbon is supplemented 
during stationary phase growth is pyruvate oxidase (PoxB). PoxB directly oxidizes pyruvate into 
acetate, bypassing the Pta-AckA pathway and therefore avoiding generation of AcP. PoxB is the 
major acetate production pathway during stationary phase (362), in part because its transcription 
depends on σS, the stationary phase sigma factor (426). Thus, when glucose is added to a 
stationary phase culture, the carbon passes through glycolysis to pyruvate where it is converted 
to acetate by PoxB. Similarly, lactate dehydrogenase directly converts lactate to pyruvate, which 
subsequently can be converted to acetate by PoxB. 
If PoxB expression prevents acetylation when glucose is added in stationary phase, why 
does acetylation still accumulate when glucose is added in the first two hours of growth? This 
suggests that glucose exerts a regulatory effect in exponential growth that restricts PoxB 
expression. While this could be directly determined by measuring poxB transcript levels, the 
literature offers some suggestions as to a mechanism by which glucose would prevent PoxB 
expression. PoxB transcription is reduced in the presence of glucose (427). Biochemical 
experimentation and in silico inference have proposed that transcription of poxB can be activated 
by Cra (428), MarA (429), OxyR (430), and SoxS (429); repressed by NsrR (431); and may be 
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regulated by Fnr (432), NarL (433), and NarP (433). Of relevance here is Cra, the catabolite 
repressor/activator protein that exerts a catabolite repressing effect independent of the cAMP-
CRP complex (434). Cra is inactive in the presence of glucose; specifically, in vitro evidence 
suggests sugar catabolites like fructose-1-phosphate bind to Cra and prevent Cra from interacting 
with operator sites, such as the one found upstream of poxB (435, 436). Indeed, this mechanism 
fits the data. When cells are exposed to glucose during exponential growth, there would be 
sufficient glucose metabolism to produce sugar catabolites that prevent Cra from functioning 
even once the cells enter stationary phase. Without active Cra, PoxB would not be expressed and 
instead acetate fermentation would proceed through Pta-AckA, generating AcP to acetylate 
proteins. In contrast, cells that have begun to express σS in the absence of glucose would activate 
poxB transcription with Cra. Once the glucose was added to these cells, PoxB would already be 
synthesized, preventing AcP generation and acetylation. 
While Cra provides the most obvious explanation, this does not preclude other 
mechanisms from mediating the different cellular responses to glucose addition at exponential 
phase and stationary phase. When cells consume glucose, acetate is formed, which can freely 
diffuse into the cell as acetic acid. Acetic acid can then dissociate in the cytoplasm, leaving a 
proton that reduces the intracellular pH and decreases the proton gradient, which may interfere 
with energy metabolism. Since PoxB is linked to the electron transport chain via ubiquinone, 
perhaps acetate production through PoxB is disadvantageous when acetate levels are already 
rising. However, a transcriptional, translational, or post-translational means of regulating PoxB 
through acetate or pH has not been reported. 
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CRP Is Required for Glucose-Induced Acetylation 
 One of the most perplexing questions about acetylation was why CRP, a transcription 
factor best known for being active in the absence of glucose, was required for glucose-induced 
acetylation. CRP binds cAMP to generate a cAMP-CRP complex that can activate transcription 
of certain genes via interactions with RNA polymerase; these interactions are mediated by 
activating regions found on CRP. Since glucose import shuts down production of cAMP, I 
hypothesized that CRP could control acetylation through a function beyond activating 
transcription. However, this was not the case. I was able to phenocopy the loss of acetylation 
observed in the Δcrp mutant by either deleting adenylate cyclase (Fig. 16B) or mutating both 
activating regions of CRP (Fig. 17A). These data suggest that transcriptional activation by CRP 
is required for glucose-induced acetylation.  
I propose that CRP is required to activate transcription of the genes encoding enzymes in 
the Embden-Meyerhof-Parnas (EMP) glycolytic pathway and the genes encoding the PTS 
system, including the major glucose transporter EIICBglc. Overexpressing EIICBglc in a Δcrp 
mutant partially restored acetylation in the presence of glucose (Fig. 13, lane 9). It is possible 
that overexpressing all of the CRP-regulated genes encoding PTS system enzymes (ptsG, ptsH, 
ptsI, and crr) could more completely restore wild-type levels of acetylation. While I did not test 
the exact target(s) of CRP in the EMP pathway, it has been shown that CRP enhances flux 
through the EMP pathway while diminishing flux through the pentose phosphate pathway (374). 
Indeed, CRP activates transcription of glycolytic enzyme encoding genes fbaA, gapA, pgk, as 
well as the genes of pyruvate dehydrogenase aceE, aceF, and lpdA (437). 
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Unexpectedly, a Δcrp mutant also lost lactate-induced acetylation (Fig. 13). E. coli 
encodes three lactate dehydrogenases that interconvert pyruvate and lactate: Dld, LdhA, and 
LldD. LdhA is an NAD+-dependent D-lactate dehydrogenase (438). Dld is quinone-dependent 
D-lactate hydrogenase (439, 440). LldD is a quinone-dependent L-lactate dehydrogenase (441, 
442). Therefore, CRP may regulate one or more of these lactate oxidation genes. In the closely 
related organism, Shewanella oneidensis MR-1, CRP is required for transcription of the genes 
that encode Dld and LldP, the outer membrane permease for lactate (443). Indeed, a Δcrp mutant 
of Shewanella cannot grow on D-lactate but can grow on L-lactate. In my experiment, the cells 
were grown on a racemic mixture of D- and L-lactate and, as such, I cannot pinpoint whether a 
single enantiomer or both enantiomers are responsible for lactate-dependent acetylation. While a 
connection between CRP and lactate assimilation has not been established in E. coli, my data 
suggest that a regulatory mechanism comparable to that in Shewanella may exist. Thus, this 
remains an active hypothesis to be tested. 
Acetylated Acs: A Marker for Catabolite Repression 
 After growth on glucose and excretion of acetate, E. coli can convert acetate back into 
AcCoA via Acs, a high affinity enzyme utilized by many bacteria to assimilate acetate for use in 
biosynthesis or generation of energy. Acetylation of a single conserved lysine (K609 in E. coli) 
inactivates Acs, which prevents growth on low concentrations of acetate (135). The acetylation is 
YfiQ-dependent and can be removed by CobB. Thus, the cells can reversibly and rapidly 
regulate Acs activity. 
 Both the acs and yfiQ genes are transcriptionally activated by CRP. Thus, these genes are 
catabolite repressed and are strongly upregulated in the absence of glucose. Transcriptionally 
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regulating both the target and KAT with the same transcription factor ensures that YfiQ will be 
available to quickly shut down Acs when necessary. In a coordinated system, Acs produces 
AcCoA, which can then be utilized by YfiQ to acetylate and inactivate Acs. 
 In my work, I consistently detected a 72 kD protein band on western blot in TB7 cultures. 
This band was also found in TB7/glucose cultures, but only once the glucose had been fully 
consumed. This band was also CRP-dependent, specifically in a class I-dependent manner (Fig. 
17A). As shown in Appendix A, I determined that this band was Acs. Knowing the identity of 
this band permitted me to perform a control experiment when determining whether my YfiQ 
construct was behaving appropriately (Fig. 27). For experiments carried out in glucose, future 
studies can use the Acs band as a sensor of whether glucose or any other catabolite-repressing 
carbon source has been depleted from the medium. Furthermore, it can act as a diagnostic marker 
for whether mutant strains are experiencing catabolite repression or not. For example, a ΔptsG 
mutant expressed Acs even though glucose was abundant in the medium. In summary, I hope 
that researchers can avoid pitfalls in data interpretation by recognizing this acetylated band is 
Acs and that its acetylation depends on YfiQ but not AcP. 
Acylation as a Selective Pressure of Protein Structure 
 One of the conclusions from my work is that acetylation is an inevitable consequence of 
metabolism. Because nearly all life has evolved to utilize activated acetate as a key molecule in 
metabolism, all organisms must inevitably cope with the potential for protein acetylation. Recent 
literature suggests that this is probably not exclusive to acetylation. Succinylation (8), 
butyrylation (5), malonylation (9, 10), crotonylation (6, 7), and propionylation (5) are all 
acylations that arise from addition of metabolites onto a lysine side chain. Acylation of a 
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catalytic lysine can be extremely detrimental to protein function, and inability to remove these 
acetylations can result in a “dead” enzyme. Similarly, acylation of lysines that make salt bridges 
between proteins, DNA, or small molecules can completely prevent a protein from performing 
its activity. Thus far, only acetylation has been shown to promote certain proteins to associate 
with aggregates of misfolded proteins, which would presumably negatively impact their function 
(409). Whether these acylations are due to non-enzymatic mechanisms or catalyzed 
enzymatically, life must have balanced the possibility of detrimental acylation with benign or 
beneficial acylations. The best ways to ensure that only the optimal lysines are being acetylated 
in a given condition is to either 1) evolve a lysine deacylase to remove deleterious modifications 
or 2) evolve proteins such that they do not have lysines susceptible to acylation. 
 Deacylation is a mechanism to ensure that a given lysine will be unmodified despite the 
presence of reactive metabolites that are endogenously produced. Almost all acetylated linear 
peptides are susceptible to CobB (205), but not all acetylated E. coli proteins are CobB-sensitive 
in vivo (57). The CobB-sensitive lysines tend to be surface exposed (205). Indeed, for a lysine to 
be deacylated, it almost certainly cannot be buried within the protein structure unless the 
acylated residue becomes accessible through protein breathing, large scale conformational 
changes of the protein structure (444). However, the extent of breathing in vivo is probably 
restricted due to molecular crowding in the cytoplasm (445). Thus, the protein must be structured 
in such a way to favor deacylation of the target lysine without disrupting the activity of the 
protein. 
 If an acylated lysine blocks protein function and is not accessible to CobB or another 
deacylase, the cell must replace that protein by degrading it and synthesizing an entirely new 
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protein. Not all lysines can be acetylated, but those that do become modified can be acetylated at 
different rates (78, 287) (Fig. 10). As buried lysines would be refractory to CobB, I would also 
expect that acetylation of these lysines is rarely enzymatic due to the inability for an enzyme to 
access the lysine. I hypothesize that evolution may have selected for molecular environments that 
disfavor acetylation of these buried and other critical lysines. For acetylation by AcP, we know 
that a lysine requires two molecular determinants (57). First, the lysine must be deprotonated by 
either an adjacent residue or by a water molecule. Second, the protein must be able to bind and 
coordinate the phosphate moiety, such that the carbonyl carbon of the acetyl group is susceptible 
to a nucleophilic attack by a deprotonated lysine. However, any changes made over evolution 
that would disfavor acetylation had to be balanced with a protein sequence that permits proper 
folding and activity. 
 Finally, we detect acetylation of many lysines that would have no obvious effect on 
protein function. While this gives support to the hypothesis that acetylation is simply 
unavoidable, I hypothesize that these lysines could serve as a sink for acetyl groups that would 
otherwise acetylate lysines with critical functions. Indeed, comparing the stoichiometry of 
acetylation on these seemingly unimportant residues versus those that occur on critical residues 
may shed some light on whether this hypothesis is valid. In addition to their possible role as a 
sink for acetyl groups, these residues may have an as of yet undetermined physiological 
consequence. 
 In conclusion, it could be possible that acetylation has prevented certain protein 
structures from forming, and thus limited the potential configurations a protein can obtain. As 
research continues to identify the molecular determinants that facilitate acylation of lysines with 
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the other acyl donors, this may further shed light on restrictions that protein structures can make. 
It would be very interesting to determine what degree of control acylations like acetylation have 
exerted over shaping the proteome along evolution. 
Physiological Consequences of Global AcP-Dependent Acetylation 
 Even though many AcP-dependent acetylations appear to be unavoidable, I propose that 
this global modification has physiological consequences. It seems likely that cells would have 
evolved to utilize such a prevalent PTM. Of the possibilities, I hypothesized that acetylation 
could be a carbon source, a metabolic feedback mechanism, and/or a preventative measure taken 
against oxidative damage of lysines. 
 To test whether acetylation was a carbon source, I competed cells with high acetylation 
(ΔackA mutants) against cells with very low acetylation (Δpta mutants) in medium without a 
carbon source (Fig. 24). These two extremes should have showed whether acetylation sustains 
survival of E. coli or whether it is irrelevant. In my experiment, there was no survival difference 
between the mutants, suggesting acetylation could not promote survival in carbon starvation. 
Perhaps acetylated proteins and their degradation products become common goods, which could 
explain why the ΔackA mutant did not outcompete the Δpta mutant (446). In eukaryotic cells, the 
product of the sirtuin reaction, O-acetyl-ADP-ribose can be degraded into acetate and ADP-
ribose. While the outcome of O-acetyl-ADP-ribose metabolism in bacteria has not been deeply 
studied, E. coli encodes at least one protein, YmdB, that has O-acetyl-ADP-ribose deacetylase 
activity and produces free acetate (447, 448). Thus, as cells die in the competition culture, the 
acetylated proteins and any free acetate originating from ΔackA mutants could be taken up and 
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consumed by either Δpta or ΔackA mutants. In future experiments, the contribution of 
reassimilation of acetate by Acs should be considered. 
 To determine whether acetylation could be a protective modification against oxidative 
damage, I qualitatively measured the differences in carbonylation between WT cells and Δpta 
mutants with the hypothesis that the acetylation in WT cells would be a preventative 
modification against carbonylation. Production of reactive oxygen species is an inherent 
downside of aerobic respiration that can generate oxidative damage to macromolecules. These 
reactive oxygen species can react with amino acids in a variety of ways, one of which is 
carbonylation. Carbonylation is the conversion of lysine, arginine, threonine, and proline side 
chains into carbonyls (277, 449, 450). These carbonyl groups are very reactive and promote 
misfolding and aggregation. However, I was unable to find any increase in carbonylation 
between WT and Δpta cells (Fig. 23). This could mean that the amount of acetylation achieved 
in WT cells in insufficient to protect against carbonylation. However, it is possible that 
acetylation does protect against carbonylation, but the assay was not sensitive enough to detect 
the effect. Since multiple different types of residues can be carbonylated, and the experiment I 
performed measures total carbonylation, carbonylation of non-lysine residues may have obscured 
the protective effect of lysine acetylation. 
 In an effort to determine whether acetylation promoted or protected against protein 
aggregation, I repeated the carbonylation experiment and purified protein aggregates and 
qualitatively assessed the amounts of aggregated proteins (Fig. 22). I was unable to determine 
any significant differences between WT, a Δpta mutant, or a Δpta ackA mutant. However, the 
literature provides two contrasting examples. First, Mizrahi et al. showed that exponential phase 
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MG1655 cells exposed to heat shock at 46°C increased their protein aggregation (407, 408). This 
heat-induced protein aggregation was further exacerbated in an isogenic Δpta ackA mutant. 
These data are in direct conflict, however, with the data presented by Kuczyńska-Wiśnik et al., 
who found that acetylation tended to disfavor protein aggregation (409). In contrast to Mizrahi et 
al., this study used a different strain background, BW25113, and did not subject the cells to heat 
stress. The latter study also used stationary phase cells grown in LB with glucose instead of 
exponential phase cells in LB alone. As we now know from my work, the cells in stationary 
phase would have strong acetylation, while those in exponential phase would have weak 
acetylation. As Kuczyńska-Wiśnik et al. suggest, this discrepancy might be attributed to AcP-
dependent phosphorylation in exponential phase versus AcP-dependent acetylation in stationary 
phase. However, my data do not fit either of these datasets. I suspect my data differs from 
Mizrahi et al. for the same reasons that Kuczyńska-Wiśnik et al. differed. I used different strain 
backgrounds, different growth phase, and different media. My experiment was much closer to 
that of Kuczyńska-Wiśnik et al. with two exceptions. First, their experiment used LB 
supplemented with glucose, while I used TB7/glucose. Addition of glucose to LB without 
buffering acidifies the media through production of acetic acid, while my conditions were 
buffered against pH changes. No attention was paid to whether acidification played any role in 
the study by Kuczyńska-Wiśnik and coworkers. Second, the purification of aggregated proteins 
was carried out in an almost identical manner, except I used 2% NP40 to separate my proteins 
from the membranes, while the other study used 2% Triton X-100. Both of these detergents 
should behave similarly, but until these are tested and shown to behave the same, the choice of 
detergent may partially explain the discrepancies. In conclusion, there appears to be a 
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contribution of acetylation to protein aggregation, but further work must be done to disentangle 
the current conflicting reports. 
Specific Examples of AcP-Dependent Acetylation 
 AcP-dependent acetylation has been shown to modify approximately 750 proteins on 
almost 2500 lysines (57). Though the stoichiometry of AcP-dependent acetylation is not known, 
the techniques capable of determining acetylation stoichiometry are becoming more tractable 
(77, 81, 451-455). Until that work is performed, we must rely on relative increases of acetylation 
to inform our hypotheses about AcP-dependent acetylation. As stated above, these fold changes 
can be a source of misleading data due to a fold change from 9% to 90% acetylated peptides 
yielding the same change as 0.1% to 1% acetylated peptides. With this caveat in mind, I will 
describe some of the proteins that have been shown to be regulated by AcP-dependent 
acetylation in other studies, and how that matches to our data acquired here. 
 Acetylation of all aminoacyl-tRNA ligases of E. coli has been detected in our studies that 
determined glucose- or AcP-regulated acetylation (57, 78, 231). These enzymes catalyze the 
charging of tRNA molecules with the appropriate amino acids. The effect of acetylation has been 
assessed for four of these amino acyl tRNA ligases, AlaRS, ArgRS, LeuRS, and TyrRS (217, 
231). These enzymes are responsible with charging tRNA molecules with alanine, arginine, 
leucine, or tyrosine, respectively. In the presence of glucose and/or AcP, we detected acetylation 
on 17 lysines on AlaRS, nine lysines on ArgRS, seven lysines on LeuRS, and eight lysines on 
TyrRS. AlaRS contained two lysines regulated by AcP and glucose (K592 and K731), and six 
upregulated by glucose (K74, K279, K536, K605, K750, and K784). LeuRS contained three 
lysines regulated by glucose (K21, K598, and K619), but none were considered regulated by 
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AcP with our thresholds. TyrRS had two lysines sensitive to glucose and AcP (K8 and K85) and 
two lysines regulated by glucose (K144 and K235). In contrast, no lysines on ArgRS achieved 
fold changes consistent or significant enough to be considered regulated by either glucose or 
AcP.  
In work performed by Umehara et al., non-canonical amino acid substitution was used to 
generate an AlaRS variant that contained an acetyllysine in place of K74, a residue known to 
interact with the 3’ end of the tRNAAla (231, 456). Acetylation of this residue reduced 
alanylation activity of the enzyme, but treatment with CobB restored the activity closer to the 
WT protein. While K74 did not achieve our threshold to be considered acetylated by AcP, it is 
glucose-regulated and does not appear to depend on YfiQ or any of the novel KATs. Therefore, 
K74 is most likely acetylated by AcCoA or AcP and reversed by CobB to regulate the activity of 
AlaRS. Interestingly, acetylation of K74 has been found in Vibrio parahaemolyticus, mice, and 
humans, which may imply a conserved mechanism of regulation (110, 457). However, the effect 
and interplay of the other acetylations on AlaRS activity remain to be tested. Ye et al. 
investigated the role of acetylation on LeuRS and ArgRS (217). Three lysine residues of LeuRS 
were chosen due to their conservation from bacteria to humans. Of these, only K619 was 
detected in our studies. A LeuRS variant with acetylation mimic K619Q exhibited decreased 
enzymatic activity, while non-canonical amino acid substitution of K619 with acetyllysine 
abolished enzymatic activity. Similarly, they determined that ArgRS variants with either 
glutamine or acetyllysine incorporation at K126 and K408 reduced enzymatic activity. Both 
lysines were sensitive to AcP and CobB in vitro, and deacetylation restored activity to the 
acetyllysine variants. However, it is uncertain whether acetylation of ArgRS would be relevant in 
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vivo since we did not determine ArgRS to be regulated by AcP or glucose. Venkat et al. 
examined how acetylation of multiple lysines on TyrRS would influence aminoacylation activity 
(222). Replacing either K85, K235, or K238 with acetyllysine abolished activity of TyrRS. 
While we detected each of these lysines as acetylated, only K85 was sensitive to AcP and 
induced by glucose. Though it may be tempting to make strong conclusions based on in vitro 
data, one should consider the native stoichiometry and whether the lysine residues are detected 
as acetylated in vivo. With this in mind, these data support AlaRS K74 and TyrRS K85 as the 
best candidates for biologically important acetylated lysines that are regulated in vivo with 
effects on enzymatic activity in vitro. 
AcP heavily acetylates central metabolism both by fold-change and by number of lysines 
acetylated on proteins (Fig. 32). However, the effect of acetylation, and more specifically AcP-
dependent acetylation, on these pathways and enzymes has only begun to be explored. In 
Borrelia burgdorferi, GAPDH is acetylated by AcP, which reduces activity (458). While the 
residue(s) that mediate this effect are unknown, E. coli GAPDH is acetylated on 15 lysines, of 
which seven are regulated by AcP and glucose. In E. coli, malate dehydrogenase (Mdh), an 
enzyme of the TCA cycle, is acetylated on 13 lysines. Four of these lysines are sensitive to AcP 
and glucose, while six are sensitive to glucose alone. Interestingly, Venkat et al. used non-
canonical amino acid substitution to demonstrate that acetylation of two AcP-sensitive lysines, 
K99 and K140, cooperatively enhanced Mdh activity. In contrast, acetylation of K162, a lysine 
that was not regulated by AcP or glucose, had no effect (219, 220). K140 could be deacetylated 
by CobB, while K99 was insensitive. Thus, Mdh activity can be regulated by acetylation, but the 
effect of the other eight regulated lysine residues remains to be determined. Finally, Nakayasu et 
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al. determined the effect of acetylation on enolase (55). Enolase generates phosphoenolpyruvate 
during the penultimate step of glycolysis and utilizes two substrate-binding lysine residues 
(K342 and K393) to perform this activity. We have detected 24 lysines acetylated on enolase, 
making it one of the most heavily acetylated proteins in E. coli. Of these lysines, six are sensitive 
to both AcP and glucose, while nine are sensitive to glucose alone. One of the lysine residues 
sensitive to glucose was K342, one of the substrate-binding residues. Nakayasu et al. generated 
two enolase variants with either K342 or K393 changed to glutamine to mimic an acetylated 
lysine and found that these variants lost catalytic activity. While we did not detect K393 as 
acetylated, Nakayasu et al. assessed proteomes of 48 species of bacteria and found the lysine 
equivalent to K393 in enolase orthologs could be acetylated in at least eight of them. Comparing 
the structures of the E. coli enolase to these other enolases could provide interesting insight into 
what makes the E. coli enolase refractory to AcP-dependent acetylation on K393, while enolase 
enzymes from other bacteria are sensitive to AcP. 
Multiple studies have shown that acetylation of multiple transcriptional regulators and the 
transcriptional machinery itself is AcP-dependent, and that acetylation has diverse effects on the 
function of these proteins. In Rhodobacter sphaeroides, FnrL is a transcriptional activator in 
response to a switch from aerobic to anaerobic growth; it is homologous to E. coli Fnr. In 
Rhodobacter, acetylation of three lysine residues (K175, K213, and K223) reduced the 
association of FnrL with DNA (250). Interestingly, the homolog from E. coli only encodes K229, 
the equivalent lysine to K223, while K213 is a glutamine, and K175 is missing entirely. As we 
utilize KQ variants to mimic acetyllysines, it appears that E. coli may have evolved to 
permanently lose the positive charge at K213 in the same way. Study of these two orthologs may 
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reveal how these bacteria have evolved to utilize acetylation of certain lysine residues for 
regulation, while other lysines are entirely dispensable. The E. coli transcription factor RcsB is 
response regulator that that positively regulates transcription of capsule biosynthesis genes for 
biofilm formation, while reducing transcription of flagellar genes. Hu et al. found that RcsB can 
be acetylated by AcP on a lysine (K154) that is found in the helix-turn-helix DNA binding motif 
(223, 459). Acetylation of K154 is both glucose- and AcP-dependent. Similarly to Fnr, this 
acetylation reduces DNA binding, which enhances migration of the bacteria and sensitizes the 
bacteria to acid (82). However, regulation of RcsB is rather complex. In addition to K154, RcsB 
can be acetylated on K180 in vitro with YfiQ, though we have yet to detect this modification in 
vivo using mass spectrometry (173). Furthermore, RcsB only activates transcription when it is 
phosphorylated. RcsB can be phosphorylated on D56 by either AcP or through its cognate sensor 
kinase RcsC (223, 460). Thus, the interplay between acetylation and phosphorylation on RcsB 
suggests E. coli regulates RcsB activity through an intricate balance that takes into account AcP 
levels, RcsC activity, and deacetylation by CobB. Besides directly influencing DNA binding, 
acetylation can modulate transcriptional activation through other mechanisms. CRP activates 
transcription of genes that mediate utilization of carbon sources by interacting with RNA 
polymerase at Class I or Class II sites on DNA. Using variant proteins encoding the acetylation 
mimic glutamine, Davis et al. inferred that acetylation of CRP on K100 had two effects (218). 
First, acetylation of K100 directly reduced Class II promoter activation by preventing 
interactions between CRP and RNA polymerase, while having no effect or mixed effects at Class 
I promoters. Acetylation of K100 also enhanced CRP stability, which may explain some of the 
mixed results from Class I-dependent promoters. Thus, acetylation of CRP at K100 may be a 
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way for the cell to specifically activate Class I sites and prevent activation of Class II sites. 
Finally, transcriptional activation can be prevented by modifying RNA polymerase rather than 
the transcription factors themselves. The α-subunit of the RNA polymerase core enzyme was 
found to be acetylated in an AcP-dependent manner in the C-terminal domain (CTD), which is 
confirmed from our mass spectrometry data (221). K291 on the α-CTD mediates interactions 
with the transcription factor CpxR, and acetylation of this lysine prevented transcription from the 
CpxR-dependent promoter cpxP. In contrast, Lima et al. inferred that acetylation of a different 
lysine, K298, depended on YfiQ and activated transcription from the cpxP promoter (201). This 
is one of the few examples identified thus far where acetylation of two lysines on the same 
protein have opposing effects on protein activity. Since RpoA is part of the core RNA 
polymerase complex, the effect of these acetylations on global transcription may be substantial 
but has yet to be explored. 
Another critical cellular process that AcP-dependent acetylation may regulate is 
maintenance and replication of the genome. Two groups have probed how acetylation impacts 
topoisomerase I and replication initiator protein DnaA activities. Topoisomerase I relaxes 
negatively supercoiled DNA that would otherwise destabilize the genome. We detected 
topoisomerase I as acetylated on eight lysines, of which three were both glucose-sensitive and 
AcP-sensitive. Zhou et al. found that in vitro acetylation of topoisomerase I with AcP yielded 
four lysines (K13, K45, K346, and K488) (224, 225). While we never detected acetylation of 
K13, K45, or K488, we did detect K346 and K484. Since K484 and K488 can be found on the 
same peptide, these may actually be the same acetylated residue that were called out differently 
because different algorithms were utilized: Skyline by our group and MaxQuant by Zhou et al. 
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Acetylation of topoisomerase I inhibited relaxation activity due to reduced DNA binding and 
reduced cleavage activity; however, the exact acetylated residue(s) that mediated this effect were 
not identified. Two of these acetylated lysines, K346 and K484/8, were glucose- and AcP-
dependent. Thus, future studies could determine whether K346 and/or K484/8 contribute to the 
reduction in topoisomerase activity. DnaA is the initiator of DNA replication that binds to oriC 
and opens the origin to generate replication forks. We have only detected DnaA acetylated on 
one residue, K455. However, two reports found 13 lysine residues were acetylated on DnaA, of 
which two had effects on DnaA activity (226, 227). K178 could be acetylated by YfiQ and AcP 
in vitro and deacetylated by CobB. This acetylation prevents interaction of DnaA with oriC. 
Similarly, K243 is acetylated by YfiQ and AcP, which can be reversed by CobB. DnaA 
acetylated on K243 cannot bind ATP. In both instances, acetylation would reduce the ability of 
DnaA to initiate replication, but through different mechanisms. Whether these acetylations work 
in concert or independently remains to be determined. 
AcP-dependent acetylation has the potential to exert wide-spread regulatory effects due 
to the vast amount of targets that are acetylated. Indeed, AcP-dependent acetylation appears to 
modify multiple enzymes in essential pathways like translation, transcription, and DNA 
replication on lysines that one would expect to affect protein function. In most cases, assays have 
been performed in vitro to test these hypotheses, yet the in vivo significance has not been 
determined for many of these acetylated lysines. Indeed, the in vivo stoichiometry of these 
lysines is unknown in most cases. Therefore, while acetylation may occur in vivo, it may not 
occur at a stoichiometry that exerts a physiological effect. Future studies should be aware of this 
and confirm the findings in vivo through phenotypic analysis when possible. By focusing on 
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those lysines that appear to be regulated by AcP or glucose, one may identify conditions under 
which acetylation by AcP is relevant. 
Overall Summary: Chapter Four 
 In Chapter Four, I discovered that E. coli encodes four KATs (PhnO, RimI, YiaC, and 
YjaB) in addition to YfiQ (Fig. 28). These proteins are conserved across phylogeny, and in one 
example, I successfully confirmed that a RimI homolog from Neisseria gonorrhoeae also has 
KAT activity like the E. coli RimI (Fig. 35).  Unfortunately, I was unable to demonstrate KAT 
activity for any of these novel KATs in vitro. Instead, protein variants, in which predicted 
catalytic residues were replaced by alanine, were found to lose function in vivo, supporting their 
roles as KATs (Fig. 29).  
We identified proteins that were acetylated by each of the KATs, and from this 
information, I was able to generate hypotheses for the roles of these proteins. I attempted to 
determine the physiological relevance of each of these novel E. coli KATs and YfiQ in multiple 
assays. Of these KATs, I found that overexpression of YiaC and YfiQ was able to reduce E. coli 
migration in soft agar plates, and this inhibition of migration depended on their KAT activities. 
However, deletion mutants had little effect on this phenotype. Thus, the KATs remain a source 
of new research. When are they expressed? What are the physiological consequences of 
acetylation by these KATs? Do the orthologs in other bacteria have the same functions as those 
in E. coli and, if they do, is the function mediated through acetylation of the same targets?  For 
example, the activity of YfiQ on Acs is highly conserved from bacteria to humans (266). Perhaps 
acetylations by these other KATs have also maintained their functions across phylogeny. Some 
of these questions are being followed up by Sarah Feid. 
172 
 
The Gutted Strain: A Tool and a Lesson 
 To identify KATs in E. coli, I generated the gutted strain that lacked both known 
mechanisms of acetylation (Δpta yfiQ) and the deacetylase CobB (ΔcobB) (Fig. 26). The gutted 
strain was successfully built to increase the signal-to-noise ratio of the putative KATs over the 
background acetylation. To ensure there was enough substrate for the KATs (i.e., AcCoA), I 
wanted to grow the cells in glucose. However, if I grew WT cells overexpressing these KATs in 
glucose, I knew that there would be a strong background of AcP-dependent acetylation, hence I 
deleted pta. While YfiQ should not be expressed in the presence of glucose since it is transcribed 
in a CRP-dependent manner (135), I wanted to minimize any possible contribution of YfiQ-
dependent acetylation to that of the KATs, especially when performing mass spectrometry to 
determine the targets of each KAT. Thus, I chose to delete YfiQ. Finally, CobB was deleted to 
ensure that any acetylation that occurred would not be reversed. 
 While I was able to successfully identify that four of the 26 putative GNATs in E. coli 
exhibited increased acetylation of certain proteins by using this gutted strain, I only determined 
this under one condition, TB7/glucose. However, we do not know under what conditions these 
KATs are expressed. Since we used overexpression constructs, I did not have to worry about 
ensuring that the enzymes were expressed under our conditions. However, the targets that we 
determined in TB7/glucose may not necessarily be bona fide targets under physiological 
conditions. For example, if I had grown the cells in a non-catabolite repressing condition like 
TB7, the expression pattern of E. coli would shift because of CRP-dependent transcriptional 
activation (169). Thus, the proteins acetylated due to overexpression of these KATs may also 
have shifted. Therefore, in addition to the caveats inherent in using overexpression constructs, 
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one should temper conclusions made when using the gutted strain to identify acetylated targets 
unless a condition that is known to natively express the KAT is used. Indeed, it would be useful 
to determine what proteins are acetylated by these KATs under different conditions. 
 I hope that the gutted strain can be used as an example for future researchers looking to 
identify mechanisms of acetylation in other bacteria. By knowing the possible sources of 
acetylation in a bacterium, both enzymatic and non-enzymatic, a bacterium can be genetically 
modified to eliminate those mechanisms. Then, by searching the genome for GNAT family 
members, these genes can be cloned and overexpressed as I have done. Perhaps a whole library 
of ORFs from the bacterium of interest could be screened initially in a dot blot assay, permitting 
that the background acetylation is low enough, and signal from the gene product is sufficiently 
high. This would also bypass one of the major caveats of using the E. coli gutted strain to assess 
heterologously expressed acetyltransferases, which is that, in many cases, E. coli may not encode 
the native targets of KATs from other bacteria. Indeed, while I was able to find that RimI from 
Neisseria acetylated a protein in E. coli, the PhnO and YfiQ homologs did not acetylate any 
proteins. Similarly, a KAT from Borrelia burgdorferi that I overexpressed in the gutted strain 
showed no effect. Therefore, if possible, the native host should be used. 
Novel KATs of E. coli 
 Using the gutted strain, I identified one or more acetylated bands when PhnO, RimI, 
YiaC, and YjaB were overexpressed (Fig. 28). Each of these enzymes is a member of the GNAT 
family of enzymes, a broadly conserved enzyme family that extends from bacteria to eukaryotes. 
These enzymes are characterized by their ability to bind AcCoA and transfer acetyl groups onto 
molecules. In this case, PhnO, RimI, YiaC, and YjaB appear to acetylate proteins, indicating that 
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these GNATs are KATs. Further confirming this hypothesis are the data in Fig. 29, where the 
acetylated bands were absent upon mutation of conserved catalytic glutamine or tyrosine amino 
acids that have been shown to be required for activity in other KATs.  
 To better understand the physiological role of these KATs, I submitted pellets of cells 
overexpressing these novel KATs for mass spectrometry to identify proteins that these KATs 
may acetylate. This analysis showed that each KAT acetylated multiple proteins, including RimI 
and YjaB, which only showed one acetylated band via western blot. Proteins separated via SDS-
PAGE migrate by size, and thus proteins that are approximately the same size migrate together. 
Alternatively, this discrepancy could be due to detection limitations of western blots compared to 
mass spectrometry. Specifically, our threshold for a lysine to be considered regulated by a KAT 
was a >4-fold increase in the KAT overexpression strain over the vector control strain. This 4-
fold increase could mean that a given lysine goes from 20% to 80% acetylation across the 
population of that lysine, or it could mean acetylation increases from 0.1% to 0.4% on that 
lysine, which likely would not be detected by western blot. Thus, future work should seek to 
determine the stoichiometry of acetylation upon overexpression of these KATs to better 
understand their physiological targets. Below, I will describe what is known about each KAT and 
what I currently hypothesize acetylation by these KATs may do. 
RimI 
 RimI was initially described as one of three N-terminal acetyltransferases (NATs) of E. 
coli in addition to RimJ and RimL. RimI acetylates the N-terminal alanine of the 30S subunit 
protein S18 (32, 391). We detected 11 proteins that were acetylated in a RimI-dependent manner. 
Interestingly, none of these proteins were an exact match for the band that was found around 40 
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kD. The closest match was the protein RarA (49.6 kD), which RimI acetylated ~6-fold above the 
vector control. RarA is a recombination factor that is suspected to be associated with DNA 
replication. Specifically, RarA is proposed to facilitate repair of stalled replication forks (461). 
The site of acetylation, K378, does not have a clear role in protein function. A similarly sized 
band as one detected in RimI is also observed in YiaC and YjaB but not PhnO, and RarA is 
detected as acetylated in both YiaC and YjaB but not PhnO. Whether this is actually RarA or 
another protein remains to be determined. The highest acetylation fold change upon RimI 
overexpression was RimI itself (~60-fold). Since the fold changes are normalized to protein 
levels, this suggests that RimI may autoacetylate or acetylate other RimI proteins. 
 RimI is part of a polycistronic operon downstream of DNA polymerase III subunit ψ and 
upstream of YjjG, a pyrimidine 5’-nucleotidase. DNA polymerase III subunit ψ forms a dimer 
with subunit χ to stabilize the DNA polymerase III preinitiation complex (395, 396). YjjG is a 
monophosphatase towards UMP, dUMP, and dTMP (462), and its nucleosidase activity also 
protects cells against mutagenic noncanonical pyrimidine nucleotides (463). If RimI truly 
regulates RarA, a DNA repair enzyme, it makes some sense that RimI is encoded near other 
DNA replication and protection enzymes. Perhaps RimI inactivates RarA when it is not needed 
during regular replication or RimI might enhance RarA activity during replication repair. No 
transcriptional regulation has been described for this operon yet. However, microarray data 
suggest that RimI expression can be activated by the cationic biocide polyhexamethylene 
biguanide (PHMB) (464), which has been shown to condense bacterial chromosomes (465). 
 RimI, RimJ, and RimL N-terminally acetylate alanine of S18, alanine of S5, and serine of 
L12, respectively. While RimI shows KAT activity, it is interesting that RimJ does not. RimL 
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was not assessed for KAT activity in this study because it was not found in the ASKA collection, 
so whether this protein does or does not have KAT activity is still an open line to test. All three 
proteins share a very low sequence identity, with RimL and RimJ having the highest identity at 
23%. All three proteins share some overlap in residues near the catalytic tyrosine Y115 of RimI 
(Y109 of RimJ, Y98 of RimL). Thus, it would be useful to identify the structural determinants 
that render RimI a KAT and NAT but RimJ only a NAT. Any insights learned from this analysis 
may inform what interfaces these KATs/NATs use to specifically acetylate their targets. 
Structures have been solved for RimI from Salmonella typhimurium (386) and E. coli (5isv), 
RimJ from Vibrio fischeri (3IGR), and RimL from Salmonella typhimurium (466). While the 
sequences of these orthologs are not identical to those of E. coli, the structures may assist in 
dissecting what differentiates these enzymes. 
 RimI was found to be the most conserved of the KATs, identified in over 4,400 bacterial 
genomes (55). Presumably this conservation is linked to its ability to acetylate the highly 
conserved ribosomal subunit. However, whether NAT and/or KAT activity of RimI has been 
conserved across phylogeny should be considered. If the RimI orthologs do acetylate lysines, it 
would be interesting to determine whether these lysines are the same as those acetylated in E. 
coli. 
PhnO 
 PhnO was initially described as an aminoalkylphosphonate acetyltransferase (392, 393). 
PhnO exists in an operon dedicated to utilization of phosphonate during phosphate starvation. 
PhnO is not absolutely required for phosphonate utilization, but it does acetylate (S)-1-
aminoethylphosphonate and aminomethylphosphonate for their utilization (393, 394). 
177 
 
Transcription of phnO can be driven from two promoters, of which one is controlled by PhoB, 
which responds to phosphate limitation. In addition, microarray studies have found PhnO 
upregulated in biofilms (467, 468) and heat shock, but downregulated in cold shock (469). 
By mass spectrometry, we identified 10 proteins acetylated when PhnO is overexpressed. 
Nine bands can be observed in the PhnO overexpression strain. Like RimI, PhnO itself was 
highly acetylated upon overexpression (~700-fold). GlyQ was the next most highly acetylated 
protein, achieving ~22-fold acetylation. A band close to 75 kD may correspond to ribonuclease II 
(78 kD), an exoribonuclease required for processing tRNAs (470) and mRNAs (471). Another 
band at about 55 kD may be another RNase, ribonuclease G (51 kD), that matures the 16S rRNA 
(472, 473) and participates in RNA turnover (474, 475). A weakly acetylated band can be seen 
just below 50 kD that may be YgiF (48.4 kD), an inorganic triphosphatase (476), of which little 
is known. Just below 37 kD, a band that might be GlyQ (35 kD) can be observed. GlyQ is 
subunit α of the glycine–tRNA ligase (477). A strong band between 20 and 25 kD may match to 
YrbL (24.3 kD), an uncharacterized protein that is part of the PhoP regulon (478). There remain 
two acetylated bands that do not have a corresponding protein, one at ~70 kD and one at 32 kD, 
which may suggest that PhnO overexpression increases the absolute amount of these proteins, 
and not the acetylation itself. Therefore, after normalization, the mass spectrometry analysis 
shows an insignificant fold-change. The above targets paint a picture where PhnO may regulate 
ribonuclease activity, perhaps in response to phosphate starvation conditions, when the cell needs 
to conserve phosphate for energy. Alternatively, it may simply free building blocks for synthesis 
of new mRNA to translate proteins necessary for responding to starvation stress. Perhaps YgiF 
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has a role in abstracting phosphate from certain molecules, and acetylation may enhance or 
reduce this activity. 
PhnO was mostly conserved in the γ-proteobacteria (22 genomes). Thus, it would be 
interesting to perform a focused study to determine whether the same proteins are acetylated by 
PhnO homologs of these other γ-proteobacteria or whether the PhnO homologs can acetylate the 
same proteins when expressed in E. coli. If acetylation of GlyQ or another target regulates its 
activity, it would be interesting to determine how other organisms outside of γ-proteobacteria 
may regulate the orthologs of these targets. 
YjaB 
 The mRNA encoding YjaB is monocistronic and expressed from a divergent promoter 
that drives transcription of homoserine O-succinyltransferase, which catalyzes the first step of de 
novo methionine biosynthesis (479). While there are no known activators of YjaB, microarray 
data suggests YjaB is downregulated upon exposure to PHMB (464) but upregulated in heat 
stress (469) and in stationary phase dependent on the stationary phase sigma factor, σS (480-482). 
 YjaB overexpression resulted in 128 proteins acetylated at a level above vector control. 
Like RimI and PhnO, it appears to be highly acetylated when overexpressed. By western blot, 
there appear to be four acetylated bands sensitive to YjaB with the most robust and reproducible 
signal coming from around 40 kD and around 17 kD. The proteins within the 40 kD band may 
correspond to one of the following: YcbX (40 kD), FtsZ (40 kD), or YfiF (38 kD). YfiF is 
annotated as a putative methyltransferase; but, as of yet, no work on YfiF has been reported. If it 
is a methyltransferase and regulated by YjaB, it would be interesting to determine how this 
cascade of modification would affect physiology. YcbX has detoxification activity toward toxic 
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N-hydroxylated base analogs (483). FtsZ assembles to form the Z-ring structure at the future cell 
division site. It is essential and highly conserved in bacteria, archaea, some chloroplasts, and 
some mitochondria (484). FtsZ is acetylated by YjaB on K380, a residue that is present in the C-
terminal variable (CTV) region of the protein. This CTV and K380, specifically, are important 
for interaction with ZapD, a protein that facilitates FtsZ polymerization. Additionally, we 
detected that acetylation of FtsA, FtsE, and FtsK was regulated by YjaB. Each of these 
participate in formation of the septal ring and cell division (485). Thus, YjaB-dependent 
acetylation may be important for regulating cell division. 
 The band corresponding to 17 kD may be comprised of one or more of the following 
proteins that approximately fit that molecular weight: YjgM (18.6 kD), SmpB (18.3 kD), Bcp (18 
kD), RpsE (17.6 kD), GreA (17.6 kD), IscU (17 kD), or YjaB itself (16.5 kD). However, the 
anti-His western blot suggests that YjaB runs below 15 kD (Fig. 29B). YjgM was one of the 
putative GNATs studied here, but nothing is known about its function. SmpB with tmRNA 
(ssrA) work together in the process called trans-translation that releases stalled ribosomes and 
tags partially synthesized proteins for degradation (486). Being a small (160 AA) protein, 
acetylation of a single residue by YjaB may critically affect SmpB activity. Bcp is a thiol 
peroxidase that can assist in detoxifying hydrogen peroxide (487), though the effect of 
acetylation by YjaB is not apparent. RpsE is one of about twenty ribosomal proteins that YjaB 
acetylates, but the only one that fits the molecular weight observed by western blot. Interestingly, 
this is protein S5 of the 30S ribosomal subunit, the same protein N-terminally acetylated by RimJ 
(32). Future studies could determine whether these acetylations undergo any cross-talk to 
regulate translation or assembly of the ribosome. GreA is a transcription elongation factor that 
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helps to release a stalled polymerase complex (488). The acetylated lysine, K43, is found on an 
exposed hairpin between two helices, and is sensitive to CobB (205). However, what acetylation 
of K43 does to the protein function is unclear. Finally, IscU is a scaffold protein for iron-sulfur 
cluster assembly (489). Since IscU must serve as a docking site for multiple proteins of this 
assembly system, acetylation might disrupt or enhance these interactions. Though not apparent 
on western blot, three more groups of proteins acetylated by YjaB may be physiologically 
interesting: cysteine biosynthesis enzymes, translation initiation enzymes, and trehalose 
metabolism enzymes.  
 CysB, a transcriptional regulator of sulfur utilization genes and cysteine biosynthetic 
genes (490), is acetylated by YjaB on K54, which is near the helix-turn-helix DNA binding 
motif. Three members of the CysB regulon are also acetylated by YjaB: CysC, CysI, and CysK. 
CysC and CysI are required for two of the steps that assimilate sulfate for subsequent utilization 
in cysteine biosynthesis. Interestingly, CysI is a protein that contains an iron sulfur cluster, which 
may suggest YjaB acetylates IscU concomitantly with cysteine biosynthetic enzymes. CysK 
generates cysteine by condensing O-acetyl-L-serine with the output of the sulfate assimilation 
pathway, hydrogen sulfide. Thus, acetylation by YjaB may be a means for the cell to regulate 
cysteine biosynthesis. 
 E. coli encodes three translation initiation factors: IF-1, IF-2, and IF-3. Each of them is 
acetylated in a YjaB-dependent manner. IF-1 is the smallest initiation factor and its function is 
not fully established, but with IF-2, it is proposed to ensure correct binding of fMet-tRNAfMet in 
the ribosomal P-site (491). The sites acetylated on IF-1 and IF-2 do not present any obvious 
interpretation of their function. IF-3 appears to stimulate dissociation of the deacylated tRNA 
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from a post-termination ribosome and may assist in recycling stalled ribosomes (492, 493). 
Excitingly, the YjaB-acetylated lysine of IF-3, K110, is important for interaction with the 30S 
subunit, and mutation of this residue reduces affinity (494). Thus, YjaB may be important for 
regulating translation. 
 Finally, YjaB acetylated three enzymes required for metabolism of trehalose. Trehalose is 
a glucose disaccharide that can serve as carbon storage, osmoprotectant, cryoprotectant, and a 
chemical chaperone of protein folding (495, 496). TreR is a repressor of trehalose import (TreB) 
and catabolism (TreC) genes. TreR is acetylated in the helix-turn-helix motif, which may prevent 
repression of its regulon. TreC allowed E. coli to utilize trehalose as the sole carbon source and 
breaks trehalose into glucose and glucose-6-phosphate (497). However, the acetylated lysine 
K144, does not appear to be in a provocative location. Finally, trehalose-6-phosphate synthase 
(otsA) catalyzes the first step in trehalose biosynthesis, which essentially catalyzes the reverse 
reaction of TreC by condensing glucose-6-phosphate and UDP-glucose to trehalose-6-phosphate 
(498). Extensive characterization of OtsA has found many residues required for substrate 
binding, but none of them correspond to the acetylated lysine, K244 (499). Since YjaB acetylates 
proteins with opposing functions, perhaps these acetylations can direct the flux of carbon to or 
from trehalose. 
YiaC 
 YiaC is encoded in a polycistronic mRNA downstream of and overlapping with Tag, 
which encodes DNA glycosylase I, one of two DNA glycosylases that protect E. coli against 
potentially mutagenic lesions. This mRNA is not known to be activated by any factors, and as 
such, this is thought to be a constitutive operon, which would imply yiaC is constitutively made. 
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However, microarray data indicate that YiaC transcription is reduced when σ32, the heat shock 
sigma factor, is overexpressed (500). YiaC transcription is also reduced by PHMB treatment 
(464). However, YiaC transcription is upregulated in stationary phase (480, 482) and when cells 
are challenged by oxidative stress (469). 
 While YiaC overexpression produces eight acetylated bands reproducibly, mass 
spectrometry revealed 251 proteins acetylated in a YiaC-dependent manner. The most intense 
bands were found at about 70, 40, 35, 25, and 20 kD. Of the proteins detected by mass 
spectrometry, six to eleven proteins could comprise each of these bands. Not only does YiaC 
produce the most acetylated proteins of any of the novel KATs, but it also exhibited some of the 
highest fold changes of any of the KATs. Indeed, 26 proteins exhibited ≥100-fold increases in 
acetylation. Ten of these proteins are ribosomal proteins, and the most highly acetylated protein 
was the 50S ribosomal subunit protein L15. In addition to the ribosomal subunits, YiaC 
acetylates the three translation initiation factors that are acetylated by YjaB. It also acetylates the 
ribosome assembly factor, BipA. This may suggest that YiaC could be a regulator of translation, 
and perhaps may have an overlapping role with YjaB. Alternatively, this could suggest that there 
are comparable determinants that dictate whether a protein is acetylated YiaC and YjaB. 
 Due to the great amount of proteins acetylated by YiaC, the role of YiaC could be truly 
extensive or simply obscured. Like YjaB, cysteine biosynthesis genes are highly acetylated by 
YiaC. YiaC may prevent glycine tRNA charging as both subunits of glycine-tRNA ligase are 
acetylated. YiaC may also regulate nucleotide biosynthesis. Pyrimidine biosynthetic gene PyrH 
and purine biosynthetic genes PurC and PurH are all acetylated, but the effect of acetylation of 
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these lysines is not clear. Finally, consistent with each other KAT, YiaC itself was acetylated, 
which implies that it can either auto-acetylate or acetylate another YiaC protein. 
Phenotypic Analysis of KATs 
 If a bacterium encodes a protein, it suggests that that protein has biological importance; 
otherwise the gene would be lost to optimize fitness (501). Thus, these KATs and presumably 
their acetyltransferase activities are important for E. coli under some condition. So, when are 
these KATs important? Hypotheses can be formed by determining when the KATs are 
expressed, the genomic neighborhood of the KATs, and the proteins acetylated by KATs. I 
searched the E. coli gene expression database for conditions when the KATs were upregulated or 
downregulated. Based on these data, I hypothesized that low temperature (24°C) or high 
temperature (42°C) may affect the growth of KAT mutant strains or KAT overexpression strains. 
At each temperature, every strain behaved like the WT reference strain (Fig. 37). Future studies 
attempting to perform a similar experiment should begin by determining whether the KATs are 
expressed under these conditions. Perhaps these KATs were not expressed in this medium and, 
thus, KAT mutants would not have any effect. Similarly, perhaps in this medium, the target of 
these KATs that is relevant is not expressed. More extreme temperatures may also be used to 
investigate the requirement for these KATs. These KATs may also have some redundant 
functions, and therefore a single deletion may not show a phenotype. 
 In the E. coli genome, yiaC is encoded downstream and overlaps four nucleotides of tag. 
Since tag encodes one of the two DNA glycosylase repair enzymes involved in base excision 
repair, I hypothesized that YiaC may regulate DNA repair. Of the YiaC targets, three are related 
to DNA repair, RarA, RuvC, and Ssb. However, these enzymes act in a separate pathway than 
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the Tag or the other DNA glycosylase, AlkA. I tested the survival of E. coli mutants deleted for 
yiaC in WT, Δtag, ΔalkA, and ΔalkA tag backgrounds against the chemical mutagen MNNG 
(Fig. 36). However, deletion of yiaC did not cause any difference compared to the parent strains. 
This suggests that YiaC does not play a role in DNA repair that Tag protects against. Perhaps 
YiaC can regulate enzymes required for other types of DNA damage, and thus ΔyiaC mutants 
should be tested in mutagens that promote other DNA lesions like single strand breaks, double 
strand breaks, or thymine dimers. 
AcCoA-Dependent Acetylation 
 I showed that residual acetylation in the gutted strain could partially be explained by the 
presence of GNATs that exhibit KAT activity. In the gutted strain that lacks YfiQ and AcP, there 
remains a low level of acetylation on many proteins (Fig. 26). While some of these proteins may 
be KAT-dependent, there are some that do not respond to KAT overexpression (Fig. 28). This 
suggests that there are either proteins with KAT activity yet to be discovered, or AcCoA could 
non-enzymatically acetylate proteins like AcP. 
 Wagner et al. used in vitro acetylation assays that mimicked the mitochondrial 
microenvironment to make the claim that non-enzymatic AcCoA-dependent acetylation could 
occur within the mitochondrion (288). Since AcCoA is a highly reactive molecule like AcP, it is 
highly probable that this chemical reaction can happen (291). The difficulty arises in trying to 
demonstrate that this mechanism of acetylation occurs in vivo. For AcP, there are no known 
enzymes that have been shown to catalyze AcP-dependent acetylation. Furthermore, by deleting 
the Pta-AckA pathway that synthesizes AcP, AcP-dependent acetylation was undetectable. The 
same cannot be said for AcCoA. KATs utilize AcCoA to catalyze acetylation. Therefore, to 
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determine whether non-enzymatic AcCoA-dependent acetylation occurs, one would first need to 
remove all KATs of the organism such that the only means of acetylating is directly by AcCoA. 
Furthermore, there is no way to completely eliminate AcCoA. AcCoA is an essential node of 
central metabolism in almost all organisms and, thus, mutations to prevent synthesis of AcCoA 
would be inviable. One possible organism that could be used is Borrelia burgdorferi, which only 
synthesizes AcCoA to make mevalonate, a precursor to cell wall lipid biosynthesis (502). By 
supplementing mevalonate, this bacterium can survive without AcCoA, Indeed, only two 
proteins were detected as acetylated by mass spectrometry analysis of a B. burgdorferi mutant 
that cannot synthesize AcCoA or AcP. Unfortunately, this study did not determine acetylated 
proteins of a strain that could synthesize AcCoA alone to determine its contribution compared to 
that of AcP.  
 In my work, I found that I could acetylate CysK in vitro with AcCoA in the absence of an 
acetyltransferase (Fig. 33). Since I was trying to demonstrate that YiaC had KAT activity in 
vitro, I manipulated the conditions in an attempt to promote enzymatic acetylation and disfavor 
non-enzymatic acetylation. I first realized that boiling my samples to stop the reaction simply 
enhanced non-enzymatic acetylation of CysK, but non-enzymatic acetylation occurred even 
without boiling (Fig. 34A). Boiling may enhance acetylation by promoting dissociation of 
AcCoA and increasing reactivity of AcCoA with protein substrates. Lysines must be 
deprotonated before becoming acetylated. In the context of a KAT, this can occur via a 
glutamate residue. In a non-enzymatic acetylation reaction, either a glutamate residue near the 
lysine can deprotonate the lysine, or the proton can be abstracted by a basic molecule from the 
medium if the pH is sufficiently high. Thus, I lowered the buffer pH from 8.0 to 7.0. Again, this 
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disfavored non-enzymatic acetylation, but was insufficient to demonstrate any KAT activity for 
YiaC. Therefore, I conclude that at least one E. coli protein can be readily non-enzymatically 
acetylated in vitro, and the conditions to promote this acetylation are high temperature and high 
pH. 
 While AcCoA cannot be eliminated from E. coli, the concentration of AcCoA within the 
cell can be modulated. AcCoA concentrations are limited by production of CoA. Pantothenate 
kinase is the first enzyme in the biosynthesis pathway for CoA, and it is highly regulated (503). 
Pantothenate kinase is sensitive to feedback regulation by CoA, and therefore limits the amount 
of CoA made (504, 505). By overexpressing pantothenate kinase and supplementing the culture 
with extra pantothenate, E. coli increases the amount of free CoA about 3-fold and AcCoA 
almost 10-fold (506, 507). Similarly, acetyl groups can be drained from AcCoA by 
overexpressing machinery required for making the bioplastic monomer polyhydroxybutyrate 
(PHB) (508). Three enzymes compose the PHB synthesis pathway, and the first enzyme 
performs a condensation reaction of two AcCoA molecules to generate acetoacetyl-CoA.  
I did not test whether PHB synthesis affected acetylation, but I did test whether 
overexpressing pantothenate kinase could increase AcP- and YfiQ-independent acetylation in the 
gutted strain. Indeed, adding 100 μM and 1 mM pantothenic acid showed a dose-dependent 
increase in acetylation, while no change was observed between 1 mM and 5 mM. These data 
suggest that AcCoA can increase global acetylation. However, this experiment was performed 
prior to identification of the KATs. Thus, the gutted strain still contained the KATs, which could 
explain any increases in acetylation. A future study could delete all of the KATs from the gutted 
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strain and repeat this experiment to determine whether non-enzymatic AcCoA-dependent 
acetylation occurs. 
Future Directions 
 These results open many paths for future work. The most efficient path would be to study 
the novel KATs. Since E. coli has maintained these enzymes over evolutionary time to acetylate 
proteins, it is reasonable to hypothesize that the catalyzed acetylations are important for E. coli. 
While we have identified four novel KATs, we still do not know when they are physiologically 
relevant. Monitoring the expression of the KATs via a transcriptional reporter or by monitoring 
production of His-tagged variants of the KATs at the native sites in the chromosome would 
allow one to rapidly test under what conditions these KATs are made. Another way to determine 
the relevance of the KATs is to perform a Tn-seq experiment in strains deleted for each of the 
novel KATs. By identifying genes that produce a synthetic lethal phenotype, one could cross-
reference these genes with the acetylated target list to identify true substrates of the KATs. 
Because we know what residues are required for the acetyltransferase activity of each KAT, if 
one would combine the inactive variant KAT with the gene that produces the synthetic 
phenotype, one could ensure that acetylation by the KAT is responsible. 
 Alternatively, we have identified hundreds of targets acetylated by these KATs. It would 
be relatively simple to make variant proteins encoding genetic mimics of a handful of these 
protein targets. Plenty of enzymes, like CysK, are acetylated in provocative locations that would 
be detrimental for the enzymatic activity. Transcription factors, like ArcA, are similarly tempting 
targets because of how acetylation could clearly block the DNA binding activity. Similarly, other 
groups have shown that HU of M. tuberculosis can alter the nucleoid compaction in the 
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bacterium. As we detect HU of E. coli as acetylated, the KATs may influence E. coli nucleoid 
compaction and transcription. 
AcP-dependent acetylation is directly tied to metabolism. It is distinctly possible that the 
inevitability of acetylation on certain lysines has little to no effect on certain proteins, which 
makes determination of which acetylations are physiologically relevant difficult. With the recent 
discovery that enolase activity can be regulated by AcP-dependent acetylation, one should 
consider testing the other central metabolic enzymes to determine whether AcP-dependent 
acetylation could be a feedback mechanism to sense glycolytic flux. Finally, we detected much 
of the translational machinery including most of the ribosomal subunits acetylated in an AcP-
dependent manner. Since ribosomes are a complex of proteins and must associate with various 
protein factors as well as RNA, each acetylation has the potential to disrupt salt bridges and/or 
sterically hinder proper interactions. To determine whether acetylation affects translation rate, 
one could perform an in vitro translation assay using highly acetylated ribosomes (from a ΔackA 
mutant) or weakly acetylated ribosomes (from a Δpta mutant) added to the PURExpress® 
ΔRibosome Kit. Similarly, translational assays could be performed using individual elongation 
or initiation factors that are highly acetylated or weakly acetylated to determine whether 
acetylated isoforms inhibit translation rate.  
Concluding Remarks 
 Metabolism is an essential process that permits generation of both biomass and energy in 
every living organism. While these metabolic processes have been honed over evolution to suit 
the needs of a particular organism, there are inevitable “extra-metabolic” reactions that may 
occur. One of these “extra-metabolic” reactions appears to be non-enzymatic AcP-dependent 
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acetylation of lysines. Indeed, the work presented here suggests that AcP-dependent acetylation 
is simply a consequence of acetate fermentation, and acetylation will accumulate during periods 
of stagnant growth when the proteome is relatively unchanging, such as stationary phase, for as 
long as a fermentable carbon source is available. This inevitability suggests that other bacteria 
that produce AcP via fermentation would experience global acetylation like E. coli. Indeed, other 
works have shown that B. subtilis and N. gonorrhoeae exhibit AcP-dependent acetylation on a 
scale comparable to E. coli. Specificity of this non-enzymatic acetylation is dictated by the three-
dimensional protein structures, which causes some lysines to be more sensitive to AcP than 
others. While I hypothesized that this global, non-enzymatic, AcP-dependent acetylation might 
protect against oxidative damage or serve as a carbon source during starvation, I was unable to 
generate data to support these ideas. Thus, whether E. coli has evolved to cope with or utilize 
non-enzymatic acetylation is an open question.  
Due to the prevalence and essentiality of AcCoA in almost all organisms, sensing these 
levels and ensuring that carbon flux to and from the AcCoA node is critical. Thus, the evolution 
of enzymes that tie their activity to AcCoA is not a surprise. I found that E. coli encodes four 
KATs in addition to the known KAT, YfiQ. Each of these KATs acetylates a distinct set of 
targets that differ not only from each other but from AcP as well. While the biological 
importance of acetylation by these KATs is not clear, deciphering when these KATs are 
expressed and which proteins are bona fide targets will help to determine how E. coli has 
evolved to utilize acetylation.  
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Due to conservation of both enzymatic and non-enzymatic acetylation, some of what is 
learned in E. coli may be applied to other organisms. Therefore, using E. coli, we can get closer 
to establishing a more complete picture of the inner workings of the cell.
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Introduction 
 The best-known and most extensively studied acetylated protein in bacteria is AcCoA 
synthetase (Acs), an enzyme conserved from bacteria to humans (266). Acs activates acetate to 
generate AcCoA via a two-step process (290). First, Acs uses ATP to adenylate acetate, which 
yields an enzyme-bound acetyl-AMP intermediate and releases pyrophosphate. Second, Acs uses 
its CoA-ligase activity to generate AcCoA and release AMP. While the enzyme is reversible, the 
reaction is essentially irreversible in vivo due to pyrophosphatases that break down 
pyrophosphate generated in the first reaction (343). Acs has high affinity for acetate and thus it is 
primarily used to scavenge low concentration of this carbon source (172, 265, 290). As such, 
Δacs mutants or cells with reduced Acs activity grow poorly or not at all in media with low 
levels of acetate (< 10 mM) as the sole carbon source. 
 In E. coli, Acs can be regulated at two levels, transcriptionally and post-translationally. 
Fis, a small nucleoid associated protein and transcriptional regulator, inhibits transcription of acs 
during exponential growth. In contrast, CRP activates transcription of the acs gene; thus, Acs 
will not be synthesized in the presence of a catabolite repressing sugar like glucose (343). 
Regulation by CRP is complex, as acs is positively regulated in an AR1-dependent manner, but 
negatively regulated in an AR2-dependent manner. Binding to the AR1-dependent site is higher 
affinity than binding to the AR2-dependent site; thus, acs is activated at lower CRP 
concentrations, but repressed at higher ones.  
Acetylation of a single lysine on Acs inactivates the protein. Strikingly, this method of 
regulation is conserved across phylogeny (134, 139, 142, 144, 146-148, 164, 199, 241, 260, 262, 
266), and extends to other Acs-like enzymes (134, 159, 164, 509). In each case, acetylation of 
this lysine blocks the first half-reaction of Acs by preventing the formation of acetyl-AMP (199). 
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In E. coli, the acetylated lysine is K609. Acetylation of this lysine is catalyzed by YfiQ, and 
deacetylation is catalyzed by CobB. In B. subtilis, Acs was found to be propionylated at this site, 
which also resulted in inactivation (388). However, this has not yet been tested in E. coli. 
In my studies, I consistently detected an acetylated band by anti-acetyllysine western blot 
that mimicked properties of Acs (Fig. 5, TB7 lane). This band was around 72 kD, the molecular 
weight of Acs. The band was present throughout growth in TB7, but it was absent in the 
presence of glucose or excess carbon source. However, once glucose or the other carbon source 
was depleted, the band appeared (Fig. 5, 24 hour lane). The band depended on CRP, specifically 
AR1. Interestingly, even in the presence of glucose, I was able to detect this band in a ΔptsG 
mutant. Since a ΔptsG mutant does not catabolite repress lactose consumption even in the 
presence of glucose, this suggests that CRP is active in a ΔptsG mutant (510). Thus, I wanted to 
confirm whether this band was truly Acs, which could then be used as a diagnostic marker for 
the presence or absence of glucose in the medium. 
Results 
 I decided to genetically determine whether the 72 kD band I observed corresponded to 
Acs. Specifically, I used a ΔptsG mutant background, which produces this band, and made one 
of two additional mutations. I either deleted yfiQ or acs. If the acetylated band is Acs, then 
deletion of yfiQ would prevent acetylation and thus detection of the band. Similarly, deleting the 
acs gene will prevent the expression of the protein, such that it can neither be acetylated nor 
detected. Thus, I grew the ΔptsG yfiQ mutant, ΔptsG acs mutant, and parent strain in 
TB7/glucose for 10 hours and performed an anti-acetyllysine western blot. There was no 
difference in protein loading or pattern as determined by Coomassie-stained SDS-PAGE gel 
analysis. As expected, while the ΔptsG single mutant produced the acetylated band, neither the 
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ΔptsG yfiQ nor ΔptsG acs mutant produced that band (Fig. 39). Taken together with my previous 
results, I conclude that this 72 kD band is Acs. 
 
Figure 39. A 72 kD Acetylated Band Corresponds to Acs. Duplicate cultures of mutant strains 
of E. coli (strain BW25113) with the indicated deletions were aerated at 37°C in TB7 
supplemented with 0.4% (w/v) glucose. After 10 hours, cells were harvested. The whole cell 
protein lysate was normalized to protein concentration, separated by 1D-SDS PAGE and stained 
with Coomassie blue stain (A) and assessed for protein acetylation by anti-acetyllysine (α-acK) 
Western immunoblot analysis (B). 
 
Discussion 
 While the data I generated and data from other papers (57) heavily suggested that the 72 
kD band could be Acs, the experiment described above fully supports that conclusion. This band 
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is catabolite-repressed, YfiQ-dependent, CRP-dependent, and Acs-dependent. In my 
experiments, I used this Acs band as a diagnostic marker to tell me when cells had completely 
consumed the glucose from their medium. Identifying that this band is Acs told me that the 
ΔptsG mutant did not appear to be experiencing catabolite repression. Also, I was able to 
confirm that the CRP variants were behaving as expected using this band (Fig. 17A). 
Furthermore, this band was used as a marker to show that a YfiQ-overexpression was working 
correctly (Fig. 27). When possible, future studies can now confidently utilize Acs as a diagnostic 
marker without the explicit need for additional experiments.
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Introduction 
Bacteria are routinely grown in complex media containing a rich assortment of nutrients. For 
example, lysogeny broth (LB) contains tryptone and yeast exact. Together, these components 
provide a rich mixture of nutrients that supports growth of numerous bacteria. However, the 
complexity of such media obscures factors governing cell behavior, especially those that limit 
cell growth. 
While studying glucose-induced protein acetylation, I found that E. coli continues to 
consume the glucose in TB7/glucose even after the cultures reach stationary phase. In fact, most 
of the glucose was consumed after the cultures ceased exponential growth. This behavior was 
contrary to my initial expectations, which were based upon the behavior of E. coli cultures in 
minimal medium containing glucose as the sole carbon source (361). Under these conditions, the 
cultures enter stationary phase when glucose is depleted. I sought to explain this confounding 
phenomenon. In doing so, I found that TB7 as well as many other peptide-based media are 
balanced between carbon and magnesium as the growth limiting nutrients. However, 
supplementation with carbon on top of these complex media, such as TB7/glucose or LB, renders 
the bacteria limited for magnesium. These data and thoughts are mostly published in (341). 
A Component of Buffered Tryptone Broth Limits Growth.  
While growing E. coli in TB7/glucose, I noticed that the cells continued to consume glucose 
even after the culture reached stationary phase (Fig. 4A). In fact, the majority of glucose was 
consumed during stationary phase. Because glucose is consumed during exponential growth in 
minimal media (e.g., M9) with glucose as the sole carbon source (361), I wondered whether 
tryptone might somehow inhibit glucose consumption by E. coli. 
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To test whether tryptone inhibited glucose consumption, I grew E. coli in M9/glucose and 
varying concentrations of tryptone. Instead of inhibiting glucose consumption as initially 
hypothesized, tryptone increased glucose consumption in a dose-dependent manner (Fig. 40). 
Tryptone also increased the growth rate and growth yield (i.e., final cell density). This suggests 
that tryptone does not inhibit glucose uptake per se but rather that some compound present in M9 
minimal medium, but not in TB7, enables better cell growth. 
 
Figure 40. Addition of Tryptone to M9 Increases Growth Rate and Glucose Consumption. 
Wild-type E. coli cells (strain BW25113) were aerated in M9 minimal medium supplemented 
with 4 g/liter glucose and increasing concentrations of tryptone: 0.1% (squares), 0.2% (circles), 
0.5% (triangles), and 1% (diamonds). Growth was measured at OD600 (solid lines) and the 
filtered culture medium assessed for glucose (dotted lines). 
 
Magnesium Increases Cell Growth in Buffered Tryptone Broth 
M9 minimal medium contains five compounds not present in TB7 medium: ferric citrate, 
calcium chloride, magnesium sulfate, thiamine, and ammonia. To determine whether the addition 
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of these compounds would increase cell growth in TB7/glucose, I first grew the cells in 
TB7/glucose supplemented with four of the five compounds. I expected that if a single 
compound were responsible for the growth yield increase, then removing it would cause the cells 
to grow as if they were in TB7/glucose alone. Indeed, I found that when magnesium sulfate was 
not added to TB7/glucose, the cells grew as if they were in TB7/glucose alone (Fig. 41). Based 
on these results, I conclude that magnesium is the limiting compound. 
 
Figure 41. Magnesium Is Necessary for Robust Growth in Buffered Tryptone Broth. Cell 
density (circles) and glucose concentration in the medium (squares) were measured hourly for 
wild-type E. coli cells (strain BW25113) aerated in TB7 supplemented with 4 g/liter glucose 
alone (open symbols), with addition of 5 M9 compounds (ferric citrate, calcium chloride, 
magnesium sulfate, thiamine, and ammonium chloride), or with 4 out of 5 M9 supplements 
(shades of gray). This was compared to cells of the same strain aerated in M9 supplemented with 
4 g/liter glucose and 1% tryptone (black symbols). Only medium supplemented without 
magnesium sulfate (dashed lines) behaved like TB7-glucose. 
 
While these results demonstrate that magnesium is necessary for robust growth in 
TB7/glucose, they do not establish that it alone is sufficient. Therefore, I tested cell growth in 
TB7/glucose supplemented with 1 mM magnesium sulfate. As shown in Fig. 42A, the addition 
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of magnesium sulfate to TB7/glucose increased the growth yield. I further found that increased 
growth yield was, in fact, due to magnesium and not to sulfate, as supplementation with 
magnesium chloride increased the growth yield, whereas potassium sulfate had no effect (Fig. 
42A). The magnesium effect was dose-dependent, where magnesium sulfate increased the 
growth yield in a dose-dependent manner up to a concentration of 1 mM (Fig. 42B). I also found 
that supplementation with magnesium or glucose alone could exert a minor enhancement on the 
growth yield in TB7, but the growth yield was greatly increased in the presence of both (Fig. 43). 
Buffering was not required to achieve an increased growth yield in the presence of both glucose 
and magnesium; however, magnesium exerted a greater effect when the medium was buffered 
with either phosphate or MOPS buffer (Fig. 43). 
 
Figure 42. Magnesium Is Sufficient for Increased Cell Growth Only When Glucose Is 
Present. (A) Wild type E. coli cells (strain BW25113) were aerated for 10 hours in TB7 
supplemented with 4 g/L glucose alone or with the addition of 1 mM MgSO4, 1 mM MgCl2, or 
1mM K2SO4. The final optical density is shown. (B) Cells were grown in TB7 supplemented 
with 4 g/L glucose and/or the indicated concentrations of MgSO4 for 10 hours. The final optical 
density is shown.  
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Figure 43. Buffering Enhances Magnesium-Dependent Growth Increase. Wild type E. coli 
cells (strain BW25113) were aerated in unbuffered tryptone broth (TB), phosphate buffered TB 
(TB7), or MOPS buffered TB (TB7M) (open bars). Cultures were supplemented with 4 g/L 
glucose (diagonal stripes), 1mM MgSO4 (horizontal stripes), or both (black bars). The final 
optical density is shown.  
 
To determine whether the effect was unique to magnesium, our collaborator James Orr 
(University of Illinois Urbana-Champaign) also tested other divalent cations. No increases in cell 
growth were observed when TB7/glucose was supplemented with calcium chloride, cobalt 
chloride, cobalt sulfate, nickel chloride, or manganese sulfate (Fig. 44A). James and I tested 
whether magnesium increased growth yield in TB7 containing seven other carbon sources 
(lactate, succinate, fructose, lactose, arabinose, pyruvate, and acetate). In all cases, magnesium 
increased the growth yield in a manner similar to glucose (Fig. 44B). Thus, this magnesium 
effect is not specific to glucose. 
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Figure 44. Magnesium Is the Only Divalent Cation That Supports Increased Growth in 
TB7 Supplemented with Various Carbon Sources. (A) Wild type E. coli cells (strain 
BW25113) were aerated in the indicated media for 10 hours. In addition to magnesium 
supplementation, other metal compounds including calcium chloride, cobalt chloride, cobalt 
sulfate, and nickel chloride were added at the indicated concentrations. The final optical density 
is shown. (B) Wild type E. coli cells (strain BW25113) were aerated in buffered TB7/glucose or 
a concentration of the indicated carbon source to provide equimolar carbon. These cultures were 
either supplemented with 1 mM MgSO4 (black bars) or left untreated (white bars).  
 
Magnesium Increases the Growth Yield in Other Peptide-Based Media 
To determine whether magnesium increases the growth yield in other peptide-based media, 
we tested growth in phosphate-buffered peptone (P7) and casamino acids (CA7), both 
supplemented with 4 g/L glucose. The cells grew best in TB7/glucose medium, slightly worse in 
CA7/glucose medium, and very poorly in P7/glucose medium (Fig. 45A). The final cell densities 
achieved in these media were directly related to the magnesium content per dry weight of these 
peptide-based media: tryptone, 195 g/g; casamino acids, 48 g/g; and peptone, 17 g/g (511). 
In all three cases, the addition of 1 mM magnesium sulfate increased growth yield. These results 
indicate that the lack of magnesium limits the growth yield in these complex, buffered peptide-
based media when carbon is in excess. 
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I also tested whether the addition of magnesium to the commonly used medium, lysogeny 
broth (LB), could increase the cell yield. The use of unbuffered LB supplemented with both 4 
g/L glucose and 1 mM magnesium resulted in a minor growth yield increase that was 
comparable to adding 1 mM magnesium alone (Fig. 45B). However, buffering LB with either 
phosphate or MOPS resulted in a greater growth yield when both glucose and magnesium were 
added, and again, magnesium alone resulted in a partial growth yield increase (Fig. 45A and B). 
 
Figure 45. E. coli Grown in Other Carbon Sources or Peptide-Based Media also Benefit 
from Magnesium Supplementation. (A) Wild type E. coli cells (strain BW25113) were 
inoculated into the indicated media supplemented with 4 g/L glucose and buffered to pH 7 with 
(black bars) or without (white bars) 1 mM MgSO4 (Mg). The base media tested here are peptone 
(P7), casamino acids (CA7), tryptone (TB7), and lysogeny broth (LB7). (B) Cells were grown in 
unbuffered LB, phosphate buffered LB (TB7), or MOPS buffered LB (LB7M) (open bars). 
Cultures were supplemented with 4 g/L glucose (diagonal stripes), 1mM MgSO4 (horizontal 
stripes), or both (black bars). The final optical density is shown.  
 
Buffering Permits Increased Growth Yield by Preventing Growth Inhibition by 
Metabolism Byproducts, Acetate and Ammonium 
I observed that buffering my media increased the growth yield upon magnesium 
supplementation to TB/glucose, LB/glucose or LB alone (Fig. 43 and Fig. 45B). Acetate 
produced from glucose consumption is known to acidify media and inhibit growth of E. coli. 
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Thus, I predicted that the differences between buffered and unbuffered media supplemented with 
magnesium resulted from inhibitory pH levels. The pH of unbuffered LB/glucose and 
TB/glucose supplemented with magnesium dropped to about 5 compared to about 7 for the 
buffered media. However, buffering also exerted a positive effect on growth in LB when 
supplemented with magnesium alone. Ammonium produced from amino acid consumption 
results in alkalization of the medium. Indeed, unbuffered LB supplemented with magnesium 
reached pH 8.7, while the buffered medium reached pH 7.5. These results indicate that 
magnesium is limiting in LB, but the effect is more pronounced when the LB is buffered and 
contains glucose. 
Magnesium Increases Cell Growth in Multiple Strains of E. coli and Species of Bacteria 
The experimental results described above were obtained using E. coli BW25113. To 
ensure the magnesium effect was not limited to this particular strain, I tested the growth of the E. 
coli strains MC4100, MG1655, and AJW678 in TB7/glucose and found that magnesium 
increased the growth yield for all three strains (Fig. 46A). I also tested whether magnesium 
increased the growth yield of B. subtilis (strain PY79) and V. fischeri (strain ES114) grown in 
TB7/glucose and TB7/glucose supplemented with 2% sodium chloride, respectively. V. fischeri 
is a marine bacterium that must be grown in higher salt conditions that mimic its natural seawater 
environment. For these bacterial species, magnesium increased growth yield, albeit to a lesser 
extent than E. coli (Fig. 46B). Even in the absence of glucose, V. fischeri achieved higher 
biomass with magnesium. The results indicate that magnesium supplementation increases the 
growth of diverse bacteria in complex peptide-based media. 
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Figure 46. Magnesium Increases Cell Growth in Multiple Strains of E. coli and Species of 
Bacteria. (A) Three strains of E. coli (MG1655, MC4100, and AJW678) were aerated in 
TB7/glucose alone (open bars) or supplemented with 1 mM MgSO4 (closed bars). (B) Bacillus 
subtilis PY79 and Vibrio fischeri ES114 were aerated for 24 hours in TB7 or TBS7, respectively. 
The media were left untreated (white bars) or supplemented with 1 mM MgSO4 (horizontal 
stripes), 4 g/L glucose (vertical stripes), or both (black bars).  
 
Magnesium Directs Glucose to Biomass Formation 
I noted that the addition of magnesium to peptide-based media supplemented with 
glucose did not alter the growth rate, but rather extended the duration of exponential growth. 
Based on this observation, I hypothesized that magnesium depletion causes cell division to cease, 
thus preventing the remaining carbon from being used for cell biomass. Whereas a TB7/glucose 
culture supplemented with magnesium increased in optical density while consuming glucose, a 
TB7/glucose culture (without added magnesium) did not increase cell growth even though it 
consumed glucose during stationary phase (Fig. 47). The cell density of the magnesium-
supplemented culture continued to increase, even after glucose was fully consumed. This appears 
to be due to consumption of excreted acetate (Fig. 18). James further established that the 
magnesium-dependent increase in optical density resulted from both increased cell number and 
increased biomass (Fig. 48). 
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Figure 47. Magnesium Diverts Carbon from Glucose into Biomass. Wild-type E. coli cells 
(strain BW25113) were aerated in TB7-glucose (black line) or TB7-glucose supplemented with 
MgSO4 (gray line) for 9 h. Optical density and glucose concentration measurements were taken 
hourly and plotted on a log-log scale. 
 
 
 
Figure 48. Magnesium Diverts Carbon into Biomass. Dry cell weight (black bars) and optical 
densities (gray bars) from the 24h time point are shown from the indicated condition. 
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Magnesium-Dependent Cell Growth Is Lost in a ΔglnA Mutant 
I next tested whether the loss of any genes would eliminate the magnesium effect. If 
magnesium-dependent cell growth simply depended on magnesium as a nutrient, then only a 
mutation that reduced maximum cell density would lose the effect. I tested various mutants of 
carbon regulation, amino acid biosynthesis, central metabolism and TCA cycle, magnesium 
transporters/sensors, and phosphate transporters/regulators. Of the mutants tested, only a ΔglnA 
mutant lost the magnesium-dependent growth yield increase (Table 6). The glnA gene encodes 
glutamine synthetase, and thus the ΔglnA mutant is a glutamine auxotroph (512). I hypothesized 
that these cells could not respond to magnesium because glutamine now was limiting. Indeed, 
supplementation with glutamine restored the magnesium-dependent biomass increase to ΔglnA 
mutants (Fig. 49). I further investigated the reason why the ΔglnA mutant does not respond to 
magnesium by testing mutants in glutamine-dependent pathways downstream of glnA. I found 
that three nucleotide biosynthesis mutants, ΔguaA, ΔpurF, and ΔcarA, also did not respond to 
magnesium (Table 7). I suspect that the ΔglnA mutant lacks sufficient glutamine for both amino 
acid and nucleotide biosynthesis and is thus limited for glutamine rather than magnesium in 
TB7/glucose. 
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Table 6. Mutants Tested for Loss of Mg2+-Dependent Biomass Increase a 
Carbon 
regulators 
Amino acid 
biosynthesis 
Central 
metabolism/ 
TCA cycle 
Magnesium 
transport 
related 
GlnA 
regulators/ 
related 
Phosphate 
related 
fnr aspA gltA corA glnB phoB 
crp aspC ackA mgtA gltB phnA 
cra glnA pta-ackA phoP glnG phnC 
arcA gdhA pgi   glnL   
    sucA   glnD   
        glnE   
        glnK   
a Mutants were grown in buffered tryptone broth supplemented with 0.4% glucose alone or with 1 mM 
MgSO4 for 10 h. Biomass increase was determined by OD600 measurements. Cells were considered 
limited for magnesium if they had increased biomass with MgSO4 supplementation relative to no 
supplementation. The ΔglnA mutant, highlighted in bold, did not respond. Growth defects and magnitudes 
of the effects are not reflected here. 
 
 
Figure 49. A ΔglnA Mutant Does Not Respond to Magnesium Unless Supplemented with 
Glutamine. Wild-type (WT) E. coli cells (strain BW25113) (circles) or an isogenic glnA mutant 
(triangles or squares [see below]) were aerated in TB7-glucose alone (open symbols) or with 1 
mM MgSO4 (closed symbols). The glnA mutant cells were supplemented with 1.4 g/liter 
glutamine (triangles) or left untreated (squares). 
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Table 7. Mutants Related to glnA That Lose the Magnesium Effect a 
Responded to magnesium b No Response c 
ybaS guaA 
yneH purF 
asnB purl 
hisH carB 
trpE carA 
crr ptsH 
ptsG ptsI 
a Mutants were grown in buffered tryptone broth supplemented with 0.4% glucose alone or with 1 mM 
MgSO4 for 24 h. Biomass was determined by OD600 measurements.  
b By 9 h of growth, mutants that had increased biomass with magnesium supplementation were considered 
responders. 
c Mutants in bold did not respond even after 24 h; other mutants responded between 9 and 24 h. 
 
Discussion 
During growth on buffered, peptide-based media (e.g., TB7) supplemented with a sugar (e.g., 
glucose), cultures of E. coli entered stationary phase prior to complete consumption of the sugar. 
The majority of the sugar was consumed after the culture stopped growing. This behavior 
provides a simple explanation for why protein acetylation occurs primarily during stationary 
phase, because that is when AcP, the major acetyl donor in E. coli (56, 57), is produced as an 
intermediate of the acetate fermentation pathway (513). When I supplemented TB7/glucose with 
magnesium, exponential growth was extended, resulting in consumption of glucose prior to entry 
into stationary phase, increased biomass, and decreased protein acetylation. I observed the same 
general behavior in other peptide-based media containing glucose and in two other bacterial 
species, Vibrio fischeri and Bacillus subtilis. Collectively, these results further our understanding 
of bacterial growth in complex media and enable us to control global acetylation levels in E. coli. 
In Gram-negative bacteria such as E. coli, magnesium is involved in stabilization of 
membrane phospholipids, lipopolysaccharide, polyphosphate compounds like DNA and RNA, 
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and the ribosome (410-412). Magnesium is also required to make ATP biologically active and 
participates in catalysis of certain enzymatic reactions through either direct or indirect 
mechanisms (514, 515). Almost half of total magnesium is found associated with NTPs 
(primarily ATP) (410), approximately one third is associated with the cell wall (412), and the 
remaining bound to various molecules or free in the cytoplasm. Almost a quarter of this 
cytoplasmic magnesium is thought to stabilize ribosomes (413). As such, magnesium deprivation 
can result in cessation of translation due to dissociation of ribosomes (413). In the magnesium-
starved conditions found in complex peptide-based media, it would not be surprising for 
ribosome control to be a mechanism by which cells cease growth and division. 
Hiroshi Nikaido proposed that the amount of magnesium in LB medium is not sufficient to 
achieve the maximum possible cell growth (516). LB contains between 30-200 M magnesium. 
In contrast, the magnesium concentration is 528 M in MOPS medium, a defined minimal 
medium that avoids the excess of any one ionic species (517). Our data suggests that magnesium 
is limiting in LB. A minor increase in growth yield was achieved in unbuffered LB supplemented 
with magnesium, while buffered LB produced a much more pronounced effect. The results were 
similar for TB, where the addition of magnesium produced a minor effect that was enhanced 
upon buffering. Likely, yeast extract provides LB with extra carbon, which allows for increased 
growth upon magnesium supplementation. However, when both carbon and magnesium were 
added together to buffered or unbuffered TB or LB, we observed a substantial increase in the cell 
yield, which then becomes limited due to some other factor(s). 
LB medium has been reported to be limited for carbon by Sezonov and coworkers (518). In 
that study, glucose supplementation of cell-free, spent LB medium was shown to support further 
cell growth upon re-inoculation with E. coli. I observed that magnesium supplementation to LB 
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or LB7 was able to permit additional growth, while glucose addition did not. The differences 
between this study and that of Sezonov and coworkers may be due to possible variation in 
different preparations of LB. LB can vary between different tryptone and yeast extract 
preparations from different companies. Thus, our LB medium may have contained a higher 
amount of carbon, creating a more balanced carbon/magnesium ratio, whereas their LB medium 
may have been relatively more magnesium-rich. 
In an attempt to find genes that may mediate the magnesium-dependent growth yield 
increase, I sought mutants that did not respond to added magnesium. I identified that a ΔglnA 
mutant did not respond to magnesium and determined the mutant did not respond because it is a 
glutamine auxotroph (512). Glutamine is the scarcest amino acid in tryptone at 0.1% (511); 
supplementation of TB7 with glutamine permitted the ΔglnA mutant to respond to magnesium. 
Glutamine is a required precursor for both protein biosynthesis and nucleotide biosynthesis. 
Presumably, TB7/glucose does not contain sufficient glutamine in the ΔglnA mutant for both 
needs, and thus its growth was limited by glutamine rather than by magnesium. Supporting this 
contention, I found that genes required for nucleotide biosynthesis downstream of glutamine also 
could not respond to magnesium. Would this have been true for other amino acid auxotrophs? 
Presumably not, because the other amino acids are present in much higher concentrations than 
glutamine in tryptone. 
The magnesium-dependent biomass increase was not exclusive to E. coli but also found to 
occur in Bacillus subtilis, a Gram-positive bacterium, and Vibrio fischeri, another Gram-negative 
bacterium. Both achieved higher optical density when magnesium was supplemented to 
TB7/glucose. I predict that magnesium limits growth for multiple bacteria in peptide-based 
media. Interestingly, V. fischeri achieved increased optical density from magnesium 
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supplementation even without the additional glucose. This suggests the possibility that V. fischeri 
may be able to more efficiently utilize amino acids for growth compared to E. coli or B. subtilis, 
or that V. fischeri simply requires more magnesium for growth. O’Shea and coworkers reported 
that V. fischeri grown in TBS (1% tryptone with 342 mM NaCl) did not benefit from addition of 
MgSO4, but did benefit from KCl (519). As I utilized TBS7, which is the same medium but 
buffered with potassium phosphate, our results suggest that V. fischeri may experience potassium 
limitation, then magnesium limitation, and finally carbon limitation in TBS. This need for high 
magnesium may reflect the naturally high magnesium concentration (~50 mM) of seawater in 
which V. fischeri lives (519).  
I conclude with the following two observations. First, there is hidden potential in peptide-
based media. The addition of excess carbon and magnesium can increase the final cell density 
anywhere from 2-fold to 17-fold. The addition of magnesium alone could also increase the final 
cell densities. Buffering the culture is important to ensure the medium does not become overly 
acidic or alkaline due to the consumption of glucose and amino acids, respectively. Second, we 
can now tune the level of acetylation in cultures without using genetic manipulation. Those who 
use E. coli for recombinant protein production may benefit most from this work. Each acetylated 
isoform of a recombinant protein has the potential to have different biological implications. To 
reduce the number of acetylated isoforms, excess carbon should be avoided (520), and the 
growth medium should be buffered and supplemented with magnesium. 
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